{"id": 44410045, "time": "2025-03-20 00:36:33", "headline": "Jabil Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["JBL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44410045/jabil-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 44410058, "time": "2025-03-20 00:42:26", "headline": "Accenture, FedEx And 3 Stocks To Watch Heading Into Thursday", "summary": " ", "symbols": ["ACN", "FDX", "JBL", "MCHP", "MU"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44410058/accenture-fedex-and-3-stocks-to-watch-heading-into-thursday", "tags": []}
{"id": 44410070, "time": "2025-03-20 00:43:50", "headline": "Reported Earlier, Australia Employment Change For February -52.8K Vs. 30.8K Est.; 30.5K (Revised) Prior", "summary": "", "symbols": ["EWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410070/reported-earlier-australia-employment-change-for-february-52-8k-vs-30-8k-est-30-5", "tags": []}
{"id": 44410073, "time": "2025-03-20 00:44:29", "headline": "Reported Earlier, Australia Full Employment Change For February -35.7K Vs. 36.9K (Revised) Prior", "summary": "", "symbols": ["EWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410073/reported-earlier-australia-full-employment-change-for-february-35-7k-vs-36-9k-rev", "tags": []}
{"id": 44410074, "time": "2025-03-20 00:44:45", "headline": "Reported Earlier, Australia Unemployment Rate For February Unchanged At 4.1%", "summary": "", "symbols": ["EWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410074/reported-earlier-australia-unemployment-rate-for-february-unchanged-at-4-1", "tags": []}
{"id": 44410075, "time": "2025-03-20 00:45:05", "headline": "Reported Earlier, China Loan Prime Rate 5Y For March Unchanged At 3.60%", "summary": "", "symbols": ["FXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410075/reported-earlier-china-loan-prime-rate-5y-for-march-unchanged-at-3-60", "tags": []}
{"id": 44410126, "time": "2025-03-20 00:45:27", "headline": "Reported Earlier, People's Bank of China Loan Prime Rate Unchanged At 3.10%", "summary": "", "symbols": ["FXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410126/reported-earlier-peoples-bank-of-china-loan-prime-rate-unchanged-at-3-10", "tags": []}
{"id": 44410136, "time": "2025-03-20 00:47:47", "headline": "S&P 500 Surges Over 1% Following Fed Decision: Investor Fear Eases, Greed Index Remains In 'Extreme Fear' Zone", "summary": " ", "symbols": ["ACN", "BA", "FDX", "MU", "NVDA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/03/44410136/sp-500-surges-over-1-following-fed-decision-investor-fear-eases-greed-index-remains-in-extreme-fear-zone", "tags": []}
{"id": 44410153, "time": "2025-03-20 00:53:37", "headline": "ZEEKR Intelligent Tech Q4 2024 Adj EPADS $(0.49) Misses $(0.04) Estimate, Sales $3.12B Miss $3.18B Estimate", "summary": "", "symbols": ["ZK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410153/zeekr-intelligent-tech-q4-2024-adj-epads-0-49-misses-0-04-estimate-sales-3-12b-miss-3-18b-estimate", "tags": []}
{"id": 44410156, "time": "2025-03-20 00:56:46", "headline": "ZEEKR's Q4 Total Vehicle Deliveries Rose 99.8% Year-Over-Year To 79,250 Units, And 2024 Deliveries Climbed 87.2% To 222,123 Units", "summary": "", "symbols": ["ZK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410156/zeekrs-q4-total-vehicle-deliveries-rose-99-8-year-over-year-to-79-250-units-and-2024-deliveries-cli", "tags": []}
{"id": 44410233, "time": "2025-03-20 01:20:21", "headline": "Nvidia Stock Slide Signals Time to Reposition, Says Wealth Manager Michael Landsberg: 'I Wouldn't Buy Tech Here On The Dip'", "summary": "Wealth manager Michael Landsberg warned that Nvidia&#39;s recent stock slide signals it&#39;s time to scale back on tech, arguing the AI trade is overcrowded and vulnerable amid slowing growth and tariff concerns, despite continued bullish analyst sentiment.", "symbols": ["NVDA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/25/03/44410233/wealth-manager-michael-landsberg-says-nvidias-slide-signals-time-to-reposition-i-wouldnt-buy-tech-here-on-the-dip", "tags": []}
{"id": 44410262, "time": "2025-03-20 01:31:09", "headline": "Bitcoin's Crisis Paradox Decoded: Bitwise CIO Explains 'Dip Then Rip' Phenomenon", "summary": "Bitwise\u00a0Chief Investment Officer\u00a0Matt Hougan explained Bitcoin\u2019s (CRYPTO: BTC) often contradictory behavior during market crises, despite its narrative as an inflation hedge.", "symbols": ["BLK", "BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/03/44410262/why-bitcoin-pulls-back-and-then-gains-after-economic-uncertainties-like-tariffsbitwise-cio-explains-dip-then-rip-phenomenon", "tags": []}
{"id": 44410288, "time": "2025-03-20 01:42:45", "headline": "111 Q4 EPS $(0.04) Up From $(0.80) YoY, Sales $527.14M Down From $578.69M YoY", "summary": "", "symbols": ["YI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410288/111-q4-eps-0-04-up-from-0-80-yoy-sales-527-14m-down-from-578-69m-yoy", "tags": ["earnings"]}
{"id": 44410350, "time": "2025-03-20 01:47:21", "headline": "JOYY Q4 2024 Adj EPS $1.77 Beats $1.18 Estimate, Sales $549.45M Miss $549.46M Estimate", "summary": "", "symbols": ["YY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410350/joyy-q4-2024-adj-eps-1-77-beats-1-18-estimate-sales-549-45m-miss-549-46m-estimate", "tags": ["earnings"]}
{"id": 44410363, "time": "2025-03-20 01:51:02", "headline": "JOYY Expects Q1 Net Revenues Between $482M-$490M Vs.$490.78M Consensus", "summary": "", "symbols": ["YY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410363/joyy-expects-q1-net-revenues-between-482m-490m-vs-490-78m-consensus", "tags": []}
{"id": 44410375, "time": "2025-03-20 01:59:53", "headline": "Reported Earlier, Akebia Therapeutics Prices $50M Public Offering Of 25M Common Shares At $2/Share", "summary": "", "symbols": ["AKBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44410375/reported-earlier-akebia-therapeutics-prices-50m-public-offering-of-25m-common-shares-at-2share", "tags": ["offering"]}
{"id": 44410465, "time": "2025-03-20 02:04:12", "headline": "Enerflex CEO Marc Rossiter Steps Down, CFO Preet Dhindsa Appointed Interim CEO; Reiterates 2025 Guidance", "summary": "", "symbols": ["EFXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44410465/enerflex-ceo-marc-rossiter-steps-down-cfo-preet-dhindsa-appointed-interim-ceo-reiterates-2025-guidan", "tags": ["analyst_other", "guidance", "management"]}
{"id": 44410470, "time": "2025-03-20 02:06:30", "headline": "SWK Holdings Q4 2024 GAAP EPS $0.54 Up From $0.23 YoY, Sales $12.36M Up From $9.89M YoY", "summary": "", "symbols": ["SWKH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410470/swk-holdings-q4-2024-gaap-eps-0-54-up-from-0-23-yoy-sales-12-36m-up-from-9-89m-yoy", "tags": ["earnings"]}
{"id": 44410479, "time": "2025-03-20 02:11:44", "headline": "Federal Reserve Brings Back 'Transitory' Inflation Amid Tariff War: Economist Mohamed El-Erian Calls It A 'Big Policy Mistake'", "summary": "Mohamed El-Erian criticizes Fed Chair Jerome Powell&#39;s use of the word &#34;transitory&#34; to describe the potential inflationary impact of tariffs.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44410479/federal-reserve-brings-back-transitory-inflation-amid-tariff-war-economist-mohamed-el-erian-calls-it-a-big-policy-mistake", "tags": []}
{"id": 44410525, "time": "2025-03-20 02:16:42", "headline": "Reported Earlier, Paratek Pharmaceuticals To Acquire Optinose In Deal Worth Up To $330M, Including $9 Cash And $5 In Milestone Cvrs Per Share", "summary": "", "symbols": ["OPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44410525/reported-earlier-paratek-pharmaceuticals-to-acquire-optinose-in-deal-worth-up-to-330m-including-9-ca", "tags": ["merger", "contract"]}
{"id": 44410537, "time": "2025-03-20 02:19:08", "headline": "Reported Earlier, Paratek Pharmaceuticals To Acquire Optinose In Deal Worth Up To $330M, Including $9 Cash And Potential $5/Share In Future Milestones", "summary": "", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44410537/reported-earlier-paratek-pharmaceuticals-to-acquire-optinose-in-deal-worth-up-to-330m-including-9-ca", "tags": ["merger", "contract"]}
{"id": 44410542, "time": "2025-03-20 02:26:59", "headline": "Sanofi To Acquire Dren Bio's DR-0201 For $600M Upfront, With Up To $1.3B In Milestone Payments", "summary": "", "symbols": ["SNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44410542/sanofi-to-acquire-dren-bios-dr-0201-for-600m-upfront-with-up-to-1-3b-in-milestone-payments", "tags": ["merger"]}
{"id": 44410584, "time": "2025-03-20 02:30:53", "headline": "Bitcoin's Recent Struggles Aside, Gold Hit A New All-Time High Shining A Bright Spotlight On These Precious Metal Cryptos That Rocked In 2025", "summary": "Gold prices hit an all-time high Wednesday as the Federal Reserve projected slower economic growth and higher inflation, boosting demand for the safe haven.\n\n\n\nWhat happened: Spot gold hit $3,056 per ounce earlier in the day before retracing slightly. Gold futures on the Commodity Exchange jumped to $3,060.20.", "symbols": ["BTCUSD", "PAXGUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/03/44410584/amid-bitcoins-decline-gold-backed-cryptos-have-returned-solid-gains-this-year", "tags": []}
{"id": 44410602, "time": "2025-03-20 02:38:00", "headline": "Elon Musk's Tesla Faces $1.4 Billion Discrepancy In Capital Expenditure: Report", "summary": "Tesla Inc. has a $1.4B gap between its expenditures and asset valuation, raising concerns over its financial strategies.", "symbols": ["TSLA"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/markets/equities/25/03/44410602/elon-musks-tesla-faces-1-4-billion-discrepancy-in-capital-expenditure-report", "tags": []}
{"id": 44410621, "time": "2025-03-20 02:40:51", "headline": "Pharming Doses First Patient In Phase II Trial of Leniolisib For CVID With Immune Dysregulation", "summary": "", "symbols": ["PHAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44410621/pharming-doses-first-patient-in-phase-ii-trial-of-leniolisib-for-cvid-with-immune-dysregulation", "tags": ["fda"]}
{"id": 44410750, "time": "2025-03-20 02:50:05", "headline": "Valneva FY Sales \u20ac169.60M Up From \u20ac153.7M YoY, Net Loss \u20ac12.2M Compared To Net Loss \u20ac101.4M YoY", "summary": "", "symbols": ["VALN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410750/valneva-fy-sales-169-60m-up-from-153-7m-yoy-net-loss-12-2m-compared-to-net-loss-101-4m-yoy", "tags": []}
{"id": 44410752, "time": "2025-03-20 02:52:31", "headline": "Pharming For 2025 Expects Product Sales Of \u20ac170M\u2013180M And Total Revenues Of \u20ac180M\u2013190M; Sees R&D Investments Of \u20ac90M\u2013100M", "summary": "", "symbols": ["VALN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410752/pharming-for-2025-expects-product-sales-of-170m-180m-and-total-revenues-of-180m-190m-sees-r-d-inves", "tags": []}
{"id": 44410763, "time": "2025-03-20 02:58:54", "headline": "VEON Q4 Sales $998.00M Beat $997.00M Estimate, EBITDA $408M Up From $367M YoY", "summary": "", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410763/veon-q4-sales-998-00m-beat-997-00m-estimate-ebitda-408m-up-from-367m-yoy", "tags": []}
{"id": 44410780, "time": "2025-03-20 03:00:35", "headline": "VEON Launches Second Phase Of Share Buyback Program With Up To $35M In ADS Repurchases", "summary": "", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44410780/veon-launches-second-phase-of-share-buyback-program-with-up-to-35m-in-ads-repurchases", "tags": ["buyback"]}
{"id": 44410798, "time": "2025-03-20 03:03:27", "headline": "VEON For 2025 Expects Underlying Local Currency Revenue YoY Growth Of 12%\u201314%, EBITDA Growth Of 13%\u201315%, And Capex Intensity Of 17%\u201319%", "summary": "", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44410798/veon-for-2025-expects-underlying-local-currency-revenue-yoy-growth-of-12-14-ebitda-growth-of-13-15-", "tags": ["earnings"]}
{"id": 44410846, "time": "2025-03-20 03:14:25", "headline": "U.K. Average Earnings Index +Bonus For January 5.8% Vs. 5.8% Est.; 6.1% (Revised) Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410846/u-k-average-earnings-index-bonus-for-january-5-8-vs-5-8-est-6-1-revised-prior", "tags": ["earnings"]}
{"id": 44410850, "time": "2025-03-20 03:14:51", "headline": "U.K. Claimant Count Change For February 44.2K Vs. 7.9K Est.; 2.8K (Revised) Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410850/u-k-claimant-count-change-for-february-44-2k-vs-7-9k-est-2-8k-revised-prior", "tags": []}
{"id": 44410851, "time": "2025-03-20 03:15:12", "headline": "U.K. Employment Change 3M/3M (MoM) For January 144K Vs. 95K Est.; 107K Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410851/u-k-employment-change-3m3m-mom-for-january-144k-vs-95k-est-107k-prior", "tags": []}
{"id": 44410880, "time": "2025-03-20 03:15:30", "headline": "U.K. Unemployment Rate For January 4.4% Vs. 4.4% Est.; 4.4% Prior", "summary": "", "symbols": ["EWU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44410880/u-k-unemployment-rate-for-january-4-4-vs-4-4-est-4-4-prior", "tags": []}
{"id": 44411005, "time": "2025-03-20 03:15:52", "headline": "Germany Producer Price Index (MoM) For February -0.2% Vs. 0.2% Est.; -0.1% Prior", "summary": "", "symbols": ["EWG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44411005/germany-producer-price-index-mom-for-february-0-2-vs-0-2-est-0-1-prior", "tags": []}
{"id": 44411007, "time": "2025-03-20 03:18:42", "headline": "Alvotech Acquires Xbrane's R&D Operations And Biosimilar Candidate XB003 In $27M Deal, Establishing Swedish Hub", "summary": "", "symbols": ["ALVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44411007/alvotech-acquires-xbranes-r-d-operations-and-biosimilar-candidate-xb003-in-27m-deal-establishing-swe", "tags": ["merger", "contract"]}
{"id": 44411029, "time": "2025-03-20 03:22:00", "headline": "Reported Earlier, HUTCHMED Presents SAVANNAH Trial Results For Savolitinib + TAGRISSO In MET-Driven NSCLC At European Lung Cancer Congress", "summary": "", "symbols": ["HCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411029/reported-earlier-hutchmed-presents-savannah-trial-results-for-savolitinib-tagrisso-in-met-driven-nsc", "tags": ["fda"]}
{"id": 44411032, "time": "2025-03-20 03:25:01", "headline": "MrBeast's New Challenges Are Absolutely Unhinged (Again): A Jet, A Jail, A Gym\u2014And $1.5 Million On The Line", "summary": "MrBeast has unveiled his wildest stunts yet\u2014offering $1.5 million across three extreme challenges involving 100 days in a jet, a jail, and a gym\u2014as he continues to blend high-stakes entertainment with viral philanthropy.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/25/03/44411032/mrbeasts-new-challenges-are-absolutely-unhinged-again-a-jet-a-jail-a-gym-and-1-5-million-on-the-line", "tags": ["offering"]}
{"id": 44411044, "time": "2025-03-20 03:28:42", "headline": "Reported Earlier, SoftBank Acquires Ampere For $6.5B, Taking Over Oracle And Carlyle Stakes in AI-Centric Semiconductor Firm", "summary": "", "symbols": ["CG", "ORCL", "SFTBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44411044/reported-earlier-softbank-acquires-ampere-for-6-5b-taking-over-oracle-and-carlyle-stakes-in-ai-centr", "tags": ["merger"]}
{"id": 44411045, "time": "2025-03-20 03:30:19", "headline": "North American Q4 2024 GAAP EPS C$1.00 Up From C$0.87 YoY, Sales C$305.59M Down From C$326.30M YoY", "summary": "", "symbols": ["NOA", "TSX:NOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44411045/north-american-q4-2024-gaap-eps-c-1-00-up-from-c-0-87-yoy-sales-c-305-59m-down-from-c-326-30m-yoy", "tags": ["earnings"]}
{"id": 44411065, "time": "2025-03-20 03:36:12", "headline": "Reported Earlier, COSCIENS Biopharma Flags Potential Delay In 2024 Annual Filings Amid Post-Merger Integration Challenges", "summary": "", "symbols": ["CSCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411065/reported-earlier-cosciens-biopharma-flags-potential-delay-in-2024-annual-filings-amid-post-merger-in", "tags": ["merger"]}
{"id": 44411069, "time": "2025-03-20 03:37:49", "headline": "Reported Earlier, i-80 Gold Completes Third-Party Processing Deals For Refractory And Oxide Material Through 2027", "summary": "", "symbols": ["IAUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411069/reported-earlier-i-80-gold-completes-third-party-processing-deals-for-refractory-and-oxide-material", "tags": []}
{"id": 44411079, "time": "2025-03-20 03:39:24", "headline": "Boeing Frustrations Reach Crescendo At Airline Founded By Warren Buffett Of India: 'We Just Don't Have Enough Aircraft To Fly'", "summary": "Akasa Air struggles with Boeing&#39;s delivery delays, leaving executives frustrated and pilots idle.", "symbols": ["BA", "LUV"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/03/44411079/boeing-frustrations-reach-crescendo-at-airline-founded-by-warren-buffett-of-india-we-just-dont-have-enough-aircraft-to-fly", "tags": []}
{"id": 44411282, "time": "2025-03-20 03:51:31", "headline": "Tesla Owners Call On Elon Musk For Advanced Security Features Amid Rising Vandalism: 'There Definitely Is Fear Right Now'", "summary": "In the wake of escalating vandalism incidents, Tesla (NASDAQ: TSLA) owners are calling on CEO Elon Musk to implement enhanced security features.", "symbols": ["TSLA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/03/44411282/tesla-owners-call-on-elon-musk-for-advanced-security-features-amid-rising-vandalism-there-definitely-is-fear-right-now", "tags": ["management"]}
{"id": 44411294, "time": "2025-03-20 03:53:59", "headline": "Amazon Takes On Used Car Market, Expands Its Auto Platform To 68 Markets: Report", "summary": "Amazon expands into used cars through the Amazon Autos platform. Aims to assist dealers and streamline the car-buying process for customers.", "symbols": ["AMZN", "TSLA"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/markets/equities/25/03/44411294/amazon-takes-on-used-car-market-expands-its-auto-platform-to-68-markets-report", "tags": []}
{"id": 44411341, "time": "2025-03-20 04:06:26", "headline": "Nokia Launches FastMile Gateway 4, Expanding Wi-Fi 7 FWA Portfolio With High-Speed 5G Connectivity", "summary": "", "symbols": ["NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411341/nokia-launches-fastmile-gateway-4-expanding-wi-fi-7-fwa-portfolio-with-high-speed-5g-connectivity", "tags": []}
{"id": 44411463, "time": "2025-03-20 04:32:14", "headline": "Earnings Scheduled For March 20, 2025", "summary": " ", "symbols": ["ACN", "ADAP", "ALAR", "AMPX", "ASO", "AUTL", "BBGI", "BRAG", "BZUN", "CAL", "CBUS", "CGTX", "CMC", "CURV", "DBI", "DRI", "DXLG", "FDS", "FDX", "FLUX", "GAMB", "GLUE", "HTHT", "IDN", "IFRX", "JBL", "KLC", "LAZR", "LE", "LEN", "MGNX", "MOGO", "MSGM", "MU", "NEUE", "NKE", "NRXS", "OUST", "PDD", "PL", "QUBT", "RKDA", "RMTI", "RWAY", "SCHL", "SCVL", "SKYE", "SNWV", "SPRY", "STRR", "TELA", "TITN", "TNON", "UAMY", "VALN", "VEEE", "VEON", "VXRT", "XLY", "XXII", "YI", "YRD", "ZK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/25/03/44411463/earnings-scheduled-for-march-20-2025", "tags": ["earnings"]}
{"id": 44411483, "time": "2025-03-20 04:36:13", "headline": "Jamie Dimon Says 'There's A Lot Of Turbulence Out There' Amid Trump Tariffs, Inflation Woes And Geopolitical Risks", "summary": "\u00a0Jamie Dimon, CEO of\u00a0JPMorgan Chase &amp; Co.\u00a0(NYSE: JPM), expressed his views on the current economic landscape, highlighting concerns over geopolitical tensions and potential tariff impacts.", "symbols": ["ADBE", "JPM"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/03/44411483/jamie-dimon-says-theres-a-lot-of-turbulence-out-there-amid-trump-tariffs-inflation-woes-and-geopolitical-risks", "tags": ["management"]}
{"id": 44411694, "time": "2025-03-20 05:06:58", "headline": "BMO Capital Reinstates Outperform on Affirm Holdings, Announces $69 Price Target", "summary": "", "symbols": ["AFRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411694/bmo-capital-reinstates-outperform-on-affirm-holdings-announces-69-price-target", "tags": []}
{"id": 44411733, "time": "2025-03-20 05:13:13", "headline": "Pebble Founder Echoes Mark Zuckerberg's Concerns, Slams Apple For Making It 'Nearly Impossible' To Build Smartwatches That Work With iPhone", "summary": "Eric Migicovsky, the creator of the original Pebble smartwatch, has said Apple Inc.&#39;s (NASDAQ:AAPL) iOS restrictions ", "symbols": ["AAPL", "GOOGL", "META"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/25/03/44411733/pebble-founder-echoes-mark-zuckerbergs-concerns-slams-apple-for-making-it-nearly-impossible-to-build-smartwatches-that-work-with-iphone", "tags": []}
{"id": 44411864, "time": "2025-03-20 05:17:10", "headline": "B. Riley Securities Initiates Coverage On ArriVent BioPharma with Buy Rating, Announces Price Target of $37", "summary": "", "symbols": ["AVBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411864/b-riley-securities-initiates-coverage-on-arrivent-biopharma-with-buy-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 44411873, "time": "2025-03-20 05:19:43", "headline": "Piper Sandler Upgrades Carvana to Overweight, Maintains Price Target to $225", "summary": "", "symbols": ["CVNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411873/piper-sandler-upgrades-carvana-to-overweight-maintains-price-target-to-225", "tags": ["analyst_up", "analyst_other"]}
{"id": 44411884, "time": "2025-03-20 05:25:13", "headline": "Piper Sandler Downgrades Rivian Automotive to Neutral, Lowers Price Target to $13", "summary": "", "symbols": ["RIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411884/piper-sandler-downgrades-rivian-automotive-to-neutral-lowers-price-target-to-13", "tags": ["analyst_down", "price_target_down"]}
{"id": 44411885, "time": "2025-03-20 05:25:18", "headline": "Qudian Q4 EPS $0.05 Up From $(0.08) YoY, Sales $7.20M Down From $8.98M YoY", "summary": "", "symbols": ["QD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44411885/qudian-q4-eps-0-05-up-from-0-08-yoy-sales-7-20m-down-from-8-98m-yoy", "tags": ["earnings"]}
{"id": 44411902, "time": "2025-03-20 05:29:11", "headline": "Aurora Mobile's GPTBots.ai Partners With ZANROO To Accelerate AI Adoption And Digital Transformation Across Southeast Asia", "summary": "", "symbols": ["JG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411902/aurora-mobiles-gptbots-ai-partners-with-zanroo-to-accelerate-ai-adoption-and-digital-transformation", "tags": ["contract"]}
{"id": 44411921, "time": "2025-03-20 05:31:19", "headline": "Oracle And Microsoft Expand Oracle Database@Azure With New Exascale And Base Services, Adding More Regional Availability", "summary": "", "symbols": ["MSFT", "ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411921/oracle-and-microsoft-expand-oracle-database-azure-with-new-exascale-and-base-services-adding-more-re", "tags": []}
{"id": 44411923, "time": "2025-03-20 05:32:10", "headline": "Tesla Expelled From Vancouver Auto Show Amid Security Concerns After Failing To 'Voluntarily Withdraw'", "summary": "Tesla Inc.\u00a0(NASDAQ: TSLA) has been expelled from the Vancouver International Auto Show by authorities due to safety concerns.", "symbols": ["TSLA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/03/44411923/tesla-expelled-from-vancouver-auto-show-amid-security-concerns-after-failing-to-voluntarily-withdraw", "tags": []}
{"id": 44411933, "time": "2025-03-20 05:33:10", "headline": "Oracle Unveils AI Agent Studio For Fusion Applications, Enabling Custom AI Agent Creation Across The Enterprise", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411933/oracle-unveils-ai-agent-studio-for-fusion-applications-enabling-custom-ai-agent-creation-across-the", "tags": []}
{"id": 44411935, "time": "2025-03-20 05:34:39", "headline": "Tesla Recalling 46,096 U.S. Cybertruck Vehicles Over Detached Panel Hazard; Tesla Service to Replace Cant Rail Assembly - NHTSA", "summary": "", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44411935/tesla-recalling-46-096-u-s-cybertruck-vehicles-over-detached-panel-hazard-tesla-service-to-replace-c", "tags": []}
{"id": 44411053, "time": "2025-03-20 03:33:23", "headline": "Anatomy Of A Correction: Magnificent 7 Fall Mirrors 2022 Pattern But It's Comparable To 2018: Caused By Repricing Of 'Animal Spirits' Explains Expert", "summary": "Data from Fidelity Investments reveals that the current market correction closely mirrors the 2022 correction but it is more like 2018.", "symbols": ["AAPL", "AMZN", "GOOG", "GOOGL", "META", "MSFT", "NVDA", "QQQ", "SPY", "TSLA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/03/44411053/anatomy-of-a-correction-magnificent-7-fall-mirrors-2022-pattern-but-its-comparable-to-2018-caused-by-repricing-of-animal-spirits-explains-expert", "tags": []}
{"id": 44412104, "time": "2025-03-20 05:46:28", "headline": "Piper Sandler Upgrades ACV Auctions to Overweight, Raises Price Target to $20", "summary": "", "symbols": ["ACVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412104/piper-sandler-upgrades-acv-auctions-to-overweight-raises-price-target-to-20", "tags": ["analyst_up", "price_target_up"]}
{"id": 44412122, "time": "2025-03-20 05:49:35", "headline": "Lloyds Banking Expands Collaboration With Oracle To Further Strengthen Its Customer Experience", "summary": "", "symbols": ["LYG", "ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412122/lloyds-banking-expands-collaboration-with-oracle-to-further-strengthen-its-customer-experience", "tags": []}
{"id": 44412148, "time": "2025-03-20 05:59:56", "headline": "Piper Sandler Maintains Overweight on Tesla, Lowers Price Target to $450", "summary": "", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412148/piper-sandler-maintains-overweight-on-tesla-lowers-price-target-to-450", "tags": ["analyst_other", "price_target_down"]}
{"id": 44412206, "time": "2025-03-20 06:01:30", "headline": "22nd Century Group Q4 2024 GAAP EPS $(10.59) Up From $(1.43 thousand) YoY, Sales $4.02M Miss $5.50M Estimate", "summary": "", "symbols": ["XXII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412206/22nd-century-group-q4-2024-gaap-eps-10-59-up-from-1-43-thousand-yoy-sales-4-02m-miss-5-50m-estimate", "tags": ["earnings"]}
{"id": 44412207, "time": "2025-03-20 06:01:38", "headline": "Baozun Q4 Sales RMB2.99B Beat RMB2.92B Estimate", "summary": "", "symbols": ["BZUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412207/baozun-q4-sales-rmb2-99b-beat-rmb2-92b-estimate", "tags": []}
{"id": 44412239, "time": "2025-03-20 06:02:54", "headline": "Rockwell Medical Q4 2024 Adj EPS $0.04 Beats $0.02 Estimate, Sales $24.70M Beat $23.65M Estimate", "summary": "", "symbols": ["RMTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412239/rockwell-medical-q4-2024-adj-eps-0-04-beats-0-02-estimate-sales-24-70m-beat-23-65m-estimate", "tags": ["earnings"]}
{"id": 44412240, "time": "2025-03-20 06:03:11", "headline": "QXO Agrees To Acquire Beacon Roofing Supply For $124.35 Per Share In Cash", "summary": "", "symbols": ["BECN", "QXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44412240/qxo-agrees-to-acquire-beacon-roofing-supply-for-124-35-per-share-in-cash", "tags": ["merger"]}
{"id": 44412274, "time": "2025-03-20 06:06:40", "headline": "Auddia Announces Addition Of New AI Model In Its Mobile Application: Launches New \"Binary AI Model\" In Faidr App, Enabling Users To Eliminate Ads And DJ Talk For Uninterrupted Music Listening", "summary": "", "symbols": ["AUUD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412274/auddia-announces-addition-of-new-ai-model-in-its-mobile-application-launches-new-binary-ai-model-in", "tags": []}
{"id": 44412297, "time": "2025-03-20 06:07:30", "headline": "Piper Sandler Downgrades Stellantis to Neutral, Lowers Price Target to $13", "summary": "", "symbols": ["STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412297/piper-sandler-downgrades-stellantis-to-neutral-lowers-price-target-to-13", "tags": ["analyst_down", "price_target_down"]}
{"id": 44412298, "time": "2025-03-20 06:07:39", "headline": "Baozun Q4 Adj EPADS $0.11 Up From $0.07 YoY, Sales $410.20M Up From $391.61M YoY", "summary": "", "symbols": ["BZUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412298/baozun-q4-adj-epads-0-11-up-from-0-07-yoy-sales-410-20m-up-from-391-61m-yoy", "tags": []}
{"id": 44412299, "time": "2025-03-20 06:08:10", "headline": "Needham Maintains Buy on Liquidia, Raises Price Target to $25", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412299/needham-maintains-buy-on-liquidia-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 44412301, "time": "2025-03-20 06:08:45", "headline": "FactSet Research Systems Q2 2025 Adj EPS $4.28 Beats $4.16 Estimate, Sales $570.66M Beat $570.61M Estimate", "summary": "", "symbols": ["FDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412301/factset-research-systems-q2-2025-adj-eps-4-28-beats-4-16-estimate-sales-570-66m-beat-570-61m-estima", "tags": ["earnings"]}
{"id": 44412319, "time": "2025-03-20 06:12:03", "headline": "HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $6 Price Target", "summary": "", "symbols": ["PGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412319/hc-wainwright-co-reiterates-buy-on-precigen-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 44412347, "time": "2025-03-20 06:12:44", "headline": "Shoe Carnival Q4 Adj $0.54 Beats $0.43 Estimate, Sales $262.94M Miss $274.21M Estimate", "summary": "", "symbols": ["SCVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412347/shoe-carnival-q4-adj-0-54-beats-0-43-estimate-sales-262-94m-miss-274-21m-estimate", "tags": []}
{"id": 44412348, "time": "2025-03-20 06:12:46", "headline": "FactSet 2025 Outlook: Raised GAAP Revenues Guidance To $2.305B-$2.325M (Up From $2.285B-$2.305B) Vs. $2.309B Est.; Reiterated Adjusted Operating Margin Of 36.0%-37.0%", "summary": "", "symbols": ["FDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412348/factset-2025-outlook-raised-gaap-revenues-guidance-to-2-305b-2-325m-up-from-2-285b-2-305b-vs-2-309b", "tags": ["guidance"]}
{"id": 44412369, "time": "2025-03-20 06:14:56", "headline": "Shoe Carnival Board of Directors Approve 11.1% Increase In Quarterly Dividend To $0.15", "summary": "", "symbols": ["SCVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412369/shoe-carnival-board-of-directors-approve-11-1-increase-in-quarterly-dividend-to-0-15", "tags": ["dividend"]}
{"id": 44412372, "time": "2025-03-20 06:15:00", "headline": "HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target", "summary": "", "symbols": ["SCPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412372/hc-wainwright-co-reiterates-buy-on-scpharmaceuticals-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 44412376, "time": "2025-03-20 06:15:26", "headline": "FactSet 2025 Outlook: Cuts GAAP EPS Guidance To $14.80-$15.40 (Down From $15.10-$15.70) Vs. $15.63 Est.; Reaffirms Adjusted EPS Of $16.80-$17.40 Vs. $17.16 Est.", "summary": "", "symbols": ["FDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412376/factset-2025-outlook-cuts-gaap-eps-guidance-to-14-80-15-40-down-from-15-10-15-70-vs-15-63-est-reaff", "tags": ["earnings", "guidance"]}
{"id": 44412536, "time": "2025-03-20 06:16:24", "headline": "HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $25 Price Target", "summary": "", "symbols": ["MDWD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412536/hc-wainwright-co-reiterates-buy-on-mediwound-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 44412537, "time": "2025-03-20 06:16:30", "headline": "Shoe Carnival Sees FY25 Revenue Of $1.15B - $1.23B Vs. $1.24B Est.", "summary": "", "symbols": ["SCVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412537/shoe-carnival-sees-fy25-revenue-of-1-15b-1-23b-vs-1-24b-est", "tags": ["earnings"]}
{"id": 44412540, "time": "2025-03-20 06:17:32", "headline": "Shoe Carnival Sees FY25 EPS Of $1.60 - $2.10 Vs. $3.32 Est.", "summary": "", "symbols": ["SCVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412540/shoe-carnival-sees-fy25-eps-of-1-60-2-10-vs-3-32-est", "tags": ["earnings"]}
{"id": 44412542, "time": "2025-03-20 06:18:13", "headline": "H World Group Q4 Adj $0.14 Misses $0.27 Estimate, Sales $825.00M Beat $798.17M Estimate", "summary": "", "symbols": ["HTHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412542/h-world-group-q4-adj-0-14-misses-0-27-estimate-sales-825-00m-beat-798-17m-estimate", "tags": []}
{"id": 44412543, "time": "2025-03-20 06:18:24", "headline": "HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $115 Price Target", "summary": "", "symbols": ["KRRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412543/hc-wainwright-co-reiterates-buy-on-korro-bio-maintains-115-price-target", "tags": ["analyst_other"]}
{"id": 44412554, "time": "2025-03-20 06:21:26", "headline": "HC Wainwright & Co. Reiterates Buy on Alumis, Lowers Price Target to $15", "summary": "", "symbols": ["ALMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412554/hc-wainwright-co-reiterates-buy-on-alumis-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 44412574, "time": "2025-03-20 06:23:59", "headline": "Nvidia CEO Jensen Huang Sees Humanoid Robots In Factories In Less Than 5 Years: 'I Think It's Pretty Good Economics'", "summary": "Nvidia CEO Jensen Huang has projected the widespread deployment of humanoid robots in manufacturing units in the next five years.", "symbols": ["NVDA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/03/44412574/nvidia-ceo-jensen-huang-sees-humanoid-robots-in-factories-in-less-than-5-years", "tags": ["management"]}
{"id": 44412589, "time": "2025-03-20 06:26:01", "headline": "HC Wainwright & Co. Reiterates Buy on Capricor Therapeutics, Maintains $77 Price Target", "summary": "", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412589/hc-wainwright-co-reiterates-buy-on-capricor-therapeutics-maintains-77-price-target", "tags": ["analyst_other"]}
{"id": 44412590, "time": "2025-03-20 06:26:09", "headline": "RWE reported Q4 Adj EPS $0.97, Sales $8.83B", "summary": "", "symbols": ["RWEOY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412590/rwe-reported-q4-adj-eps-0-97-sales-8-83b", "tags": ["earnings"]}
{"id": 44412591, "time": "2025-03-20 06:26:59", "headline": "Yiren Digital Q4 GAAP EPS $0.52 Down From $0.91 YoY, Sales $198.95M Up From $179.48M YoY", "summary": "", "symbols": ["YRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412591/yiren-digital-q4-gaap-eps-0-52-down-from-0-91-yoy-sales-198-95m-up-from-179-48m-yoy", "tags": ["earnings"]}
{"id": 44412592, "time": "2025-03-20 06:27:00", "headline": "Alvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&D Deal", "summary": "Alvotech acquires Xbrane&#39;s R&amp;D operations and biosimilar candidate for SEK 275 million, enhancing development capabilities and expanding into Sweden.", "symbols": ["ALVO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/mid-cap/25/03/44412592/alvotech-strengthens-biosimilar-portfolio-with-27-million-xbrane-rd-deal", "tags": ["merger", "contract"]}
{"id": 44412607, "time": "2025-03-20 06:28:59", "headline": "H World Expects Q1 2025 Revenue Growth To Be In The Range Of 0%-4%, For FY25 H World Expects Revenue Growth In The Range Of 2%-6%", "summary": "", "symbols": ["HTHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412607/h-world-expects-q1-2025-revenue-growth-to-be-in-the-range-of-0-4-for-fy25-h-world-expects-revenue-gr", "tags": ["earnings"]}
{"id": 44412627, "time": "2025-03-20 06:30:06", "headline": "Raymond James Upgrades GDS Holdings to Strong Buy, Maintains Price Target to $53", "summary": "", "symbols": ["GDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412627/raymond-james-upgrades-gds-holdings-to-strong-buy-maintains-price-target-to-53", "tags": ["analyst_up", "analyst_other"]}
{"id": 44412635, "time": "2025-03-20 06:30:24", "headline": "HC Wainwright & Co. Reiterates Buy on Liquidia, Maintains $29 Price Target", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412635/hc-wainwright-co-reiterates-buy-on-liquidia-maintains-29-price-target", "tags": ["analyst_other"]}
{"id": 44412636, "time": "2025-03-20 06:30:26", "headline": "H World Expects To Open Around 2,300 Hotels And Close Around 600 Hotels In FY25", "summary": "", "symbols": ["HTHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412636/h-world-expects-to-open-around-2-300-hotels-and-close-around-600-hotels-in-fy25", "tags": []}
{"id": 44412658, "time": "2025-03-20 06:32:24", "headline": "B of A Securities Maintains Buy on Immunovant, Lowers Price Target to $33", "summary": "", "symbols": ["IMVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412658/b-of-a-securities-maintains-buy-on-immunovant-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 44412661, "time": "2025-03-20 06:33:35", "headline": "PDD Holdings Q4 Adj $2.76 Beats $2.56 Estimate, Sales $15.15M Miss $15.68B Estimate", "summary": "", "symbols": ["PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412661/pdd-holdings-q4-adj-2-76-beats-2-56-estimate-sales-15-15m-miss-15-68b-estimate", "tags": []}
{"id": 44412662, "time": "2025-03-20 06:33:43", "headline": "B of A Securities Maintains Buy on Progressive, Lowers Price Target to $300", "summary": "", "symbols": ["PGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412662/b-of-a-securities-maintains-buy-on-progressive-lowers-price-target-to-300", "tags": ["analyst_other", "price_target_down"]}
{"id": 44412663, "time": "2025-03-20 06:33:44", "headline": "HC Wainwright & Co. Reiterates Buy on PMV Pharma, Maintains $5 Price Target", "summary": "", "symbols": ["PMVP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412663/hc-wainwright-co-reiterates-buy-on-pmv-pharma-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 44412664, "time": "2025-03-20 06:34:16", "headline": "SoundThinking And NYPD Extend Partnership With $43M Deal For Investigative And Resource Management Software", "summary": "", "symbols": ["SSTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412664/soundthinking-and-nypd-extend-partnership-with-43m-deal-for-investigative-and-resource-management-so", "tags": ["contract"]}
{"id": 44412665, "time": "2025-03-20 06:34:52", "headline": "Gold Royalty Q4 2024 Adjusted EPS $(0.02) Down From $0.01 YoY, Sales $3.355M Up From $1.016M YoY", "summary": "", "symbols": ["GROY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412665/gold-royalty-q4-2024-adjusted-eps-0-02-down-from-0-01-yoy-sales-3-355m-up-from-1-016m-yoy", "tags": ["earnings"]}
{"id": 44412671, "time": "2025-03-20 06:35:34", "headline": "HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target", "summary": "", "symbols": ["NRXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412671/hc-wainwright-co-reiterates-buy-on-nrx-pharmaceuticals-maintains-19-price-target", "tags": ["analyst_other"]}
{"id": 44412672, "time": "2025-03-20 06:35:47", "headline": "B of A Securities Maintains Buy on General Mills, Lowers Price Target to $68", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412672/b-of-a-securities-maintains-buy-on-general-mills-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 44412128, "time": "2025-03-20 05:53:33", "headline": "US Stocks Likely To Open Lower After Fed Decision: Any Pullback In Equities 'Offers An Opportunity,' Says Expert", "summary": "U.S. stock futures rose on Thursday following the Federal Open Market Committee&#39;s decision on Wednesday calling inflation &#39;transitory&#39;.", "symbols": ["ACN", "AGMH", "BA", "FDX", "JBL", "MCHP", "MU", "NVDA", "OPTN", "QQQ", "SPY", "VRPX", "ZCAR"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/03/44412128/us-stocks-likely-to-open-higher-as-fed-says-tariff-induced-inflation-will-be-transitory-any-pullback-in-equities-offers-an-opportunity-says-expert", "tags": []}
{"id": 44412679, "time": "2025-03-20 06:37:09", "headline": "Gold Royalty Expects Total GEOs To Increase To 5,700-7,000 In 2025", "summary": "", "symbols": ["GROY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412679/gold-royalty-expects-total-geos-to-increase-to-5-700-7-000-in-2025", "tags": []}
{"id": 44412692, "time": "2025-03-20 06:39:55", "headline": "CORRECTION: 22nd Century Group Q4 2024 GAAP EPS $(10.59) Down From $(1,413) YoY, Sales $4.02M Miss $5.50M Estimate", "summary": "", "symbols": ["XXII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412692/correction-22nd-century-group-q4-2024-gaap-eps-10-59-down-from-1-413-yoy-sales-4-02m-miss-5-50m-est", "tags": ["earnings"]}
{"id": 44412694, "time": "2025-03-20 06:40:20", "headline": "Needham Reiterates Buy on Vertex, Maintains $60 Price Target", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412694/needham-reiterates-buy-on-vertex-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 44412702, "time": "2025-03-20 06:42:12", "headline": "Needham Maintains Buy on Sportradar Gr, Raises Price Target to $27", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412702/needham-maintains-buy-on-sportradar-gr-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 44412707, "time": "2025-03-20 06:42:59", "headline": "CORRECTION: Qudian Q4 Adj EPS $(0.05) Up From $(0.08) YoY, Sales $7.16M Down From $8.98M YoY", "summary": "", "symbols": ["QD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412707/correction-qudian-q4-adj-eps-0-05-up-from-0-08-yoy-sales-7-16m-down-from-8-98m-yoy", "tags": ["earnings"]}
{"id": 44412708, "time": "2025-03-20 06:43:02", "headline": "Accenture Q2 2025 GAAP EPS $2.82 Beats $2.81 Estimate, Sales $16.66B Beat $16.62B Estimate", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412708/accenture-q2-2025-gaap-eps-2-82-beats-2-81-estimate-sales-16-66b-beat-16-62b-estimate", "tags": ["earnings"]}
{"id": 44412715, "time": "2025-03-20 06:44:32", "headline": "Goldman Sachs Initiates Coverage On Amentum Holdings with Neutral Rating, Announces Price Target of $21", "summary": "", "symbols": ["AMTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412715/goldman-sachs-initiates-coverage-on-amentum-holdings-with-neutral-rating-announces-price-target-of-2", "tags": ["analyst_init"]}
{"id": 44412725, "time": "2025-03-20 06:45:47", "headline": "Needham Reiterates Buy on CyberArk Software, Maintains $480 Price Target", "summary": "", "symbols": ["CYBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412725/needham-reiterates-buy-on-cyberark-software-maintains-480-price-target", "tags": ["analyst_other"]}
{"id": 44412923, "time": "2025-03-20 06:46:51", "headline": "Lands' End Q4 2024 Adj EPS $0.57 Misses $0.58 Estimate, Sales $441.66M Miss $458.69M Estimate", "summary": "", "symbols": ["LE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412923/lands-end-q4-2024-adj-eps-0-57-misses-0-58-estimate-sales-441-66m-miss-458-69m-estimate", "tags": ["earnings"]}
{"id": 44412925, "time": "2025-03-20 06:47:03", "headline": "Accenture Narrows FY25 Revenue Growth Outlook To 5%-7% In Local Currency, Sees FY25 Diluted EPS $12.55-$12.79 vs $12.90 Est.", "summary": "", "symbols": ["ACN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412925/accenture-narrows-fy25-revenue-growth-outlook-to-5-7-in-local-currency-sees-fy25-diluted-eps-12-55-1", "tags": ["earnings", "guidance", "offering"]}
{"id": 44412927, "time": "2025-03-20 06:47:55", "headline": "Needham Reiterates Buy on Alcon, Maintains $107 Price Target", "summary": "", "symbols": ["ALC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412927/needham-reiterates-buy-on-alcon-maintains-107-price-target", "tags": ["analyst_other"]}
{"id": 44412928, "time": "2025-03-20 06:47:59", "headline": "Caleres Q4 2024 Adj EPS $0.33 Beats $0.24 Estimate, Sales $639.23M Miss $653.86M Estimate", "summary": "", "symbols": ["CAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412928/caleres-q4-2024-adj-eps-0-33-beats-0-24-estimate-sales-639-23m-miss-653-86m-estimate", "tags": ["earnings"]}
{"id": 44412930, "time": "2025-03-20 06:48:51", "headline": "The GEO Group Entered Into A Contract With U.S. Immigration And Customs Enforcement For The Immediate Activation Of A Federal Immigration Processing Center At GEO-Owned, 1,800-bed North Lake Facility In Baldwin, Michigan, GEO Expects The Contract To Generate Over $70M In Annualized Revenues In The First Full Year Of Operations, With Margins Consistent With Geo's Company-owned Secure Services Facilities", "summary": "", "symbols": ["GEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412930/the-geo-group-entered-into-a-contract-with-u-s-immigration-and-customs-enforcement-for-the-immediate", "tags": ["contract"]}
{"id": 44412937, "time": "2025-03-20 06:49:08", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Progressive, Raises Price Target to $300", "summary": "", "symbols": ["PGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412937/keefe-bruyette-woods-maintains-outperform-on-progressive-raises-price-target-to-300", "tags": ["analyst_other", "price_target_up"]}
{"id": 44412948, "time": "2025-03-20 06:49:12", "headline": "Lands' End Expects Q1 Net Revenue Of $260M - $290M, Est $289.57M; Adjusted EPS Of $(0.22) - $(0.13), Est $(0.15)", "summary": "", "symbols": ["LE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412948/lands-end-expects-q1-net-revenue-of-260m-290m-est-289-57m-adjusted-eps-of-0-22-0-13-est-0-15", "tags": ["earnings"]}
{"id": 44412949, "time": "2025-03-20 06:49:23", "headline": "China And Europe Markets Slide; Dollar Up 0.4%, Gold Steady Near Record Highs - Global Markets Today While US Slept", "summary": "U.S. markets rose after Fed holds rates steady and projects slower growth, higher inflation. Dow, S&amp;P 500, Nasdaq post gains. Markets react to tariffs and inflation uncertainty.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/forex/25/03/44412949/china-and-europe-markets-slide-dollar-up-0-4-gold-steady-near-record-highs-global-markets-today-while-us-slept", "tags": []}
{"id": 44412950, "time": "2025-03-20 06:49:22", "headline": "Commercial Metals Q2 2025 Adj EPS $0.26 Misses $0.30 Estimate, Sales $1.75B Inline", "summary": "", "symbols": ["CMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412950/commercial-metals-q2-2025-adj-eps-0-26-misses-0-30-estimate-sales-1-75b-inline", "tags": ["earnings"]}
{"id": 44412951, "time": "2025-03-20 06:49:23", "headline": "Designer Brands Q4 2024 Adj. EPS $(0.44) Beats $(0.49) Estimate, Sales $713.572M Miss $719.323M Estimate", "summary": "", "symbols": ["DBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44412951/designer-brands-q4-2024-adj-eps-0-44-beats-0-49-estimate-sales-713-572m-miss-719-323m-estimate", "tags": ["earnings"]}
{"id": 44412967, "time": "2025-03-20 06:49:52", "headline": "Benchmark Reiterates Buy on NVIDIA, Maintains $190 Price Target", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412967/benchmark-reiterates-buy-on-nvidia-maintains-190-price-target", "tags": ["analyst_other"]}
{"id": 44412983, "time": "2025-03-20 06:50:39", "headline": "Lands' End Expects FY25 Net Revenue Of $1.33B - $1.45B, Est $1.407B; Adjusted EPS Of $0.48 - $0.86, Est $0.53", "summary": "", "symbols": ["LE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412983/lands-end-expects-fy25-net-revenue-of-1-33b-1-45b-est-1-407b-adjusted-eps-of-0-48-0-86-est-0-53", "tags": ["earnings"]}
{"id": 44412987, "time": "2025-03-20 06:50:54", "headline": "Morgan Stanley Assumes Abivax at Equal-Weight, Announces Price Target of $12", "summary": "", "symbols": ["ABVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412987/morgan-stanley-assumes-abivax-at-equal-weight-announces-price-target-of-12", "tags": []}
{"id": 44412994, "time": "2025-03-20 06:51:25", "headline": "BD Announces First Patient Treated In Investigational Device Exemption Trial Intended To Achieve FDA Premarket Approval For Use Of GalaFLEX LITE Scaffold In Breast Implant Revision Surgery", "summary": "", "symbols": ["BDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44412994/bd-announces-first-patient-treated-in-investigational-device-exemption-trial-intended-to-achieve-fda", "tags": ["fda"]}
{"id": 44413012, "time": "2025-03-20 06:52:12", "headline": "Stephens & Co. Reiterates Overweight on First Watch Restaurant Gr, Maintains $24 Price Target", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413012/stephens-co-reiterates-overweight-on-first-watch-restaurant-gr-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 44413036, "time": "2025-03-20 06:53:16", "headline": "Morgan Stanley Initiates Coverage On Celldex Therapeutics with Overweight Rating, Announces Price Target of $46", "summary": "", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413036/morgan-stanley-initiates-coverage-on-celldex-therapeutics-with-overweight-rating-announces-price-tar", "tags": ["analyst_init"]}
{"id": 44413043, "time": "2025-03-20 06:53:42", "headline": "Designer Brands Sees FY25 Diluted EPS Of $0.30-$0.50, Projects Net Sales Growth Of Low-single Digits", "summary": "", "symbols": ["DBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413043/designer-brands-sees-fy25-diluted-eps-of-0-30-0-50-projects-net-sales-growth-of-low-single-digits", "tags": ["earnings", "offering"]}
{"id": 44413053, "time": "2025-03-20 06:54:45", "headline": "Caleres 2025 Outlook: Expects Down 1% to Up 1% Sales, GAAP EPS Of $2.80\u2013$3.20 Vs. 3.99 Est.; For Q1 Sales Are Seen Down 5%\u20136% With EPS Of $0.35\u2013$0.40 Vs. $0.88 Est.", "summary": "", "symbols": ["CAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413053/caleres-2025-outlook-expects-down-1-to-up-1-sales-gaap-eps-of-2-80-3-20-vs-3-99-est-for-q1-sales-ar", "tags": ["earnings", "guidance"]}
{"id": 44413055, "time": "2025-03-20 06:54:57", "headline": "Morgan Stanley Maintains Overweight on Bloom Energy, Raises Price Target to $35", "summary": "", "symbols": ["BE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413055/morgan-stanley-maintains-overweight-on-bloom-energy-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 44413068, "time": "2025-03-20 06:56:05", "headline": "IREN Concluded Financial Statements For FY22-FY24 And Interim Statements For Three Months Ended Sept. 30, 2024 And Three & Six Months Ended Dec. 31, 2024 Should Be Amended To Reclassify Bitcoin Sale Proceeds As Investing Cash Flows ;", "summary": "", "symbols": ["IREN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413068/iren-concluded-financial-statements-for-fy22-fy24-and-interim-statements-for-three-months-ended-sept", "tags": []}
{"id": 44413084, "time": "2025-03-20 06:57:33", "headline": "NeueHealth Q4 2024 GAAP EPS $(7.41) Misses $(2.48) Estimate, Sales $232.638M Miss $251.930M Estimate", "summary": "", "symbols": ["NEUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413084/neuehealth-q4-2024-gaap-eps-7-41-misses-2-48-estimate-sales-232-638m-miss-251-930m-estimate", "tags": ["earnings"]}
{"id": 44413101, "time": "2025-03-20 07:00:03", "headline": "What's Going On Microchip Technology Stock Premarket on Thursday?", "summary": "Microchip Technology shares down premarket after announcing $1.35B public offering. Plans to use proceeds for capped call transactions and debt repayment.", "symbols": ["KNGZ", "MCHP", "XSD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/03/44413101/whats-going-on-microchip-technology-shares-premarket-on-thursday", "tags": ["why_moving", "offering"]}
{"id": 44413209, "time": "2025-03-20 07:02:02", "headline": "Destination XL Group Q4 2024 Adj EPS $0.02 Misses $0.03 Estimate, Sales $119.20M Miss $122.43M Estimate", "summary": "", "symbols": ["DXLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413209/destination-xl-group-q4-2024-adj-eps-0-02-misses-0-03-estimate-sales-119-20m-miss-122-43m-estimate", "tags": ["earnings"]}
{"id": 44413218, "time": "2025-03-20 07:02:16", "headline": "Darden Restaurants Q3 2025 EPS From Continuing Operations $2.76, Sales $3.158B Miss $3.215B Estimate", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413218/darden-restaurants-q3-2025-eps-from-continuing-operations-2-76-sales-3-158b-miss-3-215b-estimate", "tags": ["earnings"]}
{"id": 44413244, "time": "2025-03-20 07:03:03", "headline": "Titan Machinery Q4 Adj $(1.88) Misses $(0.62) Estimate, Sales $759.92M Beat $728.55M Estimate", "summary": "", "symbols": ["TITN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413244/titan-machinery-q4-adj-1-88-misses-0-62-estimate-sales-759-92m-beat-728-55m-estimate", "tags": []}
{"id": 44413246, "time": "2025-03-20 07:03:16", "headline": "Bragg Gaming Group Q4 Sales $29.00M Beat $27.39M Estimate", "summary": "", "symbols": ["BRAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413246/bragg-gaming-group-q4-sales-29-00m-beat-27-39m-estimate", "tags": []}
{"id": 44413248, "time": "2025-03-20 07:03:39", "headline": "Destination XL Expects Comparable Sales To Gradually Improve Over The Year, From  Low Double-digit Negative In Q1 To Single-digit Negative In Q2 And Return To Positive Comp Result In H2", "summary": "", "symbols": ["DXLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413248/destination-xl-expects-comparable-sales-to-gradually-improve-over-the-year-from-low-double-digit-neg", "tags": []}
{"id": 44413251, "time": "2025-03-20 07:03:58", "headline": "ARS Pharmaceuticals Q4 2024 GAAP EPS $0.48 May Not Be Comparable To $(0.14) Estimate, Sales $86.60M May Not Be Comparable To $15.82M Estimate", "summary": "", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413251/ars-pharmaceuticals-q4-2024-gaap-eps-0-48-may-not-be-comparable-to-0-14-estimate-sales-86-60m-may-n", "tags": ["earnings"]}
{"id": 44413252, "time": "2025-03-20 07:04:00", "headline": "Gambling.com Gr Q4 Adj $0.35 Beats $0.24 Estimate, Sales $35.31M Beat $35.14M Estimate", "summary": "", "symbols": ["GAMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413252/gambling-com-gr-q4-adj-0-35-beats-0-24-estimate-sales-35-31m-beat-35-14m-estimate", "tags": []}
{"id": 44413256, "time": "2025-03-20 07:04:35", "headline": "Zeekr Group Expands Through Geely Integration, Takes Controlling Interest In LYNK & CO And Issues Combined Financials", "summary": "", "symbols": ["ZK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413256/zeekr-group-expands-through-geely-integration-takes-controlling-interest-in-lynk-co-and-issues-combi", "tags": []}
{"id": 44413258, "time": "2025-03-20 07:04:51", "headline": "ARS Pharmaceuticals Says $314M In Cash, Cash Equivalents, And Short-term Investments At Year-end 2024, Supporting An Increased Investment In Commercialization In 2025 While Maintaining An Operating Runway Of At Least Three Years", "summary": "", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44413258/ars-pharmaceuticals-says-314m-in-cash-cash-equivalents-and-short-term-investments-at-year-end-202", "tags": []}
{"id": 44413259, "time": "2025-03-20 07:04:59", "headline": "Plug Power Says CEO Andy Marsh Has Committed To Accept 50% Of His Annual Salary In The Form Of Company Stock This Year", "summary": "", "symbols": ["PLUG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413259/plug-power-says-ceo-andy-marsh-has-committed-to-accept-50-of-his-annual-salary-in-the-form-of-compan", "tags": ["management"]}
{"id": 44413283, "time": "2025-03-20 07:05:14", "headline": "CORRECTION: Darden Restaurants Sees FY25 Sales ~$12.1B vs $12.092B Est., Sees FY25 Adj. EPS $9.45-$9.52 vs $9.48 Est.", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413283/correction-darden-restaurants-sees-fy25-sales-12-1b-vs-12-092b-est-sees-fy25-adj-eps-9-45-9-52-vs-9", "tags": ["earnings"]}
{"id": 44413286, "time": "2025-03-20 07:05:48", "headline": "Cognition Therapeutics FY 2024 EPS $(0.86) Misses $(0.76) Estimate", "summary": "", "symbols": ["CGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413286/cognition-therapeutics-fy-2024-eps-0-86-misses-0-76-estimate", "tags": ["earnings"]}
{"id": 44413287, "time": "2025-03-20 07:05:52", "headline": "Gambling.com Reaffirms FY25 Revenue Outlook Of $170M - $174M Vs. $167.76M Est.", "summary": "", "symbols": ["GAMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413287/gambling-com-reaffirms-fy25-revenue-outlook-of-170m-174m-vs-167-76m-est", "tags": ["earnings", "guidance"]}
{"id": 44413288, "time": "2025-03-20 07:05:56", "headline": "D-Wave Publishes New Research Paper Introducing Novel Blockchain Architecture That Uses Techniques From Its Quantum Supremacy Demonstration", "summary": "", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413288/d-wave-publishes-new-research-paper-introducing-novel-blockchain-architecture-that-uses-techniques-f", "tags": []}
{"id": 44413292, "time": "2025-03-20 07:06:46", "headline": "Beasley Broadcast Group Q4 EPS $(1.17); Sales $67.285M Up From $65.748M YoY", "summary": "", "symbols": ["BBGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413292/beasley-broadcast-group-q4-eps-1-17-sales-67-285m-up-from-65-748m-yoy", "tags": ["earnings"]}
{"id": 44413313, "time": "2025-03-20 07:07:15", "headline": "Laser Photonics Receives Two-System Order From Glaze Tool And Engineering, Terms Not Disclosed", "summary": "", "symbols": ["LASE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413313/laser-photonics-receives-two-system-order-from-glaze-tool-and-engineering-terms-not-disclosed", "tags": []}
{"id": 44413336, "time": "2025-03-20 07:07:55", "headline": "Bragg Gaming Group Sees 2025 Revenue Of EUR117.5M-EUR123.0M", "summary": "", "symbols": ["BRAG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413336/bragg-gaming-group-sees-2025-revenue-of-eur117-5m-eur123-0m", "tags": ["earnings"]}
{"id": 44413340, "time": "2025-03-20 07:08:27", "headline": "IonQ And Ansys Highlight Demonstration Showing LS-DYNA Applications Simulated Blood Pump Dynamics", "summary": "", "symbols": ["IONQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/03/44413340/ionq-and-ansys-highlight-demonstration-showing-ls-dyna-applications-simulated-blood-pump-dynamics", "tags": []}
{"id": 44413341, "time": "2025-03-20 07:08:45", "headline": "Adaptimmune Says 2024 Annual Report, Set To Be Filed On Monday, March 24, Will State That There Are Serious Concerns About The Company's Ability To Stay In Business, At The End Of 2024, Adaptimmune Had Total Liquidity Of $152M", "summary": "", "symbols": ["ADAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413341/adaptimmune-says-2024-annual-report-set-to-be-filed-on-monday-march-24-will-state-that-there-are-ser", "tags": []}
{"id": 44413346, "time": "2025-03-20 07:09:56", "headline": "Destination XL Says Not Providing FY25 Sales And Earnings Guidance, Citing Volatility Of The Market And Other Macro Uncertainties Such As Tariffs", "summary": "", "symbols": ["DXLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413346/destination-xl-says-not-providing-fy25-sales-and-earnings-guidance-citing-volatility-of-the-market-a", "tags": ["earnings", "guidance"]}
{"id": 44413362, "time": "2025-03-20 07:12:23", "headline": "Stifel Maintains Hold on Target, Lowers Price Target to $120", "summary": "", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413362/stifel-maintains-hold-on-target-lowers-price-target-to-120", "tags": ["analyst_other", "price_target_down"]}
{"id": 44413363, "time": "2025-03-20 07:12:27", "headline": "UnitedHealth's Optum Rx Plans To Align Payment Models More Closely To The Costs Pharmacies May Face Due To Manufacturer Pricing Actions", "summary": "", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413363/unitedhealths-optum-rx-plans-to-align-payment-models-more-closely-to-the-costs-pharmacies-may-face-d", "tags": []}
{"id": 44413380, "time": "2025-03-20 07:13:05", "headline": "EON Resources Signs Expanded Non-Binding LOI With Enstream Capital Management For $52.8M In A Revenue Sharing And Volumetric Funding Arrangement", "summary": "", "symbols": ["EQNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413380/eon-resources-signs-expanded-non-binding-loi-with-enstream-capital-management-for-52-8m-in-a-revenue", "tags": ["earnings"]}
{"id": 44413385, "time": "2025-03-20 07:13:22", "headline": "Baker Hughes Enters Multi-year Fully Integrated Completions Systems Contract With Petrobras", "summary": "", "symbols": ["BKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413385/baker-hughes-enters-multi-year-fully-integrated-completions-systems-contract-with-petrobras", "tags": ["contract"]}
{"id": 44413387, "time": "2025-03-20 07:13:32", "headline": "Paramount Says It Secured Approval From Oregon State Agencies For Proposed Technologies And Processes At Its Wholly Owned Grassy Mountain Gold Project", "summary": "", "symbols": ["PZG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413387/paramount-says-it-secured-approval-from-oregon-state-agencies-for-proposed-technologies-and-processe", "tags": []}
{"id": 44413388, "time": "2025-03-20 07:14:03", "headline": "Chardan Capital Maintains Buy on Regenxbio, Maintains $52 Price Target", "summary": "", "symbols": ["RGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413388/chardan-capital-maintains-buy-on-regenxbio-maintains-52-price-target", "tags": ["analyst_other"]}
{"id": 44413390, "time": "2025-03-20 07:14:12", "headline": "SolarBank Receives Approval From State Energy Research and Development Authority For $1.06M In Incentives For 3.26 MW Camillus Solar Project", "summary": "", "symbols": ["SUUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/25/03/44413390/solarbank-receives-approval-from-state-energy-research-and-development-authority-for-1-06m-in-incent", "tags": []}
{"id": 44413389, "time": "2025-03-20 07:14:20", "headline": "Top 3 Tech And Telecom That Could Lead To Your Biggest Gains This Month", "summary": " ", "symbols": ["CMLS", "PLTK", "TTD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44413389/top-3-tech-and-telecom-that-could-lead-to-your-biggest-gains-this-month", "tags": []}
{"id": 44413391, "time": "2025-03-20 07:14:25", "headline": "Stifel Maintains Hold on Walmart, Lowers Price Target to $93", "summary": "", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413391/stifel-maintains-hold-on-walmart-lowers-price-target-to-93", "tags": ["analyst_other", "price_target_down"]}
{"id": 44413404, "time": "2025-03-20 07:14:59", "headline": "Aurora Cannabis Reveals Discovery Of Novel Source Of Genetic Resistance Against Powdery Mildew, PM2, That Provides Strong Protection Against Pathogen In Cannabis Sativa", "summary": "", "symbols": ["ACB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413404/aurora-cannabis-reveals-discovery-of-novel-source-of-genetic-resistance-against-powdery-mildew-pm2-t", "tags": []}
{"id": 44413413, "time": "2025-03-20 07:15:16", "headline": "Autolus Therapeutics Q4 2024 GAAP EPS $(0.86) Misses $(0.20) Estimate", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413413/autolus-therapeutics-q4-2024-gaap-eps-0-86-misses-0-20-estimate", "tags": ["earnings"]}
{"id": 44413564, "time": "2025-03-20 07:16:21", "headline": "Precision BioSciences To Present Preclinical Safety And Efficacy Data For PBGENE-HBV At Global Hepatitis Summit 2025 On Mar. 21", "summary": "", "symbols": ["DTIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44413564/precision-biosciences-to-present-preclinical-safety-and-efficacy-data-for-pbgene-hbv-at-global-he", "tags": []}
{"id": 44413621, "time": "2025-03-20 07:16:51", "headline": "Chardan Capital Maintains Buy on Prime Medicine, Raises Price Target to $16", "summary": "", "symbols": ["PRME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413621/chardan-capital-maintains-buy-on-prime-medicine-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 44413623, "time": "2025-03-20 07:17:10", "headline": "Monte Rosa Therapeutics Reports Q4 Collaboration Revenue Of $60.647M, Exits Quarter With Cash And Equivalents Worth $377M", "summary": "", "symbols": ["GLUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413623/monte-rosa-therapeutics-reports-q4-collaboration-revenue-of-60-647m-exits-quarter-with-cash-and-equi", "tags": ["earnings"]}
{"id": 44413624, "time": "2025-03-20 07:17:16", "headline": "Clearside Biomedical Highlights CLS-AX Presentation At 2025 Wet AMD & Diabetic Eye Disease Summit", "summary": "", "symbols": ["CLSD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44413624/clearside-biomedical-highlights-cls-ax-presentation-at-2025-wet-amd-diabetic-eye-disease-summit", "tags": []}
{"id": 44413625, "time": "2025-03-20 07:17:43", "headline": "Stifel Maintains Buy on Costco Wholesale, Lowers Price Target to $1035", "summary": "", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413625/stifel-maintains-buy-on-costco-wholesale-lowers-price-target-to-1035", "tags": ["analyst_other", "price_target_down"]}
{"id": 44413626, "time": "2025-03-20 07:18:08", "headline": "Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY", "summary": "", "symbols": ["SION"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413626/sionna-therapeutics-q4-eps-3-38-up-from-3-93-yoy", "tags": ["earnings"]}
{"id": 44413639, "time": "2025-03-20 07:19:55", "headline": "Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target", "summary": "", "symbols": ["COYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413639/chardan-capital-maintains-buy-on-coya-therapeutics-maintains-14-price-target", "tags": ["analyst_other"]}
{"id": 44413671, "time": "2025-03-20 07:24:26", "headline": "Telsey Advisory Group Maintains Outperform on Williams-Sonoma, Lowers Price Target to $220", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413671/telsey-advisory-group-maintains-outperform-on-williams-sonoma-lowers-price-target-to-220", "tags": ["analyst_other", "price_target_down"]}
{"id": 44413730, "time": "2025-03-20 07:26:12", "headline": "Mogo Q4 Adj EPS $(0.01) , Sales $12.90M.", "summary": "", "symbols": ["MOGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413730/mogo-q4-adj-eps-0-01-sales-12-90m", "tags": ["earnings"]}
{"id": 44413738, "time": "2025-03-20 07:27:22", "headline": "Barinthus Biotherapeutics FY 2024 GAAP EPS $(1.55) Beats $(1.67) Estimate, Sales $14.97M Inline", "summary": "", "symbols": ["BRNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413738/barinthus-biotherapeutics-fy-2024-gaap-eps-1-55-beats-1-67-estimate-sales-14-97m-inline", "tags": ["earnings"]}
{"id": 44413739, "time": "2025-03-20 07:27:53", "headline": "Telsey Advisory Group Maintains Market Perform on Signet Jewelers, Raises Price Target to $62", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413739/telsey-advisory-group-maintains-market-perform-on-signet-jewelers-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 44413743, "time": "2025-03-20 07:28:41", "headline": "Morgan Stanley Maintains Equal-Weight on Five Below, Lowers Price Target to $110", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413743/morgan-stanley-maintains-equal-weight-on-five-below-lowers-price-target-to-110", "tags": ["analyst_other", "price_target_down"]}
{"id": 44413744, "time": "2025-03-20 07:28:57", "headline": "Barinthus Biotherapeutics Says As Of December 31, 2024 Cash, Cash Equivalents And Restricted Cash Was $112.4M That Is Expected To Provide Cash Runway Into 2027", "summary": "", "symbols": ["BRNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44413744/barinthus-biotherapeutics-says-as-of-december-31-2024-cash-cash-equivalents-and-restricted-cash-w", "tags": []}
{"id": 44413775, "time": "2025-03-20 07:30:12", "headline": "Morgan Stanley Maintains Equal-Weight on Williams-Sonoma, Lowers Price Target to $185", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413775/morgan-stanley-maintains-equal-weight-on-williams-sonoma-lowers-price-target-to-185", "tags": ["analyst_other", "price_target_down"]}
{"id": 44413803, "time": "2025-03-20 07:31:09", "headline": "Wall Street's Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 6% Dividend Yields", "summary": " ", "symbols": ["DKL", "EPD", "PAA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44413803/wall-streets-most-accurate-analysts-weigh-in-on-3-energy-stocks-with-over-6-dividend-yields-3", "tags": ["dividend"]}
{"id": 44413806, "time": "2025-03-20 07:31:24", "headline": "Telsey Advisory Group Maintains Outperform on Lululemon Athletica, Maintains $445 Price Target", "summary": "", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413806/telsey-advisory-group-maintains-outperform-on-lululemon-athletica-maintains-445-price-target", "tags": ["analyst_other"]}
{"id": 44413810, "time": "2025-03-20 07:31:33", "headline": "Morgan Stanley Maintains Equal-Weight on Ollie's Bargain Outlet, Raises Price Target to $118", "summary": "", "symbols": ["OLLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413810/morgan-stanley-maintains-equal-weight-on-ollies-bargain-outlet-raises-price-target-to-118", "tags": ["analyst_other", "price_target_up"]}
{"id": 44413824, "time": "2025-03-20 07:32:05", "headline": "Plus Therapeutics Announces FDA Accepted The Name REYOBIQ For Co.'s Lead Asset", "summary": "", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44413824/plus-therapeutics-announces-fda-accepted-the-name-reyobiq-for-co-s-lead-asset", "tags": ["fda"]}
{"id": 44413842, "time": "2025-03-20 07:33:27", "headline": "InflaRx FY 2024 GAAP EPS \u20ac(0.78) Beats \u20ac(0.95) Estimate, Sales \u20ac165.79K Miss \u20ac306.80K Estimate", "summary": "", "symbols": ["IFRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413842/inflarx-fy-2024-gaap-eps-0-78-beats-0-95-estimate-sales-165-79k-miss-306-80k-estimate", "tags": ["earnings"]}
{"id": 44413843, "time": "2025-03-20 07:34:03", "headline": "Eyenovia Enters Non-binding Letter Of Intent Contemplating Potential Reverse Merger Transaction With Betaliq; Proposed Transaction Assumes Value For Betaliq Of  $77M And Eyenovia Of $15M", "summary": "", "symbols": ["EYEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44413843/eyenovia-enters-non-binding-letter-of-intent-contemplating-potential-reverse-merger-transaction-with", "tags": ["merger"]}
{"id": 44413847, "time": "2025-03-20 07:34:12", "headline": "Rosenblatt Maintains Buy on Five9, Maintains $58 Price Target", "summary": "", "symbols": ["FIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413847/rosenblatt-maintains-buy-on-five9-maintains-58-price-target", "tags": ["analyst_other"]}
{"id": 44413848, "time": "2025-03-20 07:34:22", "headline": "Oppenheimer Upgrades Mosaic to Outperform, Maintains Price Target to $33", "summary": "", "symbols": ["MOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413848/oppenheimer-upgrades-mosaic-to-outperform-maintains-price-target-to-33", "tags": ["analyst_up", "analyst_other"]}
{"id": 44413852, "time": "2025-03-20 07:35:48", "headline": "InflaRx's Cash, Cash Equivalents, And Marketable Securities Were \u20ac55.2M As Of December 31, 2024, Additional \u20ac28.7 Million (~$30M) In Gross Proceeds Subsequently Raised By An Underwritten Public Offering Extending Cash Runway Into 2027", "summary": "", "symbols": ["IFRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44413852/inflarxs-cash-cash-equivalents-and-marketable-securities-were-55-2m-as-of-december-31-2024-additi", "tags": ["offering"]}
{"id": 44413855, "time": "2025-03-20 07:36:32", "headline": "Abeona Therapeutics 2024 EPS $(1.55) Up From $(2.53) YoY", "summary": "", "symbols": ["ABEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413855/abeona-therapeutics-2024-eps-1-55-up-from-2-53-yoy", "tags": ["earnings"]}
{"id": 44413891, "time": "2025-03-20 07:38:53", "headline": "Market-Moving News for March 20th", "summary": "", "symbols": ["EYEN", "FIVE", "PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44413891/market-moving-news-for-march-20th", "tags": []}
{"id": 44413896, "time": "2025-03-20 07:39:51", "headline": "Alarum Technologies Q4 2024 Adj EPS $0.20 Beats $0.13 Estimate, Sales $7.40M Miss $7.48M Estimate", "summary": "", "symbols": ["ALAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44413896/alarum-technologies-q4-2024-adj-eps-0-20-beats-0-13-estimate-sales-7-40m-miss-7-48m-estimate", "tags": ["earnings"]}
{"id": 44413904, "time": "2025-03-20 07:41:20", "headline": "Stephens & Co. Reiterates Equal-Weight on Darden Restaurants, Maintains $175 Price Target", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413904/stephens-co-reiterates-equal-weight-on-darden-restaurants-maintains-175-price-target", "tags": ["analyst_other"]}
{"id": 44413909, "time": "2025-03-20 07:42:40", "headline": "Alarum Technologies Sees Q1 Revenues Of $7.3M (\u00b13%) Vs. Cons. $7.87M, Adj. EBITDA Of $0.8M-$1.2M", "summary": "", "symbols": ["ALAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413909/alarum-technologies-sees-q1-revenues-of-7-3m-3-vs-cons-7-87m-adj-ebitda-of-0-8m-1-2m", "tags": []}
{"id": 44413936, "time": "2025-03-20 07:44:58", "headline": "Broadcom Shares Up Over 3% After This Signal", "summary": "A significant trading signal occurred for Broadcom stock, as it demonstrated a Power Inflow at $192.17, after which AVGO rose up to 3.2%.", "symbols": ["AVGO"], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/markets/equities/25/03/44413936/broadcom-shares-up-over-3-after-this-signal", "tags": []}
{"id": 44413951, "time": "2025-03-20 07:46:07", "headline": "QXO Seals $11 Billion Beacon Roofing Supply Buyout, Ending Takeover Battle With Cash-Packed Deal", "summary": "NYSE: QXO trading higher premarket after announcing merger with NASDAQ: BECN for $124.35 per share in cash. Tender offer extended until 3/31/2025.", "symbols": ["BECN", "QXO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/mid-cap/25/03/44413951/qxo-seals-11-billion-beacon-roofing-supply-buyout-ending-takeover-battle-with-cash-packed-deal", "tags": ["merger", "contract"]}
{"id": 44414161, "time": "2025-03-20 07:46:44", "headline": "D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target", "summary": "", "symbols": ["NRXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414161/d-boral-capital-maintains-buy-on-nrx-pharmaceuticals-maintains-31-price-target", "tags": ["analyst_other"]}
{"id": 44414166, "time": "2025-03-20 07:47:17", "headline": "Jabil Q2 Adj $1.94 Beats $1.83 Estimate, Sales $6.73B Beat $6.40B Estimate", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44414166/jabil-q2-adj-1-94-beats-1-83-estimate-sales-6-73b-beat-6-40b-estimate", "tags": []}
{"id": 44414177, "time": "2025-03-20 07:49:02", "headline": "D. Boral Capital Maintains Buy on Can Fite Biofarma, Maintains $10 Price Target", "summary": "", "symbols": ["CANF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414177/d-boral-capital-maintains-buy-on-can-fite-biofarma-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 44414186, "time": "2025-03-20 07:49:17", "headline": "Jabil Sees Q3 Revenue OF $6.7B - $7.3B Vs. $6.74B Est; Adj EPS Of $2.08 - $2.48 Vs. $2.22 Est.", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414186/jabil-sees-q3-revenue-of-6-7b-7-3b-vs-6-74b-est-adj-eps-of-2-08-2-48-vs-2-22-est", "tags": ["earnings"]}
{"id": 44414187, "time": "2025-03-20 07:49:20", "headline": "Elon Musk's Tesla Recalls Over 46,000 Cybertrucks Due To Safety Concerns", "summary": "Tesla recalling 46,096 Cybertruck vehicles in the U.S. due to exterior panel safety issue. This adds to a series of recalls for the electric vehicle.", "symbols": ["TSLA"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/markets/equities/25/03/44414187/elon-musks-tesla-recalls-over-46000-cybertrucks-due-to-safety-concerns", "tags": []}
{"id": 44414200, "time": "2025-03-20 07:49:56", "headline": "Wolfe Research Initiates Coverage On InvenTrust Properties with Peer Perform Rating", "summary": "", "symbols": ["IVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414200/wolfe-research-initiates-coverage-on-inventrust-properties-with-peer-perform-rating", "tags": ["analyst_init"]}
{"id": 44414207, "time": "2025-03-20 07:50:26", "headline": "Jabil Sees FY25 Revenue Of $27.9B Vs. $28.76B Est; Adj EPS Of $8.95 Vs. $10.1 Est.", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414207/jabil-sees-fy25-revenue-of-27-9b-vs-28-76b-est-adj-eps-of-8-95-vs-10-1-est", "tags": ["earnings"]}
{"id": 44414209, "time": "2025-03-20 07:50:48", "headline": "MetaVia 2024 EPS $(3.56) Down From $(2.46) YoY", "summary": "", "symbols": ["MTVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44414209/metavia-2024-eps-3-56-down-from-2-46-yoy", "tags": ["earnings"]}
{"id": 44414213, "time": "2025-03-20 07:51:38", "headline": "B of A Securities Maintains Underperform on Five Below, Lowers Price Target to $75", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414213/b-of-a-securities-maintains-underperform-on-five-below-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 44414234, "time": "2025-03-20 07:52:34", "headline": "Creative Medical Says FDA Cleared Expanded Dose Escalation For Phase 1/2 Trial Of StemSpine Using AlloStem For Chronic Lower Back Pain", "summary": "", "symbols": ["CELZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414234/creative-medical-says-fda-cleared-expanded-dose-escalation-for-phase-12-trial-of-stemspine-using-all", "tags": ["fda"]}
{"id": 44414235, "time": "2025-03-20 07:52:48", "headline": "Top Republican Lawmakers Oppose Potential Pentagon Reshuffle Amid Reports: 'Such Moves Risk Undermining American Deterrence'", "summary": "Top Republican lawmakers overseeing the Pentagon have expressed concerns over reports of possible adjustments to U.S. military commands under the Trump administration.", "symbols": [], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/25/03/44414235/republican-leaders-oppose-potential-pentagon-reshuffle-amid-reports-such-moves-risk-undermining-american-deterrence", "tags": []}
{"id": 44414255, "time": "2025-03-20 07:54:06", "headline": "Barrington Research Maintains Outperform on TD Synnex, Raises Price Target to $156", "summary": "", "symbols": ["SNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414255/barrington-research-maintains-outperform-on-td-synnex-raises-price-target-to-156", "tags": ["analyst_other", "price_target_up"]}
{"id": 44414266, "time": "2025-03-20 07:55:41", "headline": "Wedbush Initiates Coverage On Zenas BioPharma with Outperform Rating", "summary": "", "symbols": ["ZBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414266/wedbush-initiates-coverage-on-zenas-biopharma-with-outperform-rating", "tags": ["analyst_init"]}
{"id": 44414283, "time": "2025-03-20 07:58:19", "headline": "Copper Surges As Arbitrage Opportunity Drives US Imports", "summary": "Copper prices soar above $10,000/MT on LME due to supply concerns and potential tariffs. U.S. imports of copper reach record levels.", "symbols": ["COPX", "CPER", "ERO", "FCX", "FQVLF", "JJCTF", "LUNMF", "MTAL", "SCCO"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/25/03/44414283/copper-surges-as-arbitrage-opportunity-drives-us-imports", "tags": []}
{"id": 44414293, "time": "2025-03-20 07:59:05", "headline": "Sunoco Plans Private Offering Of Senior Notes Due 2033 In An Aggregate Principal Amount Of $750M", "summary": "", "symbols": ["SUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414293/sunoco-plans-private-offering-of-senior-notes-due-2033-in-an-aggregate-principal-amount-of-750m", "tags": ["offering"]}
{"id": 44414295, "time": "2025-03-20 07:59:17", "headline": "Jim Cramer Recommends Deckers Outdoor, Realty Income: 'Get A Good Basis'", "summary": "Deckers Outdoor posted &#34;exceptional&#34; results and record quarterly revenue in Q3, according to CEO Stefano Caroti.", "symbols": ["DECK", "LAND", "O"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/media/25/03/44414295/jim-cramer-recommends-deckers-outdoor-realty-income-get-a-good-basis", "tags": ["earnings", "management"]}
{"id": 44414391, "time": "2025-03-20 08:00:18", "headline": "Oklo Enters Interface Agreement With Idaho National Laboratory", "summary": "", "symbols": ["OKLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414391/oklo-enters-interface-agreement-with-idaho-national-laboratory", "tags": ["contract"]}
{"id": 44414435, "time": "2025-03-20 08:00:40", "headline": "Deep Dive Into Vertex Stock: Analyst Perspectives (7 Ratings)", "summary": " ", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44414435/deep-dive-into-vertex-stock-analyst-perspectives-7-ratings", "tags": []}
{"id": 44414445, "time": "2025-03-20 08:00:49", "headline": "What Analysts Are Saying About Walmart Stock", "summary": " ", "symbols": ["WMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44414445/what-analysts-are-saying-about-walmart-stock", "tags": []}
{"id": 44414471, "time": "2025-03-20 08:01:15", "headline": "Expert Outlook: Target Through The Eyes Of 22 Analysts", "summary": " ", "symbols": ["TGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44414471/expert-outlook-target-through-the-eyes-of-22-analysts", "tags": ["guidance"]}
{"id": 44414478, "time": "2025-03-20 08:01:27", "headline": "BlackBerry's QNX And Advantech Expand Collaboration To Better Serve Joint-customers Across Embedded Systems Industry", "summary": "", "symbols": ["BB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414478/blackberrys-qnx-and-advantech-expand-collaboration-to-better-serve-joint-customers-across-embedded-s", "tags": []}
{"id": 44414479, "time": "2025-03-20 08:01:27", "headline": "Demystifying Costco Wholesale: Insights From 16 Analyst Reviews", "summary": " ", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44414479/demystifying-costco-wholesale-insights-from-16-analyst-reviews", "tags": []}
{"id": 44414480, "time": "2025-03-20 08:01:32", "headline": "Clashing Opinions Deliver Ample Trading Grounds For Direxion's TSLA Bull And Bear ETFs", "summary": " ", "symbols": ["TSLA", "TSLL", "TSLS"], "source": "benzinga", "author": "JE Insights", "url": "https://www.benzinga.com/25/03/44414480/clashing-opinions-deliver-ample-trading-grounds-for-direxions-tsla-bull-and-bear-etfs", "tags": []}
{"id": 44414487, "time": "2025-03-20 08:01:53", "headline": "Demystifying TD Synnex: Insights From 7 Analyst Reviews", "summary": " ", "symbols": ["SNX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44414487/demystifying-td-synnex-insights-from-7-analyst-reviews", "tags": []}
{"id": 44414494, "time": "2025-03-20 08:02:09", "headline": "Keybanc Downgrades Thor Industries to Underweight, Announces $65 Price Target", "summary": "", "symbols": ["THO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414494/keybanc-downgrades-thor-industries-to-underweight-announces-65-price-target", "tags": ["analyst_down"]}
{"id": 44414495, "time": "2025-03-20 08:02:11", "headline": "A Glimpse Into The Expert Outlook On Capricor Therapeutics Through 4 Analysts", "summary": " ", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44414495/a-glimpse-into-the-expert-outlook-on-capricor-therapeutics-through-4-analysts", "tags": ["guidance"]}
{"id": 44414509, "time": "2025-03-20 08:02:31", "headline": "These Analysts Slash Their Forecasts On Five Below After Q4 Results", "summary": " ", "symbols": ["FIVE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44414509/these-analysts-slash-their-forecasts-on-five-below-after-q4-results", "tags": ["earnings"]}
{"id": 44414518, "time": "2025-03-20 08:03:05", "headline": "Candel Therapeutics And IDEA Pharma Announce Commercial Partnership, IDEA To Provide Commercial Input Throughout Candel's Development And Commercialization Process For CAN-2409", "summary": "", "symbols": ["CADL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414518/candel-therapeutics-and-idea-pharma-announce-commercial-partnership-idea-to-provide-commercial-in", "tags": ["contract"]}
{"id": 44414537, "time": "2025-03-20 08:04:03", "headline": "Academy Sports Q4 2024 Adj. EPS $1.96 Beats $1.83 Estimate, Sales $1.676B Miss $1.677B Estimate", "summary": "", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44414537/academy-sports-q4-2024-adj-eps-1-96-beats-1-83-estimate-sales-1-676b-miss-1-677b-estimate", "tags": ["earnings"]}
{"id": 44414540, "time": "2025-03-20 08:04:10", "headline": "Vyne Therapeutics To Present At Autoimmune & Inflammatory Disease Virtual Conference March 27", "summary": "", "symbols": ["VYNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414540/vyne-therapeutics-to-present-at-autoimmune-inflammatory-disease-virtual-conference-march-27", "tags": []}
{"id": 44414546, "time": "2025-03-20 08:04:14", "headline": "Immutep Announces TACTI-004 Phase III Trial Poster Presentation For Eftilagimod Alfa In Combination With Keytruda And Chemotherapy For 750 Advanced NSCLC Patients Across 150 Sites In 25 Countries At ELCC, March 26-29, 2025", "summary": "", "symbols": ["IMMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414546/immutep-announces-tacti-004-phase-iii-trial-poster-presentation-for-eftilagimod-alfa-in-combinati", "tags": ["fda"]}
{"id": 44414550, "time": "2025-03-20 08:04:39", "headline": "Keybanc Downgrades Malibu Boats to Sector Weight", "summary": "", "symbols": ["MBUU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414550/keybanc-downgrades-malibu-boats-to-sector-weight", "tags": ["analyst_down"]}
{"id": 44414560, "time": "2025-03-20 08:05:11", "headline": "Esperion Announces Alignment With FDA On Path To Initiate Phase 3 Clinical Trials Of Bempedoic Acid Alone And In Combination With Ezetimibe", "summary": "", "symbols": ["ESPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414560/esperion-announces-alignment-with-fda-on-path-to-initiate-phase-3-clinical-trials-of-bempedoic-acid", "tags": ["fda"]}
{"id": 44414578, "time": "2025-03-20 08:05:34", "headline": "Actinium Pharmaceuticals To Collaborate With Memorial Sloan Kettering For Clinical Expansion Of Actimab-A's Backbone Therapy Strategy", "summary": "", "symbols": ["ATNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414578/actinium-pharmaceuticals-to-collaborate-with-memorial-sloan-kettering-for-clinical-expansion-of-a", "tags": ["fda"]}
{"id": 44414582, "time": "2025-03-20 08:05:35", "headline": "Corvus Pharmaceuticals Announces Additional Data From Phase 1/1b Clinical Trial Of Soquelitinib For The Treatment Of Patients With T Cell Lymphoma Is Being Presented At The Annual T-Cell Lymphoma Forum Taking Place March 20-22, 2025", "summary": "", "symbols": ["CRVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414582/corvus-pharmaceuticals-announces-additional-data-from-phase-11b-clinical-trial-of-soquelitinib-fo", "tags": ["fda"]}
{"id": 44414589, "time": "2025-03-20 08:06:11", "headline": "Academy Sports Declared Quarterly Cash Dividend Of $0.13 Per Share Of Common Stock, Which Is An Increase Of 18% From Previous Quarterly Dividend Payment; Dividend Is Payable On April 17", "summary": "", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414589/academy-sports-declared-quarterly-cash-dividend-of-0-13-per-share-of-common-stock-which-is-an-increa", "tags": ["dividend"]}
{"id": 44414596, "time": "2025-03-20 08:06:42", "headline": "BriaCell Announces DSMB Recommends Continuation Of Phase 3 Bria-IMT Study For Metastatic Breast Cancer; No Safety Concerns Found; Study Under FDA Fast Track Designation", "summary": "", "symbols": ["BCTX", "TSX:BCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414596/briacell-announces-dsmb-recommends-continuation-of-phase-3-bria-imt-study-for-metastatic-breast-c", "tags": ["fda"]}
{"id": 44414599, "time": "2025-03-20 08:06:42", "headline": "Founder Group Wins $2.6M Contract For 'Build A Roof-Top' Solar Generating Facility In Malaysia", "summary": "", "symbols": ["FGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414599/founder-group-wins-2-6m-contract-for-build-a-roof-top-solar-generating-facility-in-malaysia", "tags": ["contract"]}
{"id": 44414626, "time": "2025-03-20 08:07:25", "headline": "Neuraxis Q4 EPS $(0.23) Up From $(0.85) YoY, Sales $761.16K Up From $531.46K YoY", "summary": "", "symbols": ["NRXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44414626/neuraxis-q4-eps-0-23-up-from-0-85-yoy-sales-761-16k-up-from-531-46k-yoy", "tags": ["earnings"]}
{"id": 44414628, "time": "2025-03-20 08:07:39", "headline": "Indaptus Therapeutics Reports Insight Indicating Weekly Decoy20 Treatment Leads To Broad, Blood-based Immune Cell Trafficking", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414628/indaptus-therapeutics-reports-insight-indicating-weekly-decoy20-treatment-leads-to-broad-blood-ba", "tags": []}
{"id": 44414629, "time": "2025-03-20 08:07:41", "headline": "TrisMas Names Teresa Finley As Interim CFO Effective March 20", "summary": "", "symbols": ["TRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414629/trismas-names-teresa-finley-as-interim-cfo-effective-march-20", "tags": ["management"]}
{"id": 44414656, "time": "2025-03-20 08:08:33", "headline": "Academy Sports Sees FY25 Net Revenues Of $6.090B-$6.265B Vs. $6.240B Estimate; Projects Adjusted EPS Of $5.75-$6.20 Vs. $6.46 Estimate", "summary": "", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414656/academy-sports-sees-fy25-net-revenues-of-6-090b-6-265b-vs-6-240b-estimate-projects-adjusted-eps-of-5", "tags": ["earnings"]}
{"id": 44414660, "time": "2025-03-20 08:08:47", "headline": "Coinbase Sold 12,652 ETH, According To Standard Chartered Analysis", "summary": "Standard Chartered&#39;s Geoffrey Kendrick on Thursday warned that activity on Coinbase&#39;s (NASDAQ:COIN) Base network is influencing Ethereum (CRYPTO: ETH) price dynamics throug", "symbols": ["COIN", "ETHUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44414660/coinbase-sold-12652-eth-according-to-standard-chartered-analysis", "tags": []}
{"id": 44414661, "time": "2025-03-20 08:08:52", "headline": "Johnson & Johnson To Present Data At 2025 European Lung Cancer Congress Including Results From Phase 3 MARIPOSA Study Of RYBREVANT Plus LAZCLUZE vs Osimertinib", "summary": "", "symbols": ["JNJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414661/johnson-johnson-to-present-data-at-2025-european-lung-cancer-congress-including-results-from-phas", "tags": ["fda"]}
{"id": 44414681, "time": "2025-03-20 08:09:20", "headline": "PTC Therapeutics Announces Phase 3 APHENITY Trial Results: Over 97% Of Subjects Participating In The Phe Tolerance Protocol Of The APHENITY Open-Label Extension Study Demonstrate The Ability To Liberalize Their Diet While On Sepiapterin Treatment, With A Mean Increase In Protein Intake Of 126%", "summary": "", "symbols": ["PTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414681/ptc-therapeutics-announces-phase-3-aphenity-trial-results-over-97-of-subjects-participating-in-th", "tags": ["fda"]}
{"id": 44414682, "time": "2025-03-20 08:09:29", "headline": "Williams-Sonoma Analysts Cut Their Forecasts After Q4 Results", "summary": " ", "symbols": ["WSM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44414682/williams-sonoma-analysts-cut-their-forecasts-after-q4-results", "tags": ["earnings"]}
{"id": 44414689, "time": "2025-03-20 08:09:47", "headline": "12 Industrials Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["BGSF", "CLIR", "CYCU", "FBGL", "HOVR", "ICON", "NCEW", "OPXS", "PITA", "RHLD", "SFHG", "SKIL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44414689/12-industrials-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 44414692, "time": "2025-03-20 08:09:53", "headline": "12 Health Care Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["ADTX", "AEON", "AKBA", "BDRX", "GHRS", "MHUA", "MSPR", "OPTN", "PSTV", "RMTI", "TNFA", "WINT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44414692/12-health-care-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 44414693, "time": "2025-03-20 08:10:01", "headline": "12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["AIEV", "DBI", "DMN", "DTC", "HTHT", "JFBR", "LOBO", "MSN", "NTCL", "PDD", "RAY", "SAG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44414693/12-consumer-discretionary-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 44414695, "time": "2025-03-20 08:10:08", "headline": "Temu Parent PDD Holdings Drops After Q4 Revenue Miss: Details", "summary": "PDD Holdings reports fiscal Q4  results, missing revenue estimates but beating earnings. Stock trading lower premarket.", "symbols": ["KPDD", "ONLN", "PDD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/25/03/44414695/temu-parent-pdd-holdings-drops-after-q4-revenue-miss-details", "tags": ["earnings"]}
{"id": 44414696, "time": "2025-03-20 08:10:10", "headline": "Hikma Announces Health Canada Approval Of KLOXXADO Nasal Spray; To Be Marketed, Sold By Emergent BioSolutions Under 6-Year Commercial Agreement", "summary": "", "symbols": ["EBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414696/hikma-announces-health-canada-approval-of-kloxxado-nasal-spray-to-be-marketed-sold-by-emergent-bi", "tags": ["contract"]}
{"id": 44414704, "time": "2025-03-20 08:10:12", "headline": "12 Financials Stocks Moving In Thursday's Pre-Market Session", "summary": " ", "symbols": ["AGMH", "CNF", "FG", "FRGE", "HPH", "LGHL", "MFI", "PRA", "PWM", "RVSB", "RVYL", "XYF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44414704/12-financials-stocks-moving-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 44414709, "time": "2025-03-20 08:10:12", "headline": "Elevation Oncology To Discontinue Development Of EO-3021; Continuing To Advance Potentially Differentiated HER3 ADC, EO-1022, Which Utilizes An MMAE Payload And Glycan Site-Specific Conjugation", "summary": "", "symbols": ["ELEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414709/elevation-oncology-to-discontinue-development-of-eo-3021-continuing-to-advance-potentially-differ", "tags": []}
{"id": 44414708, "time": "2025-03-20 08:10:13", "headline": "Invivyd FY 2024 GAAP EPS $(1.43) Beats $(1.48) Estimate, Sales $25.38M Beat $25.15M Estimate", "summary": "", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44414708/invivyd-fy-2024-gaap-eps-1-43-beats-1-48-estimate-sales-25-38m-beat-25-15m-estimate", "tags": ["earnings"]}
{"id": 44414747, "time": "2025-03-20 08:11:30", "headline": "Jefferies Downgrades Open Lending to Hold, Lowers Price Target to $3.7", "summary": "", "symbols": ["LPRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414747/jefferies-downgrades-open-lending-to-hold-lowers-price-target-to-3-7", "tags": ["analyst_down", "price_target_down"]}
{"id": 44414749, "time": "2025-03-20 08:11:38", "headline": "Top 2 Defensive Stocks That May Keep You Up At Night In March", "summary": " ", "symbols": ["CCU", "CELH"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/short-ideas/25/03/44414749/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-march", "tags": []}
{"id": 44414758, "time": "2025-03-20 08:11:53", "headline": "Microchip Technology Engages Macquarie To Market And Sell Tempe, Arizona Wafer Facility Under Restructuring Plan; Production Shifts To Oregon And Colorado. Terms Not Disclosed", "summary": "", "symbols": ["MCHP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414758/microchip-technology-engages-macquarie-to-market-and-sell-tempe-arizona-wafer-facility-under-restruc", "tags": []}
{"id": 44414787, "time": "2025-03-20 08:14:00", "headline": "Medera Receives DSMB Clearance To Initiate Phase 2 Portion Of MUSIC-HFrEF Phase 1b/2 Trial For SRD-001 Gene Therapy In Heart Failure With Reduced Ejection Fraction", "summary": "", "symbols": ["KVAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414787/medera-receives-dsmb-clearance-to-initiate-phase-2-portion-of-music-hfref-phase-1b2-trial-for-srd", "tags": ["fda"]}
{"id": 44414790, "time": "2025-03-20 08:14:22", "headline": "Nvidia Acquires Synthetic Data Firm Gretel To Train AI Models: Report", "summary": "Nvidia (NASDAQ: NVDA) has acquired synthetic data startup Gretel in a deal exceeding $320 million. The acquisition strengthens Nvidia&#39;s AI capabilities, integrating Gretel&#39;s technology into its cloud-based services. With new products launched at the GTC event, Nvidia is set to enhance AI models, including generative tools and humanoid robotics, driving innovation in AI training and infrastructure.", "symbols": ["MSFT", "NVDA"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/03/44414790/nvidia-acquires-synthetic-data-firm-gretel-to-train-ai-models-report", "tags": ["merger", "contract"]}
{"id": 44414809, "time": "2025-03-20 08:15:06", "headline": "Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday", "summary": " ", "symbols": ["ALMS", "BE", "LQDA", "OLLI", "PGR", "SNX", "SRAD", "TGT", "TSLA", "WSM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44414809/tesla-to-450-here-are-10-top-analyst-forecasts-for-thursday", "tags": []}
{"id": 44414811, "time": "2025-03-20 08:15:16", "headline": "JP Morgan Initiates Coverage On International Paper with Overweight Rating, Announces Price Target of $59", "summary": "", "symbols": ["IP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44414811/jp-morgan-initiates-coverage-on-international-paper-with-overweight-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 44414829, "time": "2025-03-20 08:16:18", "headline": "AI-Powered Grid? Itron And NVIDIA Join Forces To Transform Utilities With Smarter, Faster Solutions", "summary": "Itron has partnered with NVIDIA to integrate AI-powered solutions at the grid edge, optimizing utility operations and enhancing grid resilience.", "symbols": ["ITRI", "NVDA"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/03/44414829/ai-powered-grid-itron-and-nvidia-join-forces-to-transform-utilities-with-smarter-faster-solutions", "tags": []}
{"id": 44415039, "time": "2025-03-20 08:17:34", "headline": "Raymond James Maintains Outperform on Braze, Lowers Price Target to $45", "summary": "", "symbols": ["BRZE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415039/raymond-james-maintains-outperform-on-braze-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 44414592, "time": "2025-03-20 08:06:20", "headline": "Windtree Enters License And Supply Agreement To Become A Sourcing Partner For Evofem Biosciences For Evofem's PHEXXI", "summary": "", "symbols": ["EVFM", "WINT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44414592/windtree-enters-license-and-supply-agreement-to-become-a-sourcing-partner-for-evofem-biosciences-", "tags": ["contract"]}
{"id": 44415045, "time": "2025-03-20 08:18:13", "headline": "JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session", "summary": " ", "symbols": ["AKBA", "EFXT", "GHRS", "MAZE", "MCHP", "RGC", "TIGR", "YY", "ZTO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44415045/joyy-akebia-therapeutics-microchip-technology-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session", "tags": ["why_moving"]}
{"id": 44415046, "time": "2025-03-20 08:18:14", "headline": "JP Morgan Upgrades Freeport-McMoRan to Overweight, Raises Price Target to $52", "summary": "", "symbols": ["FCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415046/jp-morgan-upgrades-freeport-mcmoran-to-overweight-raises-price-target-to-52", "tags": ["analyst_up", "price_target_up"]}
{"id": 44415047, "time": "2025-03-20 08:18:18", "headline": "Recession 'Will Rear Its Ugly Head' As Early As July, Warns Expert As 2 Rate Cuts Projected For 2025: 'Buy Bonds On Dips'", "summary": "Federal Reserve has released its economic projections, David Rosenberg issued a strong warning about a potential recession, based on data.", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/government/regulations/25/03/44415047/recession-will-rear-its-ugly-head-as-early-as-july-warns-expert-amid-two-rate-cuts-projected-for-2025-buy-bonds-on-dips", "tags": []}
{"id": 44415084, "time": "2025-03-20 08:19:49", "headline": "Hovde Group Maintains Market Perform on United Community Banks, Lowers Price Target to $32", "summary": "", "symbols": ["UCB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415084/hovde-group-maintains-market-perform-on-united-community-banks-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 44415088, "time": "2025-03-20 08:20:19", "headline": "Truist Securities Maintains Hold on Five Below, Lowers Price Target to $86", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415088/truist-securities-maintains-hold-on-five-below-lowers-price-target-to-86", "tags": ["analyst_other", "price_target_down"]}
{"id": 44415104, "time": "2025-03-20 08:21:17", "headline": "JP Morgan Upgrades Spire to Overweight, Raises Price Target to $85", "summary": "", "symbols": ["SR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415104/jp-morgan-upgrades-spire-to-overweight-raises-price-target-to-85", "tags": ["analyst_up", "price_target_up"]}
{"id": 44415109, "time": "2025-03-20 08:23:04", "headline": "Morgan Stanley Maintains Overweight on Vertex, Raises Price Target to $60", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415109/morgan-stanley-maintains-overweight-on-vertex-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 44415111, "time": "2025-03-20 08:23:29", "headline": "Nokia Strengthens Home Broadband Offerings With New 5G Gateway, Wi-Fi 7 Support", "summary": "Nokia also disclosed a contract with Worldstream to adopt a network security technology to safeguard businesses in the Netherlands.", "symbols": ["IDGT", "NOK", "SIXG"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/25/03/44415111/nokia-strengthens-home-broadband-offerings-5g-gateway-wi-fi-7-support", "tags": ["contract"]}
{"id": 44415112, "time": "2025-03-20 08:23:32", "headline": "JP Morgan Upgrades Cava Group to Overweight, Maintains Price Target to $110", "summary": "", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415112/jp-morgan-upgrades-cava-group-to-overweight-maintains-price-target-to-110", "tags": ["analyst_up", "analyst_other"]}
{"id": 44415149, "time": "2025-03-20 08:27:20", "headline": "STRATA Skin Sciences Announces Japanese Study Validating Technological Advantages Of Excimer Laser Over Excimer Light In Treating Vitiligo, Psoriasis, Alopecia Areata, And Atopic Dermatitis; Study Highlights Deeper Penetration And Greater Activation Of Melanocyte Cells For Superior Clinical Outcomes", "summary": "", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415149/strata-skin-sciences-announces-japanese-study-validating-technological-advantages-of-excimer-lase", "tags": ["fda"]}
{"id": 44415151, "time": "2025-03-20 08:27:29", "headline": "BMO Capital Maintains Market Perform on MP Materials, Raises Price Target to $29", "summary": "", "symbols": ["MP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415151/bmo-capital-maintains-market-perform-on-mp-materials-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 44415152, "time": "2025-03-20 08:27:35", "headline": "Microsoft To Launch Malaysia's First Cloud Region With Three Data Centers", "summary": "Microsoft&#39;s upcoming Malaysia West cloud region will offer businesses better performance and local data storage, ensuring compliance with regulations. Set to open in 2025, it will drive economic growth by generating $10.9 billion in new revenue and creating over 37,500 jobs.", "symbols": ["MSFT"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/tech/25/03/44415152/microsoft-to-launch-malaysias-first-cloud-region-with-three-data-centers", "tags": ["earnings"]}
{"id": 44415161, "time": "2025-03-20 08:27:57", "headline": "JP Morgan Downgrades ZTO Express (Cayman) to Neutral, Lowers Price Target to $23", "summary": "", "symbols": ["ZTO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415161/jp-morgan-downgrades-zto-express-cayman-to-neutral-lowers-price-target-to-23", "tags": ["analyst_down", "price_target_down"]}
{"id": 44415167, "time": "2025-03-20 08:28:24", "headline": "Microsoft, Morgan Stanley And A Basic Materials Stock On CNBC's 'Final Trades'", "summary": " ", "symbols": ["CRH", "MS", "MSFT", "NVDA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/25/03/44415167/microsoft-morgan-stanley-and-a-basic-materials-stock-on-cnbcs-final-trades", "tags": []}
{"id": 44415229, "time": "2025-03-20 08:30:11", "headline": "Philadelphia Fed Manufacturing Index (Mar) 12.5 vs 8.8 Est.; Prior 18.1", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44415229/philadelphia-fed-manufacturing-index-mar-12-5-vs-8-8-est-prior-18-1", "tags": []}
{"id": 44415237, "time": "2025-03-20 08:30:18", "headline": "USA Initial Jobless Claims 223K Vs 224K Est.; 221K Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44415237/usa-initial-jobless-claims-223k-vs-224k-est-221k-prior", "tags": []}
{"id": 44415239, "time": "2025-03-20 08:30:20", "headline": "Philly Fed Employment For March 19.7 Vs 5.3 Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44415239/philly-fed-employment-for-march-19-7-vs-5-3-prior", "tags": []}
{"id": 44415240, "time": "2025-03-20 08:30:23", "headline": "Continuing Jobless Claims 1.892M Vs 1.89M Expected; 1.859M Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44415240/continuing-jobless-claims-1-892m-vs-1-89m-expected-1-859m-prior", "tags": []}
{"id": 44415245, "time": "2025-03-20 08:30:56", "headline": "Melius Research Upgrades Southwest Airlines to Hold, Raises Price Target to $34", "summary": "", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415245/melius-research-upgrades-southwest-airlines-to-hold-raises-price-target-to-34", "tags": ["analyst_up", "price_target_up"]}
{"id": 44415268, "time": "2025-03-20 08:31:22", "headline": "NASA Selects TOMI Environmental Solutions For Biosecurity Operation", "summary": "", "symbols": ["TOMZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415268/nasa-selects-tomi-environmental-solutions-for-biosecurity-operation", "tags": []}
{"id": 44415294, "time": "2025-03-20 08:32:34", "headline": "Star Equity Hldgs Q4 2024 Adj EPS $0.15 Beats $(0.17) Estimate, Sales $17.09M Beat $15.55M Estimate", "summary": "", "symbols": ["STRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44415294/star-equity-hldgs-q4-2024-adj-eps-0-15-beats-0-17-estimate-sales-17-09m-beat-15-55m-estimate", "tags": ["earnings"]}
{"id": 44415295, "time": "2025-03-20 08:32:34", "headline": "Oppenheimer Maintains Outperform on Aeva Technologies, Raises Price Target to $6", "summary": "", "symbols": ["AEVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415295/oppenheimer-maintains-outperform-on-aeva-technologies-raises-price-target-to-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 44415297, "time": "2025-03-20 08:32:39", "headline": "How To Earn $500 A Month From Micron Technology Stock Ahead Of Q2 Earnings", "summary": " ", "symbols": ["MU"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/03/44415297/how-to-earn-500-a-month-from-micron-technology-stock-ahead-of-q2-earnings", "tags": ["earnings"]}
{"id": 44415298, "time": "2025-03-20 08:32:49", "headline": "SR Bancorp Announces Payment Of Initial Quarterly Cash Dividend Of $0.05 Per Share", "summary": "", "symbols": ["SRBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415298/sr-bancorp-announces-payment-of-initial-quarterly-cash-dividend-of-0-05-per-share", "tags": ["dividend"]}
{"id": 44415299, "time": "2025-03-20 08:32:51", "headline": "Agnico Eagle Mines To Subscribe For 20,770,000 Units Of Cartier Resources In Non-Brokered Private Placement At C$0.13 Per Unit", "summary": "", "symbols": ["AEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415299/agnico-eagle-mines-to-subscribe-for-20-770-000-units-of-cartier-resources-in-non-brokered-private-pl", "tags": ["offering"]}
{"id": 44415319, "time": "2025-03-20 08:33:20", "headline": "Intelligent Bio Solutions Says Co Will Receive 6th U.S. Patent", "summary": "", "symbols": ["INBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415319/intelligent-bio-solutions-says-co-will-receive-6th-u-s-patent", "tags": []}
{"id": 44415320, "time": "2025-03-20 08:33:44", "headline": "IceCure Reports Continued Discussions With FDA Regarding Marketing Authorization For ProSense Cryoablation In Early-Stage Breast Cancer", "summary": "", "symbols": ["ICCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415320/icecure-reports-continued-discussions-with-fda-regarding-marketing-authorization-for-prosense-cry", "tags": ["fda"]}
{"id": 44415323, "time": "2025-03-20 08:33:54", "headline": "Universe Pharmaceuticals INC Announces 1-For-40 Share Consolidation, Effective March 24, 2025", "summary": "", "symbols": ["UPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415323/universe-pharmaceuticals-inc-announces-1-for-40-share-consolidation-effective-march-24-2025", "tags": []}
{"id": 44415325, "time": "2025-03-20 08:33:58", "headline": "How To Approach Investing Amid Current volatility? Remember Risk Management?", "summary": "&#34;Don&#39;t be married to your beliefs&#34; - says this contributor, who manages client portfolios for high net-worth clients.", "symbols": [], "source": "benzinga", "author": "bfs@theirsay.com", "url": "https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44415325/how-to-approach-investing-amid-current-volatility-remember-risk-management", "tags": []}
{"id": 44415331, "time": "2025-03-20 08:34:25", "headline": "Autonomix Medical Granted U.S. Patent Covering Sensing Data Collection And Processing With Company's Proprietary Catheter-Based Technology", "summary": "", "symbols": ["AMIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415331/autonomix-medical-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-company", "tags": []}
{"id": 44415341, "time": "2025-03-20 08:34:54", "headline": "Yoshiharu Secures $1.9M In Financing From Multiple Parties; To Achieve Nasdaq Minimum Price Ahead Of April 1 Hearing", "summary": "", "symbols": ["YOSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415341/yoshiharu-secures-1-9m-in-financing-from-multiple-parties-to-achieve-nasdaq-minimum-price-ahead-of-a", "tags": []}
{"id": 44415343, "time": "2025-03-20 08:35:33", "headline": "Dyadic Receives Funding award From CEPI To Use C1 For Development Of Protein-Based Vaccines; CEPI Providing $4.5M To Non-Profit Fondazione Biotecnopolo di Siena For Proof-Of-Concept Research To Explore Producing Antigens In C1 Filamentous Fungus", "summary": "", "symbols": ["DYAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415343/dyadic-receives-funding-award-from-cepi-to-use-c1-for-development-of-protein-based-vaccines-cepi-pro", "tags": []}
{"id": 44415348, "time": "2025-03-20 08:35:52", "headline": "Lucid Diagnostics Announced NCCN Guidelines Update Endorsing Non-Endoscopic Biomarker Tests, Including EsoGuard, As Alternative To Endoscopy For Barrett's Esophagus Screening", "summary": "", "symbols": ["LUCD", "PAVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415348/lucid-diagnostics-announced-nccn-guidelines-update-endorsing-non-endoscopic-biomarker-tests-inclu", "tags": []}
{"id": 44415361, "time": "2025-03-20 08:36:10", "headline": "Niagen Bioscience Secures US Patent For Composition Of Matter For Nicotinamide Riboside Salt Forms", "summary": "", "symbols": ["NAGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415361/niagen-bioscience-secures-us-patent-for-composition-of-matter-for-nicotinamide-riboside-salt-forms", "tags": []}
{"id": 44415362, "time": "2025-03-20 08:36:20", "headline": "Citigroup Upgrades Coty to Buy, Raises Price Target to $8", "summary": "", "symbols": ["COTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415362/citigroup-upgrades-coty-to-buy-raises-price-target-to-8", "tags": ["analyst_up", "price_target_up"]}
{"id": 44415363, "time": "2025-03-20 08:36:25", "headline": "Neurocrine Biosciences Presents New 48-Week Remission Data On Treatment Of Tardive Dyskinesia With INGREZZA Capsules", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415363/neurocrine-biosciences-presents-new-48-week-remission-data-on-treatment-of-tardive-dyskinesia-wit", "tags": []}
{"id": 44415382, "time": "2025-03-20 08:37:13", "headline": "Akari Therapeutics Appoints Abizer Gaslightwala As President And CEO", "summary": "", "symbols": ["AKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415382/akari-therapeutics-appoints-abizer-gaslightwala-as-president-and-ceo", "tags": ["management"]}
{"id": 44415396, "time": "2025-03-20 08:37:57", "headline": "Twin Vee Powercats FY24 EPS $(1.10) Down From $(0.76) YoY; Revenue $14.39M Down From $33.43M YoY", "summary": "", "symbols": ["VEEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44415396/twin-vee-powercats-fy24-eps-1-10-down-from-0-76-yoy-revenue-14-39m-down-from-33-43m-yoy", "tags": ["earnings"]}
{"id": 44415403, "time": "2025-03-20 08:38:21", "headline": "Twin Vee PowerCats Expects Q1 2025 Revenues To Grow Sequentially More Than 50%", "summary": "", "symbols": ["VEEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415403/twin-vee-powercats-expects-q1-2025-revenues-to-grow-sequentially-more-than-50", "tags": []}
{"id": 44415405, "time": "2025-03-20 08:38:35", "headline": "Donald Trump Reportedly Making 'Big Announcement' For 'Next Steps In Crypto Policy' At Digital Asset Summit On Thursday", "summary": "President Donald Trump is set to address the Digital Asset Summit (DAS) in New York City later today and is expected to make key announcements related to crypto policies in the United States.", "symbols": ["BTCUSD", "MSTR", "XRPUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44415405/donald-trump-reportedly-making-big-announcement-for-next-steps-in-crypto-policy-at-digital-asset-summit-on-thursday", "tags": []}
{"id": 44415433, "time": "2025-03-20 08:39:34", "headline": "Citigroup Downgrades Constellation Brands to Neutral, Lowers Price Target to $200", "summary": "", "symbols": ["STZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415433/citigroup-downgrades-constellation-brands-to-neutral-lowers-price-target-to-200", "tags": ["analyst_down", "price_target_down"]}
{"id": 44415434, "time": "2025-03-20 08:39:37", "headline": "B. Riley Securities Maintains Buy on Hyperfine, Lowers Price Target to $1.2", "summary": "", "symbols": ["HYPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415434/b-riley-securities-maintains-buy-on-hyperfine-lowers-price-target-to-1-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 44415440, "time": "2025-03-20 08:40:14", "headline": "Accenture Q2 FY2025 Earnings Almost Inline With Expectations, New Bookings Fall To $20.9 Billion, Tightens Annual Sales Growth Forecast", "summary": "Accenture posted Q2 revenue of $16.66 billion with 5% growth, while narrowing its full-year outlook and forecasting 2025 EPS below analyst expectations.", "symbols": ["ACN"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/03/44415440/accenture-q2-fy2025-earnings-almost-inline-with-expectations-new-bookings-fall-to-209-billion-tightens-annual-sales-growth-forecast", "tags": ["earnings", "guidance"]}
{"id": 44415481, "time": "2025-03-20 08:43:05", "headline": "Above Food Group Announces Strategic Restructuring To Pivot Towards Agri-Tech And Fin-Tech Sectors", "summary": "", "symbols": ["ABVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415481/above-food-group-announces-strategic-restructuring-to-pivot-towards-agri-tech-and-fin-tech-sectors", "tags": []}
{"id": 44415482, "time": "2025-03-20 08:43:09", "headline": "Aptevo's Mipletamig Achieves 90% Remission Rate in AML Trials, Surpassing Previous 66%; No Cytokine Release Syndrome In RAINIER Trial; Cohort 2 Enrollment Nearly Complete", "summary": "", "symbols": ["APVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415482/aptevos-mipletamig-achieves-90-remission-rate-in-aml-trials-surpassing-previous-66-no-cytokine-re", "tags": ["fda"]}
{"id": 44415537, "time": "2025-03-20 08:45:07", "headline": "Shoe Carnival Q4 Earnings: Sales Miss & EPS Beat, New Shoe Station Strategy, Gloomy Outlook And More", "summary": "Shoe Carnival shares fell in premarket trading following fourth-quarter earnings report. The company posted a 6.15% YoY sales decline to $262.94 million, missing analysts&#39; estimates. Comparable store sales fell 6.3%, while gross profit dropped 8.1%. Despite this, adjusted EPS of $0.54 beat the consensus estimate.", "symbols": ["SCVL"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/earnings/25/03/44415537/shoe-carnival-q4-earnings-sales-miss-eps-beat-new-shoe-station-strategy-gloomy-outlook-and-more", "tags": ["earnings", "guidance"]}
{"id": 44415563, "time": "2025-03-20 08:46:27", "headline": "Formula Systems Q4 EPADS $1.28 Up From $1.01 YoY; Revenue $691.5M Up From $640.3M YoY.", "summary": "", "symbols": ["FORTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44415563/formula-systems-q4-epads-1-28-up-from-1-01-yoy-revenue-691-5m-up-from-640-3m-yoy", "tags": ["earnings"]}
{"id": 44415768, "time": "2025-03-20 08:48:31", "headline": "Conduent Announces Ireland's Adoption Of Maven Disease Surveillance System For HSE To Monitor Public Health Threats; 5-Year Contract Includes Software Implementation, Maintenance, And Support", "summary": "", "symbols": ["CNDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415768/conduent-announces-irelands-adoption-of-maven-disease-surveillance-system-for-hse-to-monitor-publ", "tags": ["contract"]}
{"id": 44415863, "time": "2025-03-20 08:52:25", "headline": "Faraday Future Announces First FX 6 Prototype Mules Have Arrived At Its LA Headquarters; Will Begin U.S. Product Development And Testing Focusing On ADAS; FX Currently Plans For Up To Three Models: An AI-MPV Product Named The Super One, The FX 5, With A Price Target Between $20K-$30K, And The FX 6, With A Price Target Between $30K-$50K", "summary": "", "symbols": ["FFAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415863/faraday-future-announces-first-fx-6-prototype-mules-have-arrived-at-its-la-headquarters-will-begin-u", "tags": []}
{"id": 44415880, "time": "2025-03-20 08:53:33", "headline": "Allstate Announces Estimated Catastrophe Losses For The Month Of February Of $92M Or $73M, After-Tax; Total Catastrophe Losses For February Year-To-Date Were $1.17B Or $922M, After-Tax", "summary": "", "symbols": ["ALL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44415880/allstate-announces-estimated-catastrophe-losses-for-the-month-of-february-of-92m-or-73m-after-tax-t", "tags": []}
{"id": 44415886, "time": "2025-03-20 08:54:37", "headline": "'The Competition In China's Electric Vehicle Market Is Becoming More Intense Due To The Accelerated Advancement Of Intelligent Driving Technology. According To Recent Rumors, Qualcomm Has Entered The Supply Chain For Fundamental Smart Driving Models Of First-Tier Automakers By Cutting Prices' - DigiTimes Alert", "summary": "", "symbols": ["QCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415886/the-competition-in-chinas-electric-vehicle-market-is-becoming-more-intense-due-to-the-accelerated-ad", "tags": []}
{"id": 44415887, "time": "2025-03-20 08:54:44", "headline": "VEON Reports 4.7% Q4 Sales Growth As Digital Push Accelerates, Eyes Double-Digit Gains In 2025", "summary": "VEON reported strong Q4 2024 results with 4.7% sales growth and 42.4% rise in digital revenues. Multiplay customers grew 17.7% and buyback announced.", "symbols": ["VEON"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/buybacks/25/03/44415887/veon-reports-4-7-q4-sales-growth-as-digital-push-accelerates-eyes-double-digit-gains-in-2025", "tags": ["earnings", "buyback"]}
{"id": 44415893, "time": "2025-03-20 08:55:03", "headline": "Citigroup Upgrades Boston Beer Co to Buy, Raises Price Target to $280", "summary": "", "symbols": ["SAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415893/citigroup-upgrades-boston-beer-co-to-buy-raises-price-target-to-280", "tags": ["analyst_up", "price_target_up"]}
{"id": 44415905, "time": "2025-03-20 08:55:26", "headline": "Chevron CEO Reportedly Seeks Trump's Support For Venezuela Exit Extension", "summary": "In the wake of the Trump administration&#39;s decision to revoke\u00a0Chevron Corp.\u00a0(NYSE: CVX) license to operate in Venezuela, CEO Mike Wirth is seeking an extension to wind down the company&#39;s operations in the country.", "symbols": ["CVX"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/03/44415905/chevron-ceo-reportedly-seeks-trumps-support-for-venezuela-exit-extension", "tags": ["management"]}
{"id": 44415942, "time": "2025-03-20 08:57:54", "headline": "Galmed Pharmaceuticals Announces The Grant Of A New Patent Related To Aramchol; Patent Covers The Use Of A Combination Therapy Of Aramchol And Resmetirom For The Treatment Of Non-Alcoholic Steatohepatitis, Also Known As Metabolic Dysfunction-Associated Steatohepatitis, And Liver Fibrosis", "summary": "", "symbols": ["GLMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44415942/galmed-pharmaceuticals-announces-the-grant-of-a-new-patent-related-to-aramchol-patent-covers-the-", "tags": []}
{"id": 44415948, "time": "2025-03-20 08:59:30", "headline": "Citigroup Downgrades BRP to Sell, Lowers Price Target to $29", "summary": "", "symbols": ["DOOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44415948/citigroup-downgrades-brp-to-sell-lowers-price-target-to-29", "tags": ["analyst_down", "price_target_down"]}
{"id": 44416031, "time": "2025-03-20 09:00:18", "headline": "The Analyst Verdict: Freeport-McMoRan In The Eyes Of 10 Experts", "summary": " ", "symbols": ["FCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44416031/the-analyst-verdict-freeport-mcmoran-in-the-eyes-of-10-experts", "tags": []}
{"id": 44416062, "time": "2025-03-20 09:00:23", "headline": "What Does the Market Think About BXP?", "summary": " ", "symbols": ["BXP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44416062/what-does-the-market-think-about-bxp", "tags": []}
{"id": 44416087, "time": "2025-03-20 09:00:29", "headline": "What Does the Market Think About Oshkosh?", "summary": " ", "symbols": ["OSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44416087/what-does-the-market-think-about-oshkosh", "tags": []}
{"id": 44416102, "time": "2025-03-20 09:00:31", "headline": "Breaking Down Southwest Airlines: 9 Analysts Share Their Views", "summary": " ", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44416102/breaking-down-southwest-airlines-9-analysts-share-their-views", "tags": []}
{"id": 44416112, "time": "2025-03-20 09:00:34", "headline": "What Does the Market Think About Semtech?", "summary": " ", "symbols": ["SMTC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44416112/what-does-the-market-think-about-semtech", "tags": []}
{"id": 44416117, "time": "2025-03-20 09:00:37", "headline": "Expert Outlook: Boston Beer Co Through The Eyes Of 7 Analysts", "summary": " ", "symbols": ["SAM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44416117/expert-outlook-boston-beer-co-through-the-eyes-of-7-analysts", "tags": ["guidance"]}
{"id": 44416120, "time": "2025-03-20 09:00:45", "headline": "Deep Dive Into Coty Stock: Analyst Perspectives (12 Ratings)", "summary": " ", "symbols": ["COTY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44416120/deep-dive-into-coty-stock-analyst-perspectives-12-ratings", "tags": []}
{"id": 44416124, "time": "2025-03-20 09:00:53", "headline": "What Analysts Are Saying About Cava Group Stock", "summary": " ", "symbols": ["CAVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44416124/what-analysts-are-saying-about-cava-group-stock", "tags": []}
{"id": 44416134, "time": "2025-03-20 09:01:10", "headline": "4 Analysts Assess Malibu Boats: What You Need To Know", "summary": " ", "symbols": ["MBUU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44416134/4-analysts-assess-malibu-boats-what-you-need-to-know", "tags": []}
{"id": 44416157, "time": "2025-03-20 09:01:17", "headline": "Longeveron Says Co. And FDA Reached Foundational Alignment On Overall Study Design Supporting Laromestrocel In Alzheimer's Disease", "summary": "", "symbols": ["LGVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416157/longeveron-says-co-and-fda-reached-foundational-alignment-on-overall-study-design-supporting-laromes", "tags": ["fda"]}
{"id": 44416173, "time": "2025-03-20 09:01:53", "headline": "OneStream Highlights FedRAMP High Authorization", "summary": "", "symbols": ["OS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416173/onestream-highlights-fedramp-high-authorization", "tags": []}
{"id": 44416187, "time": "2025-03-20 09:02:14", "headline": "Frequency Electronics Receives $12M Contract Increase", "summary": "", "symbols": ["FEIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416187/frequency-electronics-receives-12m-contract-increase", "tags": ["contract"]}
{"id": 44416210, "time": "2025-03-20 09:02:49", "headline": "Olive Garden Parent Darden Restaurants Q3 Earnings: Sales Miss & EPS Beat, Tightened EPS Outlook And More", "summary": "Darden Restaurants reported a 6.2% YoY revenue increase to $3.158 billion for Q3, falling short of consensus. The company&#39;s same-restaurant sales rose 0.7%, driven by acquisitions. Darden&#39;s operating income grew 7.9%, and adjusted EPS of $2.80 surpassed expectations. ", "symbols": ["DRI"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/03/44416210/darden-restaurants-posts-mixed-q3-earnings-stock-slides", "tags": ["earnings", "guidance"]}
{"id": 44416211, "time": "2025-03-20 09:02:50", "headline": "Darden And Uber Announces Cheddar's Scratch Kitchen Is Next Darden Brand To Pilot On-Demand Delivery", "summary": "", "symbols": ["DRI", "UBER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416211/darden-and-uber-announces-cheddars-scratch-kitchen-is-next-darden-brand-to-pilot-on-demand-delivery", "tags": []}
{"id": 44416213, "time": "2025-03-20 09:02:55", "headline": "BioMarin Presents New Data Demonstrating Favorable Safety And Strong Adherence In Real-World Clinical Practice With VOXZOGO In Children Under 3 With Achondroplasia At 2025 ACMG Annual Clinical Genetics Meeting", "summary": "", "symbols": ["BMRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44416213/biomarin-presents-new-data-demonstrating-favorable-safety-and-strong-adherence-in-real-world-clin", "tags": ["fda"]}
{"id": 44416229, "time": "2025-03-20 09:03:44", "headline": "Tetra Tech Announces 5-Year Contract For Stormwater Management Services, Size Not Disclosed", "summary": "", "symbols": ["TTEK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416229/tetra-tech-announces-5-year-contract-for-stormwater-management-services-size-not-disclosed", "tags": ["contract"]}
{"id": 44416234, "time": "2025-03-20 09:03:49", "headline": "Phoenix Motor Expands Autonomous Tech Portfolio With Smart Delivery Robots", "summary": "Phoenix Motor Inc. (NASDAQ: PEV) rises premarket on launching autonomous robots for package pickup and delivery. AI-driven tech for contactless logistics.", "symbols": ["PEV"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/small-cap/25/03/44416234/phoenix-motor-expands-autonomous-tech-portfolio-with-smart-delivery-robots", "tags": []}
{"id": 44416235, "time": "2025-03-20 09:03:57", "headline": "XTI Aerospace Announces TriFan Engine Air Inlet And Exhaust Update", "summary": "", "symbols": ["XTIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416235/xti-aerospace-announces-trifan-engine-air-inlet-and-exhaust-update", "tags": []}
{"id": 44416271, "time": "2025-03-20 09:05:26", "headline": "IGC Pharma Announces CALMA Phase 2 Trial Expansion With The Addition Of Canadian Hamilton Health Sciences In Ontario, Canada", "summary": "", "symbols": ["IGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44416271/igc-pharma-announces-calma-phase-2-trial-expansion-with-the-addition-of-canadian-hamilton-health-", "tags": ["fda"]}
{"id": 44416287, "time": "2025-03-20 09:06:00", "headline": "the Information: 'Apple Streaming Losses Top $1 Billion a Year'", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416287/the-information-apple-streaming-losses-top-1-billion-a-year", "tags": []}
{"id": 44416298, "time": "2025-03-20 09:06:44", "headline": "'Klarna lands buy now, pay later deal with DoorDash' -CNBC Report", "summary": "", "symbols": ["DASH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416298/klarna-lands-buy-now-pay-later-deal-with-doordash-cnbc-report", "tags": ["contract"]}
{"id": 44416301, "time": "2025-03-20 09:06:49", "headline": "Benson Hill Files Voluntary Petitions For Relief Under Chapter 11 Of Title 11 Of The U.S. Bankruptcy Code; Intends To Pursue A Sale Of Its Business Under Section 363 Of The Bankruptcy Code, Including A Sale Of All Or A Portion Of The Co's Assets", "summary": "", "symbols": ["BHIL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416301/benson-hill-files-voluntary-petitions-for-relief-under-chapter-11-of-title-11-of-the-u-s-bankruptcy", "tags": []}
{"id": 44416313, "time": "2025-03-20 09:07:08", "headline": "UnitedHealth To Overhaul Payment Model To Support Independent Pharmacies", "summary": "Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting independent pharmacies nationwide.", "symbols": ["UNH"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/03/44416313/unitedhealths-optum-rx-to-overhaul-payment-model-to-support-independent-pharmacies-soon-after-cutting-reauthorizations-on-80-drugs", "tags": []}
{"id": 44416330, "time": "2025-03-20 09:07:32", "headline": "Citigroup Downgrades Polaris to Sell, Lowers Price Target to $33", "summary": "", "symbols": ["PII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416330/citigroup-downgrades-polaris-to-sell-lowers-price-target-to-33", "tags": ["analyst_down", "price_target_down"]}
{"id": 44416334, "time": "2025-03-20 09:08:02", "headline": "Solventum Reaffirms FY25 Guidance", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416334/solventum-reaffirms-fy25-guidance", "tags": ["guidance"]}
{"id": 44416338, "time": "2025-03-20 09:08:28", "headline": "VAYK Forms Partnership With Airbnb Investing Group To Launch Its Service Solution In The Near Future", "summary": "", "symbols": ["ABNB", "VAYK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416338/vayk-forms-partnership-with-airbnb-investing-group-to-launch-its-service-solution-in-the-near-future", "tags": ["contract"]}
{"id": 44416343, "time": "2025-03-20 09:09:30", "headline": "Citigroup Reinstates Neutral on Frontier Group Holdings, Announces $7.25 Price Target", "summary": "", "symbols": ["ULCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416343/citigroup-reinstates-neutral-on-frontier-group-holdings-announces-7-25-price-target", "tags": []}
{"id": 44416348, "time": "2025-03-20 09:10:06", "headline": "Leading And Lagging Sectors For March 20, 2025", "summary": " ", "symbols": ["XLC", "XLE", "XLF", "XLI", "XLK", "XLP", "XLRE", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/25/03/44416348/leading-and-lagging-sectors-for-march-20-2025", "tags": []}
{"id": 44416353, "time": "2025-03-20 09:10:16", "headline": "RLJ Lodging Trust CFO Sean Mahoney To Retire; Company Has Succession Process Underway", "summary": "", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416353/rlj-lodging-trust-cfo-sean-mahoney-to-retire-company-has-succession-process-underway", "tags": ["management"]}
{"id": 44416369, "time": "2025-03-20 09:11:14", "headline": "Roth MKM Reiterates Buy on Ispire Technology, Maintains $9 Price Target", "summary": "", "symbols": ["ISPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416369/roth-mkm-reiterates-buy-on-ispire-technology-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 44416370, "time": "2025-03-20 09:11:20", "headline": "Solventum To Present Value Creation Formula And Long-Range Plan At Investor Day; Accelerate Organic Sales Growth Of 4%-5% In 2028; Expand Operating Margins To Be 23%-25% In 2028; Generate EPS CAGR Of 10% Over The 3-Year Period Ending 2028; Drive Free Cash Flow Conversion Of 80%+", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416370/solventum-to-present-value-creation-formula-and-long-range-plan-at-investor-day-accelerate-organic-s", "tags": ["earnings"]}
{"id": 44416418, "time": "2025-03-20 09:14:17", "headline": "Oxbridge Re Holdings'  SurancePlus Announces A Strategic Partnership With Plume; Collaboration Will Significantly Enhance The Distribution Of SurancePlus' 2025-2026 Tokenized Reinsurance Securities-ZetaCat Re And EtaCat Re-Which Target Annual Returns Of 20% And 42%, Respectively", "summary": "", "symbols": ["OXBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416418/oxbridge-re-holdings-suranceplus-announces-a-strategic-partnership-with-plume-collaboration-will-sig", "tags": ["contract"]}
{"id": 44416434, "time": "2025-03-20 09:15:38", "headline": "Scotiabank Initiates Coverage On Microsoft with Sector Outperform Rating, Announces Price Target of $470", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416434/scotiabank-initiates-coverage-on-microsoft-with-sector-outperform-rating-announces-price-target-of-4", "tags": ["analyst_init"]}
{"id": 44416435, "time": "2025-03-20 09:15:44", "headline": "Oracle Expands Microsoft Partnership, Enhances Cloud Offerings", "summary": "Oracle Corp. disclosed contracts and product enhancements, including Exadata Database Service on Exascale Infrastructure, easier management and pay-as-you-go pricing, and boosted employee experience.", "symbols": ["IGV", "ORCL", "TRFK"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/03/44416435/oracle-expands-microsoft-partnership-enhances-cloud-offerings-and-secures-major-deals", "tags": ["contract"]}
{"id": 44416437, "time": "2025-03-20 09:15:52", "headline": "A Potential Challenger For AstraZeneca's Blockbuster Lung Cancer Drug?", "summary": "AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.", "symbols": ["AZN"], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/general/biotech/25/03/44416437/a-potential-challenger-for-astrazenecas-blockbuster-lung-cancer-drug", "tags": ["fda"]}
{"id": 44416444, "time": "2025-03-20 09:16:02", "headline": "Willdan Wins $17.7M Electric Vehicle Charging And Solar Contract For Paramount Unified School District", "summary": "", "symbols": ["WLDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416444/willdan-wins-17-7m-electric-vehicle-charging-and-solar-contract-for-paramount-unified-school-distric", "tags": ["contract"]}
{"id": 44416665, "time": "2025-03-20 09:17:06", "headline": "Darden Restaurants Exec Says About 80% Of Our Product Is Domestically Sourced, On What We Import, We Will Negotiate With Suppliers", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416665/darden-restaurants-exec-says-about-80-of-our-product-is-domestically-sourced-on-what-we-import-we-wi", "tags": []}
{"id": 44416666, "time": "2025-03-20 09:18:06", "headline": "Roth MKM Reiterates Buy on Byrna Technologies, Maintains $33 Price Target", "summary": "", "symbols": ["BYRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416666/roth-mkm-reiterates-buy-on-byrna-technologies-maintains-33-price-target", "tags": ["analyst_other"]}
{"id": 44416668, "time": "2025-03-20 09:18:16", "headline": "urban-gro Announces Its Architectural Division Has Signed A Professional Services Agreement Valued At ~$1.2M To Provide Architectural Design Services For Campus Enclosures With The Muscogee County School District In Georgia", "summary": "", "symbols": ["UGRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416668/urban-gro-announces-its-architectural-division-has-signed-a-professional-services-agreement-valued-a", "tags": ["contract"]}
{"id": 44416670, "time": "2025-03-20 09:19:10", "headline": "Guggenheim Maintains Buy on Reddit, Lowers Price Target to $170", "summary": "", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416670/guggenheim-maintains-buy-on-reddit-lowers-price-target-to-170", "tags": ["analyst_other", "price_target_down"]}
{"id": 44416703, "time": "2025-03-20 09:19:35", "headline": "Petros Pharmaceuticals Announces A Collaboration With Renowned Big Data And Analytics Leader To Enhance The Development Of Its Proprietary Technology Solutions Designed To Facilitate Rx-To-OTC Switches For Pharmaceutical Products", "summary": "", "symbols": ["PTPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44416703/petros-pharmaceuticals-announces-a-collaboration-with-renowned-big-data-and-analytics-leader-to-e", "tags": []}
{"id": 44416711, "time": "2025-03-20 09:20:35", "headline": "Top 10 Trending Stocks On WallStreetBets As Of March 20, 2025 (Via Swaggy Stocks)", "summary": "", "symbols": ["GLD", "GOOGL", "LINE", "MSTR", "NVDA", "QQQ", "RDDT", "TSLA", "WAR", "X"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44416711/top-10-trending-stocks-on-wallstreetbets-as-of-march-20-2025-via-swaggy-stocks", "tags": []}
{"id": 44416713, "time": "2025-03-20 09:20:47", "headline": "BTCS FY 2024 GAAP EPS $(0.08) Beats $(0.25) Estimate, Sales $4.074M Beat $3.900M Estimate", "summary": "", "symbols": ["BTCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44416713/btcs-fy-2024-gaap-eps-0-08-beats-0-25-estimate-sales-4-074m-beat-3-900m-estimate", "tags": ["earnings"]}
{"id": 44416716, "time": "2025-03-20 09:21:01", "headline": "What's Going On With Five Below Stock Thursday?", "summary": "Five Below Inc (NASDAQ:FIVE) shares are trading higher Thursday after the company reported better-than-expected financial results for the fourth quarter and issued strong first-quarter guidance.", "symbols": ["FIVE"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/25/03/44416716/whats-going-on-with-five-below-stock-thursday", "tags": ["guidance", "why_moving"]}
{"id": 44416728, "time": "2025-03-20 09:21:37", "headline": "Coherent Highlights Launch Of 2x400G-FR4 Lite Optical Transceiver", "summary": "", "symbols": ["COHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416728/coherent-highlights-launch-of-2x400g-fr4-lite-optical-transceiver", "tags": []}
{"id": 44416730, "time": "2025-03-20 09:21:58", "headline": "FactSet Surpasses Q2 Earnings Estimates, Raises FY25 Revenue Outlook Amid Client Growth", "summary": "FactSet reported Q2 earnings of $4.28 per share, surpassing estimates, and raised its FY25 revenue outlook amid strong client growth.", "symbols": ["FDS", "GABF"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/03/44416730/factset-surpasses-q2-earnings-estimates-issues-upbeat-fy25-revenue-outlook-amid-client-growth", "tags": ["earnings", "guidance"]}
{"id": 44416747, "time": "2025-03-20 09:22:49", "headline": "MAIA Biotechnology Announces The Publication Of Preclinical Data For Its Lead Proprietary Telomere-Targeting THIO Dimer In The Peer-Reviewed Scientific Journal Naunyn-Schmiedeberg's Archives Of Pharmacology; Novel THIO Dimer Shows Promise As A New Compound With A Dual Mechanism Of Action For Enhancing Standard Cancer Treatments And Overcoming Resistance", "summary": "", "symbols": ["MAIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44416747/maia-biotechnology-announces-the-publication-of-preclinical-data-for-its-lead-proprietary-telomer", "tags": []}
{"id": 44416748, "time": "2025-03-20 09:22:52", "headline": "OptiNose Stock Is Soaring Today: What's Going On?", "summary": "OptiNose Inc (NASDAQ:OPTN) shares are trading higher Thursday after Paratek Pharmaceuticals announced a deal to acquire the company.", "symbols": ["OPTN"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/25/03/44416748/optinose-stock-is-soaring-today-whats-going-on", "tags": ["why_moving", "merger", "contract"]}
{"id": 44416760, "time": "2025-03-20 09:23:49", "headline": "UBS Downgrades KE Holdings to Neutral, Announces $24.5 Price Target", "summary": "", "symbols": ["BEKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416760/ubs-downgrades-ke-holdings-to-neutral-announces-24-5-price-target", "tags": ["analyst_down"]}
{"id": 44416283, "time": "2025-03-20 09:05:52", "headline": "Carronade Capital Issued Letter To Board Of Cannae Holdings; Believes Proposed Initiatives Could Result In Share Price Upside Of At Least 50%", "summary": "", "symbols": ["CNNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416283/carronade-capital-issued-letter-to-board-of-cannae-holdings", "tags": []}
{"id": 44416776, "time": "2025-03-20 09:25:20", "headline": "Bon Natural Life Announces Patent For Revolutionary Postbiotic Ingredient, Slated To Cut Post-Meal Blood Sugar By 15%-30%", "summary": "", "symbols": ["BON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44416776/bon-natural-life-announces-patent-for-revolutionary-postbiotic-ingredient-slated-to-cut-post-meal", "tags": []}
{"id": 44416778, "time": "2025-03-20 09:25:50", "headline": "UBS Upgrades Southwest Airlines to Neutral, Raises Price Target to $36", "summary": "", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416778/ubs-upgrades-southwest-airlines-to-neutral-raises-price-target-to-36", "tags": ["analyst_up", "price_target_up"]}
{"id": 44416780, "time": "2025-03-20 09:26:02", "headline": "Golar LNG Signs Finance Lease Agreements For FLNG Gimi; Sale Leaseback Facility Will Be ~$1.2B", "summary": "", "symbols": ["GLNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416780/golar-lng-signs-finance-lease-agreements-for-flng-gimi-sale-leaseback-facility-will-be-1-2b", "tags": []}
{"id": 44416781, "time": "2025-03-20 09:26:08", "headline": "Diana Shipping Announces Time Charter Contract For m/v DSI Andromeda With Cargill; Gross Charter Rate Is $14,000 Per Day; Employment Of \"DSI Andromeda\" Is Anticipated To Generate ~$3.18M Of Gross Revenue For The Minimum Scheduled Period Of The Time Charter", "summary": "", "symbols": ["DSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416781/diana-shipping-announces-time-charter-contract-for-mv-dsi-andromeda-with-cargill-gross-charter-rate", "tags": ["earnings", "contract"]}
{"id": 44416782, "time": "2025-03-20 09:26:20", "headline": "Trump Pressures Fed To Cut Interest Rates As 'Liberation Day In America' Looms", "summary": "Trump pressures Fed for rate cut, calling tariffs Liberation Day. Fed signals economic uncertainty, lower growth forecasts, higher inflation.", "symbols": ["SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/government/regulations/25/03/44416782/trump-pressures-fed-to-cut-interest-rates-as-liberation-day-in-america-looms", "tags": []}
{"id": 44416804, "time": "2025-03-20 09:29:02", "headline": "UBS Upgrades Williams-Sonoma to Neutral, Raises Price Target to $165", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416804/ubs-upgrades-williams-sonoma-to-neutral-raises-price-target-to-165", "tags": ["analyst_up", "price_target_up"]}
{"id": 44416805, "time": "2025-03-20 09:29:16", "headline": "VivoPower International To Spin-Off Of Caret Digital Through Direct Listing On Nasdaq And Dividend Share Distribution; $250M Implied Market Capitalization", "summary": "", "symbols": ["VVPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416805/vivopower-international-to-spin-off-of-caret-digital-through-direct-listing-on-nasdaq-and-dividend-s", "tags": ["dividend"]}
{"id": 44416844, "time": "2025-03-20 09:31:14", "headline": "Guggenheim Maintains Buy on Immunome, Lowers Price Target to $25", "summary": "", "symbols": ["IMNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416844/guggenheim-maintains-buy-on-immunome-lowers-price-target-to-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 44416856, "time": "2025-03-20 09:32:28", "headline": "Ird Nvs pus Genetics Inc Filed Complaint For Patent Infringement Of Certain Ryzumvi Patents Against Sandoz In District Of New Jersey; Complaint Seeks, Among Other Relief, Equitable Relief Enjoining Sandoz From Infringing Ryzumvi Patents", "summary": "", "symbols": ["IRD", "NVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416856/ird-nvs-pus-genetics-inc-filed-complaint-for-patent-infringement-of-certain-ryzumvi-patents-against", "tags": []}
{"id": 44416877, "time": "2025-03-20 09:34:33", "headline": "Guggenheim Reiterates Buy on Absci, Maintains $10 Price Target", "summary": "", "symbols": ["ABSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416877/guggenheim-reiterates-buy-on-absci-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 44416896, "time": "2025-03-20 09:35:46", "headline": "XRP Soars 7% On SEC Win, Outperforms Bitcoin, Ethereum", "summary": "XRP (CRYPTO: XRP) is up 8.3% over the last seven days, outperforming other leading cryptocurrencies. ", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44416896/xrp-soars-7-on-sec-win-outperforms-bitcoin-ethereum", "tags": []}
{"id": 44416910, "time": "2025-03-20 09:36:17", "headline": "Trump To Unveil Next Crypto Policy Steps Thursday; Tesla Recalls 46,000 Cybertrucks Over Safety Issue With Exterior Panel; Amazon Expands Auto Platform To 68 Markets, Enters Used Car Space \u2013 Top Headlines While The U.S. Slept", "summary": " ", "symbols": ["BTCUSD", "ETHUSD", "SPY"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/03/44416910/trump-to-unveil-next-crypto-policy-steps-thursday-tesla-recalls-46000-cybertrucks-over-safety-issue-amazon-expands-auto-platform-to-68-markets-enters-used-car-space-report-top-headlines-while-the-us-slept", "tags": []}
{"id": 44416911, "time": "2025-03-20 09:36:21", "headline": "Wells Fargo Upgrades KKR to Overweight, Lowers Price Target to $141", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416911/wells-fargo-upgrades-kkr-to-overweight-lowers-price-target-to-141", "tags": ["analyst_up", "price_target_down"]}
{"id": 44416941, "time": "2025-03-20 09:37:34", "headline": "Top Analyst Urges Elon Musk To Do These 2 Things To Restore Investor Confidence In Tesla", "summary": "Wedbush analyst\u00a0Dan Ives\u00a0has urged for sweeping changes at\u00a0Tesla Inc.\u00a0(NASDAQ: TSLA) in response to the ongoing decline in the company&#39;s share price.", "symbols": ["TSLA"], "source": "benzinga", "author": "Namrata Sen", "url": "https://www.benzinga.com/markets/25/03/44416941/top-analyst-urges-elon-musk-to-do-these-2-things-to-restore-investor-confidence-in-tesla", "tags": []}
{"id": 44416968, "time": "2025-03-20 09:39:17", "headline": "Kraken To Buy NinjaTrader For $1.5 Billion, Entering US Crypto Futures Market In 2025", "summary": "Kraken to acquire NinjaTrader for $1.5 billion, expanding its offerings beyond digital assets into traditional futures trading and entering the U.S. crypto futures market with regulatory backing.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44416968/kraken-to-buy-ninjatrader-for-1-5-billion-entering-us-crypto-futures-market-in-2025", "tags": ["merger"]}
{"id": 44416994, "time": "2025-03-20 09:41:02", "headline": "Barclays Maintains Underweight on Digital Realty Trust, Lowers Price Target to $139", "summary": "", "symbols": ["DLR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416994/barclays-maintains-underweight-on-digital-realty-trust-lowers-price-target-to-139", "tags": ["analyst_other", "price_target_down"]}
{"id": 44416999, "time": "2025-03-20 09:42:05", "headline": "Barclays Maintains Equal-Weight on Equinix, Raises Price Target to $834", "summary": "", "symbols": ["EQIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44416999/barclays-maintains-equal-weight-on-equinix-raises-price-target-to-834", "tags": ["analyst_other", "price_target_up"]}
{"id": 44417000, "time": "2025-03-20 09:42:56", "headline": "Barclays Maintains Equal-Weight on Five Below, Lowers Price Target to $93", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417000/barclays-maintains-equal-weight-on-five-below-lowers-price-target-to-93", "tags": ["analyst_other", "price_target_down"]}
{"id": 44417004, "time": "2025-03-20 09:43:15", "headline": "Guggenheim Reiterates Buy on NextEra Energy, Maintains $89 Price Target", "summary": "", "symbols": ["NEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417004/guggenheim-reiterates-buy-on-nextera-energy-maintains-89-price-target", "tags": ["analyst_other"]}
{"id": 44417041, "time": "2025-03-20 09:45:18", "headline": "UK Green Transition Pushes Investment Costs, Energy Prices Higher", "summary": " ", "symbols": [], "source": "benzinga", "author": "European Capital Insights", "url": "https://www.benzinga.com/markets/eurozone/25/03/44417041/uk-green-transition-pushes-investment-costs-energy-prices-higher", "tags": []}
{"id": 44417050, "time": "2025-03-20 09:46:15", "headline": "Barclays Maintains Overweight on Iron Mountain, Lowers Price Target to $118", "summary": "", "symbols": ["IRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417050/barclays-maintains-overweight-on-iron-mountain-lowers-price-target-to-118", "tags": ["analyst_other", "price_target_down"]}
{"id": 44417203, "time": "2025-03-20 09:47:03", "headline": "Smart Money Is Betting Big In HOOD Options", "summary": " ", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44417203/smart-money-is-betting-big-in-hood-options", "tags": []}
{"id": 44417233, "time": "2025-03-20 09:47:20", "headline": "Guggenheim Reiterates Buy on Immunovantto Buy", "summary": "", "symbols": ["IMVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417233/guggenheim-reiterates-buy-on-immunovantto-buy", "tags": ["analyst_other"]}
{"id": 44417277, "time": "2025-03-20 09:50:27", "headline": "Stephens & Co. Reiterates Overweight on Origin Bancorp, Maintains $45 Price Target", "summary": "", "symbols": ["OBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417277/stephens-co-reiterates-overweight-on-origin-bancorp-maintains-45-price-target", "tags": ["analyst_other"]}
{"id": 44417227, "time": "2025-03-20 09:46:56", "headline": "This Southwest Airlines Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday", "summary": " ", "symbols": ["CVNA", "KKR", "LUV", "MOS", "SAM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44417227/this-southwest-airlines-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-thursday", "tags": ["analyst_up"]}
{"id": 44417305, "time": "2025-03-20 09:52:54", "headline": "Stephens & Co. Reiterates Overweight on Immunome, Maintains $30 Price Target", "summary": "", "symbols": ["IMNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417305/stephens-co-reiterates-overweight-on-immunome-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 44417322, "time": "2025-03-20 09:54:48", "headline": "Stephens & Co. Reiterates Equal-Weight on Ncino, Maintains $38 Price Target", "summary": "", "symbols": ["NCNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417322/stephens-co-reiterates-equal-weight-on-ncino-maintains-38-price-target", "tags": ["analyst_other"]}
{"id": 44417331, "time": "2025-03-20 09:55:09", "headline": "This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday", "summary": " ", "symbols": ["AMTM", "AVBP", "CLDX", "IP", "MSFT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44417331/this-microsoft-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday", "tags": ["analyst_init"]}
{"id": 44417350, "time": "2025-03-20 09:55:49", "headline": "'Coronis Health Enhances Healthcare Delivery Systems Through UiPath Platform' - UiPath", "summary": "", "symbols": ["PATH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417350/coronis-health-enhances-healthcare-delivery-systems-through-uipath-platform-uipath", "tags": []}
{"id": 44417393, "time": "2025-03-20 09:58:21", "headline": "'Unilever To Sell The Vegetarian Butcher To Vivera' - Unilever", "summary": "", "symbols": ["UL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417393/unilever-to-sell-the-vegetarian-butcher-to-vivera-unilever", "tags": []}
{"id": 44417408, "time": "2025-03-20 09:59:05", "headline": "Cantor Fitzgerald Reiterates Overweight on Alumisto Overweight", "summary": "", "symbols": ["ALMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417408/cantor-fitzgerald-reiterates-overweight-on-alumisto-overweight", "tags": ["analyst_other"]}
{"id": 44417418, "time": "2025-03-20 09:59:15", "headline": "CORRECTION: Jabil Raises FY25 Outlook: Adj EPS From $8.75 to $8.95 vs $8.74 Estimate; Sales From $27.30B to $27.90B vs $27.32B Estimate", "summary": "", "symbols": ["JBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417418/correction-jabil-raises-fy25-outlook-adj-eps-from-8-75-to-8-95-vs-8-74-estimate-sales-from-27-30b-to", "tags": ["earnings", "guidance"]}
{"id": 44417436, "time": "2025-03-20 10:00:05", "headline": "UBS Maintains Neutral on Ollie's Bargain Outlet, Raises Price Target to $123", "summary": "", "symbols": ["OLLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417436/ubs-maintains-neutral-on-ollies-bargain-outlet-raises-price-target-to-123", "tags": ["analyst_other", "price_target_up"]}
{"id": 44417481, "time": "2025-03-20 10:00:19", "headline": "Here's How Much $1000 Invested In Wix.com 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["WIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44417481/heres-how-much-1000-invested-in-wix-com-10-years-ago-would-be-worth-today", "tags": []}
{"id": 44417491, "time": "2025-03-20 10:00:27", "headline": "5 Analysts Assess Frontier Group Holdings: What You Need To Know", "summary": " ", "symbols": ["ULCC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44417491/5-analysts-assess-frontier-group-holdings-what-you-need-to-know", "tags": []}
{"id": 44417498, "time": "2025-03-20 10:00:39", "headline": "Expert Outlook: Origin Bancorp Through The Eyes Of 7 Analysts", "summary": " ", "symbols": ["OBK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44417498/expert-outlook-origin-bancorp-through-the-eyes-of-7-analysts", "tags": ["guidance"]}
{"id": 44417500, "time": "2025-03-20 10:00:53", "headline": "What Analysts Are Saying About Braze Stock", "summary": " ", "symbols": ["BRZE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44417500/what-analysts-are-saying-about-braze-stock", "tags": []}
{"id": 44417516, "time": "2025-03-20 10:01:08", "headline": "6 Analysts Have This To Say About Ollie's Bargain Outlet", "summary": " ", "symbols": ["OLLI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44417516/6-analysts-have-this-to-say-about-ollies-bargain-outlet", "tags": []}
{"id": 44417533, "time": "2025-03-20 10:01:23", "headline": "Cantor Fitzgerald Initiates Coverage On Titan Intl with Overweight Rating, Announces Price Target of $11", "summary": "", "symbols": ["TWI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417533/cantor-fitzgerald-initiates-coverage-on-titan-intl-with-overweight-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 44417535, "time": "2025-03-20 10:01:26", "headline": "This Is What Whales Are Betting On Deere", "summary": " ", "symbols": ["DE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44417535/this-is-what-whales-are-betting-on-deere", "tags": []}
{"id": 44417536, "time": "2025-03-20 10:01:26", "headline": "US Existing Home Sales For Feb. 4.26M Vs 3.95M Est.; 4.09M Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44417536/us-existing-home-sales-for-feb-4-26m-vs-3-95m-est-4-09m-prior", "tags": []}
{"id": 44417537, "time": "2025-03-20 10:01:29", "headline": "Expert Outlook: Equinix Through The Eyes Of 12 Analysts", "summary": " ", "symbols": ["EQIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44417537/expert-outlook-equinix-through-the-eyes-of-12-analysts", "tags": ["guidance"]}
{"id": 44417538, "time": "2025-03-20 10:01:32", "headline": "A Closer Look at NVIDIA's Options Market Dynamics", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44417538/a-closer-look-at-nvidias-options-market-dynamics", "tags": []}
{"id": 44417547, "time": "2025-03-20 10:02:09", "headline": "US Existing Home Sales (MoM) For Feb. 4.2% Vs -4.7% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44417547/us-existing-home-sales-mom-for-feb-4-2-vs-4-7-prior", "tags": []}
{"id": 44417570, "time": "2025-03-20 10:02:51", "headline": "This Constellation Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday", "summary": " ", "symbols": ["BEKE", "RIVN", "STZ", "THO", "ZTO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44417570/this-constellation-brands-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday-2", "tags": ["analyst_down"]}
{"id": 44417573, "time": "2025-03-20 10:02:58", "headline": "Highwire Confirms Acquisition Plan Of SPAR Group", "summary": "", "symbols": ["SGRP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44417573/highwire-confirms-acquisition-plan-of-spar-group", "tags": []}
{"id": 44417585, "time": "2025-03-20 10:03:06", "headline": "Cantor Fitzgerald Reiterates Overweight on Domo, Maintains $11 Price Target", "summary": "", "symbols": ["DOMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417585/cantor-fitzgerald-reiterates-overweight-on-domo-maintains-11-price-target", "tags": ["analyst_other"]}
{"id": 44417599, "time": "2025-03-20 10:03:49", "headline": "Roth MKM Maintains Buy on Energy Vault Holdings, Lowers Price Target to $1.5", "summary": "", "symbols": ["NRGV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417599/roth-mkm-maintains-buy-on-energy-vault-holdings-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44417609, "time": "2025-03-20 10:04:24", "headline": "Jabil Q2 Earnings Beat Estimates Amid Cloud And Data Center Growth, Stock Surges On Upbeat Outlook", "summary": "Jabil Q2 earnings of $1.94 per share surpassed estimates, driven by cloud and data center growth, while raising its FY25 revenue and EPS outlook.", "symbols": ["CNAV", "JBL"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/03/44417609/jabil-q2-earnings-beat-estimates-amid-cloud-and-data-center-growth-stock-surges-on-upbeat-outlook", "tags": ["earnings", "guidance"]}
{"id": 44417266, "time": "2025-03-20 09:49:21", "headline": "Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development With Clinical Trial For Canine Osteoarthritis", "summary": "", "symbols": ["CANF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44417266/xcan-fite-partner-vetbiolix-accelerate-piclidenoson-development-with-clinical-trial-for-canine-os", "tags": ["fda"]}
{"id": 44417687, "time": "2025-03-20 10:06:13", "headline": "US Leading Index (MoM) For Feb. -0.3% Vs -0.2% Est.; -0.2% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44417687/us-leading-index-mom-for-feb-0-3-vs-0-2-est-0-2-prior", "tags": []}
{"id": 44417718, "time": "2025-03-20 10:07:09", "headline": "Cantor Fitzgerald Maintains Overweight on Cigna Group, Raises Price Target to $365", "summary": "", "symbols": ["CI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417718/cantor-fitzgerald-maintains-overweight-on-cigna-group-raises-price-target-to-365", "tags": ["analyst_other", "price_target_up"]}
{"id": 44417746, "time": "2025-03-20 10:07:28", "headline": "Roth MKM Maintains Buy on BGSF, Lowers Price Target to $9", "summary": "", "symbols": ["BGSF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417746/roth-mkm-maintains-buy-on-bgsf-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44417764, "time": "2025-03-20 10:07:58", "headline": "What's Going On With Plug Power Stock Today?", "summary": "Plug Power CEO Andy Marsh commits to taking 50% of his salary in company stock.", "symbols": ["HYDR", "PLUG"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/03/44417764/whats-going-on-with-plug-power-stock-today", "tags": ["why_moving", "management"]}
{"id": 44417783, "time": "2025-03-20 10:08:26", "headline": "Ollie's Bargain Outlet Analysts Boost Their Forecasts After Q4 Results", "summary": " ", "symbols": ["OLLI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44417783/ollies-bargain-outlet-analysts-boost-their-forecasts-after-q4-results", "tags": ["earnings"]}
{"id": 44417882, "time": "2025-03-20 10:12:19", "headline": "Raymond James Maintains Strong Buy on Mid-America Apartment, Raises Price Target to $185", "summary": "", "symbols": ["MAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417882/raymond-james-maintains-strong-buy-on-mid-america-apartment-raises-price-target-to-185", "tags": ["analyst_other", "price_target_up"]}
{"id": 44417891, "time": "2025-03-20 10:13:24", "headline": "H World Posts Q4 Revenue Beat, Projects 6% Revenue Growth For 2025", "summary": "H World Group Limited shares are\u00a0trading higher on Thursday after the company\u00a0reported fourth-quarter\u00a0results.", "symbols": ["CRUZ", "HTHT", "PGJ"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/25/03/44417891/h-world-posts-q4-revenue-beat-projects-6-revenue-growth-for-2025", "tags": ["earnings"]}
{"id": 44417892, "time": "2025-03-20 10:13:24", "headline": "Raymond James Maintains Outperform on NexPoint Residential, Lowers Price Target to $44", "summary": "", "symbols": ["NXRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417892/raymond-james-maintains-outperform-on-nexpoint-residential-lowers-price-target-to-44", "tags": ["analyst_other", "price_target_down"]}
{"id": 44417899, "time": "2025-03-20 10:13:47", "headline": "Cantor Fitzgerald Reiterates Overweight on Capricor Therapeutics, Maintains $30 Price Target", "summary": "", "symbols": ["CAPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417899/cantor-fitzgerald-reiterates-overweight-on-capricor-therapeutics-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 44417951, "time": "2025-03-20 10:14:32", "headline": "Darden Restaurants Expands Uber Delivery Option To Cheddar's Following Successful Rollout At Olive Garden", "summary": "Darden Restaurants Inc (NYSE:DRI) provided a positive update on its partnership with Uber Technologies Inc (NYSE:UBER) on Thursday. The company plans to expand its delivery offering following a successful rollout.", "symbols": ["DRI", "UBER"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44417951/darden-restaurants-expands-uber-delivery-option-to-cheddars-following-successful-rollout-at-olive-garden", "tags": ["offering", "contract"]}
{"id": 44417966, "time": "2025-03-20 10:15:17", "headline": "Here's How Much $100 Invested In Morningstar 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["MORN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44417966/heres-how-much-100-invested-in-morningstar-10-years-ago-would-be-worth-today", "tags": []}
{"id": 44417977, "time": "2025-03-20 10:15:26", "headline": "UBS Maintains Buy on Signet Jewelers, Raises Price Target to $89", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44417977/ubs-maintains-buy-on-signet-jewelers-raises-price-target-to-89", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418198, "time": "2025-03-20 10:17:17", "headline": "Behind the Scenes of Eli Lilly's Latest Options Trends", "summary": " ", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44418198/behind-the-scenes-of-eli-lillys-latest-options-trends", "tags": []}
{"id": 44418200, "time": "2025-03-20 10:17:43", "headline": "What's Going On With Windtree Therapeutics Shares Thursday?", "summary": "Windtree shares are trading higher on Thursday after the company entered a license and supply agreement with Evofem.", "symbols": ["WINT"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/25/03/44418200/whats-going-on-with-windtree-therapeutics-shares-thursday", "tags": ["why_moving", "contract"]}
{"id": 44418210, "time": "2025-03-20 10:17:59", "headline": "Benchmark Maintains Buy on Sportradar Gr, Raises Price Target to $26", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418210/benchmark-maintains-buy-on-sportradar-gr-raises-price-target-to-26", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418218, "time": "2025-03-20 10:18:15", "headline": "UBS Maintains Neutral on Allegiant Travel, Lowers Price Target to $61", "summary": "", "symbols": ["ALGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418218/ubs-maintains-neutral-on-allegiant-travel-lowers-price-target-to-61", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418247, "time": "2025-03-20 10:19:21", "headline": "Piper Sandler Maintains Neutral on Aptiv, Raises Price Target to $67", "summary": "", "symbols": ["APTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418247/piper-sandler-maintains-neutral-on-aptiv-raises-price-target-to-67", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418250, "time": "2025-03-20 10:19:29", "headline": "UBS Maintains Buy on Alaska Air Gr, Lowers Price Target to $75", "summary": "", "symbols": ["ALK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418250/ubs-maintains-buy-on-alaska-air-gr-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418271, "time": "2025-03-20 10:20:24", "headline": "Piper Sandler Maintains Overweight on BorgWarner, Lowers Price Target to $36", "summary": "", "symbols": ["BWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418271/piper-sandler-maintains-overweight-on-borgwarner-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418273, "time": "2025-03-20 10:21:12", "headline": "Piper Sandler Maintains Neutral on Ford Motor, Lowers Price Target to $9", "summary": "", "symbols": ["F"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418273/piper-sandler-maintains-neutral-on-ford-motor-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418276, "time": "2025-03-20 10:21:19", "headline": "Reported Earlier: \"Eli Lilly Launches Weight-Loss Drug Mounjaro In India At $50 For 5mg Vial, Beating Novo Nordisk\" - Reuters News", "summary": "", "symbols": ["LLY", "NVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44418276/reported-earlier-eli-lilly-launches-weight-loss-drug-mounjaro-in-india-at-50-for-5mg-vial-beating", "tags": []}
{"id": 44418282, "time": "2025-03-20 10:22:11", "headline": "Piper Sandler Maintains Neutral on General Motors, Raises Price Target to $48", "summary": "", "symbols": ["GM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418282/piper-sandler-maintains-neutral-on-general-motors-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418299, "time": "2025-03-20 10:23:06", "headline": "CORRECTION: Coda Octopus Group Q1 2025 GAAP EPS $0.08 Beats $0.03 Estimate; Sales $5.21M Beats $5.10M Estimate", "summary": "", "symbols": ["CODA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44418299/correction-coda-octopus-group-q1-2025-gaap-eps-0-08-beats-0-03-estimate-sales-5-21m-beats-5-10m-est", "tags": ["earnings"]}
{"id": 44418300, "time": "2025-03-20 10:23:07", "headline": "Joby, Archer Navigate eVTOL Uncertainty As FAA Delays, Market Shifts Persist", "summary": "Analyst predicts longer, rockier road to commercialization for eVTOLs due to FAA delays &amp; regulatory hurdles. Market shrinks but defense offers potential.", "symbols": ["ACHR", "JOBY"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44418300/joby-archer-navigate-evtol-uncertainty-as-faa-delays-market-shifts-persist", "tags": []}
{"id": 44418302, "time": "2025-03-20 10:23:21", "headline": "Piper Sandler Maintains Neutral on Mobileye Global, Raises Price Target to $17", "summary": "", "symbols": ["MBLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418302/piper-sandler-maintains-neutral-on-mobileye-global-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418314, "time": "2025-03-20 10:24:07", "headline": "Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results", "summary": " ", "symbols": ["ACN", "ADAP", "BHIL", "ELEV", "OPTN", "SAG", "WINT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44418314/dow-gains-over-100-points-accenture-shares-plunge-after-q2-results", "tags": ["earnings"]}
{"id": 44418337, "time": "2025-03-20 10:25:42", "headline": "Benchmark Maintains Buy on OmniAb, Lowers Price Target to $6", "summary": "", "symbols": ["OABI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418337/benchmark-maintains-buy-on-omniab-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418354, "time": "2025-03-20 10:26:30", "headline": "Baird Maintains Outperform on Quest Diagnostics, Raises Price Target to $191", "summary": "", "symbols": ["DGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418354/baird-maintains-outperform-on-quest-diagnostics-raises-price-target-to-191", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418376, "time": "2025-03-20 10:27:27", "headline": "Is Nvidia Sitting On The AI Goldmine No One Sees Yet?", "summary": "JPMorgan analyst sees Nvidia dominating in AI and potentially outgrowing data center spending with next-gen chips and potential AI factory investments.", "symbols": ["NVDA"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/25/03/44418376/is-nvidia-sitting-on-the-ai-goldmine-no-one-sees-yet", "tags": []}
{"id": 44418379, "time": "2025-03-20 10:27:42", "headline": "Baird Maintains Neutral on Vestis, Lowers Price Target to $13", "summary": "", "symbols": ["VSTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418379/baird-maintains-neutral-on-vestis-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418380, "time": "2025-03-20 10:27:43", "headline": "UBS Maintains Buy on Five Below, Lowers Price Target to $110", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418380/ubs-maintains-buy-on-five-below-lowers-price-target-to-110", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418389, "time": "2025-03-20 10:27:57", "headline": "Citizens Capital Markets Reiterates Market Perform on Adobeto Market Perform", "summary": "", "symbols": ["ADBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418389/citizens-capital-markets-reiterates-market-perform-on-adobeto-market-perform", "tags": ["analyst_other"]}
{"id": 44418400, "time": "2025-03-20 10:29:46", "headline": "Benzinga Market Summary: S&P Continues To Rise Following Wed. Fed Decision, US Existing Home Sales Rise In Feb., Piper Sandler Downgrades Stellantis", "summary": "", "symbols": ["RMAX", "SPY", "STLA", "VTI", "Z", "ZG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44418400/benzinga-market-summary-s-p-continues-to-rise-following-wed-fed-decision-us-exist", "tags": ["analyst_down"]}
{"id": 44418407, "time": "2025-03-20 10:30:12", "headline": "If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["INTU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44418407/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 44418409, "time": "2025-03-20 10:30:16", "headline": "B of A Securities Maintains Buy on Insmed, Raises Price Target to $96", "summary": "", "symbols": ["INSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418409/b-of-a-securities-maintains-buy-on-insmed-raises-price-target-to-96", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418436, "time": "2025-03-20 10:31:43", "headline": "USA Natural Gas Storage 9B Vs 3B Est.; -62B Prior", "summary": "", "symbols": ["SPY", "UNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44418436/usa-natural-gas-storage-9b-vs-3b-est-62b-prior", "tags": []}
{"id": 44418438, "time": "2025-03-20 10:31:44", "headline": "Citizens Capital Markets Reiterates Market Outperform on Amazon.com, Maintains $285 Price Target", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418438/citizens-capital-markets-reiterates-market-outperform-on-amazon-com-maintains-285-price-target", "tags": ["analyst_other"]}
{"id": 44418501, "time": "2025-03-20 10:33:02", "headline": "UBS Maintains Buy on Omnicom Group, Lowers Price Target to $104", "summary": "", "symbols": ["OMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418501/ubs-maintains-buy-on-omnicom-group-lowers-price-target-to-104", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418531, "time": "2025-03-20 10:36:03", "headline": "Alphabet's Waymo Receives Mapping Permit For San Francisco Airport In A Step Toward SFO Robotaxi Service", "summary": "Waymo has received a temporary permit to map roadways at San Francisco International Airport (SFO), a significant milestone in the expansion of its robotaxi services.\u00a0", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/25/03/44418531/alphabets-waymo-to-begin-mapping-san-francisco-airport", "tags": []}
{"id": 44418547, "time": "2025-03-20 10:36:41", "headline": "Citizens Capital Markets Maintains Market Outperform on GDS Holdings, Raises Price Target to $40", "summary": "", "symbols": ["GDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418547/citizens-capital-markets-maintains-market-outperform-on-gds-holdings-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418578, "time": "2025-03-20 10:38:21", "headline": "UBS Maintains Buy on United Airlines Holdings, Lowers Price Target to $107", "summary": "", "symbols": ["UAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418578/ubs-maintains-buy-on-united-airlines-holdings-lowers-price-target-to-107", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418581, "time": "2025-03-20 10:38:42", "headline": "Citizens Capital Markets Reiterates Market Outperform on Precigen, Maintains $6 Price Target", "summary": "", "symbols": ["PGEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418581/citizens-capital-markets-reiterates-market-outperform-on-precigen-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 44418595, "time": "2025-03-20 10:39:48", "headline": "Why Is Specialty Retailer Designer Brands Stock Rising Today?", "summary": "Designer Brands reported a 5.4% sales decline in Q4, totaling $713.57 million, falling short of estimates. Despite this, adjusted EPS of $(0.44) beat expectations. The company expanded its gross profit margin by 80 basis points and incurred a smaller operating loss of $25.8 million. ", "symbols": ["DBI"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/earnings/25/03/44418595/why-is-specialty-retailer-designer-brands-stock-rising-today", "tags": ["earnings", "why_moving"]}
{"id": 44418617, "time": "2025-03-20 10:40:51", "headline": "UBS Maintains Neutral on Frontier Group Holdings, Lowers Price Target to $7", "summary": "", "symbols": ["ULCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418617/ubs-maintains-neutral-on-frontier-group-holdings-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418639, "time": "2025-03-20 10:42:52", "headline": "Sanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal", "summary": "Sanofi is set to acquire DR-0201 from Dren Bio for up to $1.9 billion, aiming to expand its autoimmune disease pipeline with a promising bispecific antibody.", "symbols": ["SNY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/03/44418639/sanofi-strengthens-its-immune-system-focused-pipeline-with-around-2-billion-dren-bio-deal", "tags": ["merger", "contract"]}
{"id": 44418649, "time": "2025-03-20 10:43:39", "headline": "Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday", "summary": " ", "symbols": ["CAPR", "CLEU", "CVNA", "DRI", "FIVE", "GAMB", "IMCR", "JBL", "PRA", "QXO", "RGC", "SAM", "SPRY", "TITN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44418649/jabil-posts-better-than-expected-earnings-joins-darden-restaurants-qxo-five-below-and-other-big-stocks-moving-higher-on-thursday", "tags": ["earnings", "why_moving"]}
{"id": 44418668, "time": "2025-03-20 10:44:11", "headline": "Citizens Capital Markets Reiterates Market Outperform on Sportradar Gr, Raises Price Target to $24", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418668/citizens-capital-markets-reiterates-market-outperform-on-sportradar-gr-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418677, "time": "2025-03-20 10:45:16", "headline": "$100 Invested In Linde 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["LIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44418677/100-invested-in-linde-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44418678, "time": "2025-03-20 10:45:22", "headline": "P/E Ratio Insights for Ciena", "summary": " ", "symbols": ["CIEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44418678/pe-ratio-insights-for-ciena", "tags": []}
{"id": 44418675, "time": "2025-03-20 10:45:04", "headline": "Watching Ibotta; The Bear Cave Newsletter Issues Report On Co Titled \"Problems At Ibotta (IBTA)\"", "summary": "", "symbols": ["IBTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418675/watching-ibotta-the-bear-cave-issues-report-titled-problems-at-ibotta-ibta", "tags": []}
{"id": 44418837, "time": "2025-03-20 10:48:42", "headline": "Citizens Capital Markets Reiterates Market Outperform on Vertex, Maintains $61 Price Target", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418837/citizens-capital-markets-reiterates-market-outperform-on-vertex-maintains-61-price-target", "tags": ["analyst_other"]}
{"id": 44418838, "time": "2025-03-20 10:48:43", "headline": "JP Morgan Maintains Overweight on Sportradar Gr, Raises Price Target to $26", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418838/jp-morgan-maintains-overweight-on-sportradar-gr-raises-price-target-to-26", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418854, "time": "2025-03-20 10:50:32", "headline": "Craig-Hallum Initiates Coverage On Veracyte with Buy Rating, Announces Price Target of $45", "summary": "", "symbols": ["VCYT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418854/craig-hallum-initiates-coverage-on-veracyte-with-buy-rating-announces-price-target-of-45", "tags": ["analyst_init"]}
{"id": 44418859, "time": "2025-03-20 10:51:22", "headline": "JP Morgan Maintains Overweight on Syndax Pharmaceuticals, Raises Price Target to $41", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418859/jp-morgan-maintains-overweight-on-syndax-pharmaceuticals-raises-price-target-to-41", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418860, "time": "2025-03-20 10:51:26", "headline": "Keybanc Maintains Overweight on Camping World Holdings, Lowers Price Target to $22", "summary": "", "symbols": ["CWH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418860/keybanc-maintains-overweight-on-camping-world-holdings-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418861, "time": "2025-03-20 10:51:27", "headline": "\"Southwest Air Extends Job Cuts To Workers At Four U.S. Airports; Southwest Airlines Co. Is Eliminating 120 More Jobs At Four Airports, Extending A Round Of Cutbacks That Included The Carrier's First Ever Involuntary Layoffs\" - Bloomberg News", "summary": "", "symbols": ["LUV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418861/southwest-air-extends-job-cuts-to-workers-at-four-u-s-airports-southwest-airlines-co-is-eliminating", "tags": []}
{"id": 44418866, "time": "2025-03-20 10:52:39", "headline": "Nike Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["NKE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/03/44418866/nike-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 44418876, "time": "2025-03-20 10:53:06", "headline": "FinTech Mortgage Lender Beeline's Stock Surges On AI Sales Agent Launch", "summary": "Beeline Holdings, Inc. (NASDAQ:BLNE) is set to debut its AI-driven sales platform, MagicBlocks, on April 1, 2025. Following a successful Beta phase with 16 clients, the platform demonstrates strong global expansion potential.", "symbols": ["BLNE"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/news/25/03/44418876/fintech-mortgage-lender-beelines-stock-surges-on-ai-sales-agent-launch", "tags": []}
{"id": 44418887, "time": "2025-03-20 10:53:45", "headline": "Alpha Buying: Why REIT Insiders Are Betting Big Amid Economic Uncertainty", "summary": " ", "symbols": ["DRH", "PEB"], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/25/03/44418887/alpha-buying-why-reit-insiders-are-betting-big-amid-economic-uncertainty", "tags": []}
{"id": 44418891, "time": "2025-03-20 10:54:10", "headline": "US Home Sales Jump In February, Median Price Nears $400,000: 'Next Big Move Could Shock Everyone,' Analysts Say", "summary": "Existing home sales rebounded in February, with prices inching closer to $400,000. Analysts say tight inventory may drive another surge despite affordability concerns.", "symbols": ["SPY", "VNQ"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44418891/us-home-sales-jump-in-february-median-price-nears-400000-next-big-move-could-shock-everyone-analysts-say", "tags": []}
{"id": 44418892, "time": "2025-03-20 10:54:11", "headline": "Goldman Sachs Assumes Coinbase Global at Neutral, Announces Price Target of $195", "summary": "", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418892/goldman-sachs-assumes-coinbase-global-at-neutral-announces-price-target-of-195", "tags": []}
{"id": 44418893, "time": "2025-03-20 10:54:30", "headline": "Keybanc Maintains Overweight on Winnebago Industries, Lowers Price Target to $47", "summary": "", "symbols": ["WGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418893/keybanc-maintains-overweight-on-winnebago-industries-lowers-price-target-to-47", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418894, "time": "2025-03-20 10:54:35", "headline": "JP Morgan Maintains Neutral on Veeva Systems, Raises Price Target to $249", "summary": "", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418894/jp-morgan-maintains-neutral-on-veeva-systems-raises-price-target-to-249", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418939, "time": "2025-03-20 10:57:28", "headline": "Impact BioMedical Shares Halted On Circuit Breaker To The Upside, Stock Now 228.3%", "summary": "", "symbols": ["IBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44418939/impact-biomedical-shares-halted-on-circuit-breaker-to-the-upside-stock-now-228-3", "tags": ["halt"]}
{"id": 44418942, "time": "2025-03-20 10:58:11", "headline": "JP Morgan Maintains Neutral on Williams-Sonoma, Raises Price Target to $168", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418942/jp-morgan-maintains-neutral-on-williams-sonoma-raises-price-target-to-168", "tags": ["analyst_other", "price_target_up"]}
{"id": 44418944, "time": "2025-03-20 10:58:18", "headline": "Wedbush Reiterates Outperform on Immunome, Maintains $33 Price Target", "summary": "", "symbols": ["IMNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418944/wedbush-reiterates-outperform-on-immunome-maintains-33-price-target", "tags": ["analyst_other"]}
{"id": 44418958, "time": "2025-03-20 10:59:46", "headline": "Maxim Group Maintains Buy on scPharmaceuticals, Lowers Price Target to $12", "summary": "", "symbols": ["SCPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418958/maxim-group-maintains-buy-on-scpharmaceuticals-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 44418983, "time": "2025-03-20 11:00:09", "headline": "Preview: Baiya International Group Inc Set To IPO Tomorrow", "summary": " ", "symbols": ["BIYA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/ipos/25/03/44418983/preview-baiya-international-group-inc-set-to-ipo-tomorrow", "tags": []}
{"id": 44418991, "time": "2025-03-20 11:00:10", "headline": "This Senator Just Sold Up To $500K In PepsiCo Stock", "summary": " ", "symbols": ["GIS", "PEP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/government/25/03/44418991/this-senator-just-sold-up-to-500k-in-pepsico-stock", "tags": []}
{"id": 44418995, "time": "2025-03-20 11:00:15", "headline": "Avalanche Falls More Than 3% In 24 hours", "summary": "Avalanche&#39;s (CRYPTO: AVAX) price has decreased 3.12% over the past 24 hours to $19.14. This is contrary to the coins performance over the past week where it has experienced an up-trend of 2.0%, moving from $18.57 to its current price.", "symbols": ["AVAXUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/25/03/44418995/avalanche-falls-more-than-3-in-24-hours", "tags": []}
{"id": 44418996, "time": "2025-03-20 11:00:15", "headline": "Here's How Much You Would Have Made Owning Strategy Stock In The Last 20 Years", "summary": " ", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44418996/heres-how-much-you-would-have-made-owning-strategy-stock-in-the-last-20-years", "tags": []}
{"id": 44418997, "time": "2025-03-20 11:00:15", "headline": "Market Analysis: NVIDIA And Competitors In Semiconductors &amp; Semiconductor Equipment Industry", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44418997/market-analysis-nvidia-and-competitors-in-semiconductors-amp-semiconductor-equipment-industry", "tags": []}
{"id": 44418998, "time": "2025-03-20 11:00:15", "headline": "JP Morgan Maintains Neutral on Yum Brands, Raises Price Target to $160", "summary": "", "symbols": ["YUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44418998/jp-morgan-maintains-neutral-on-yum-brands-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419007, "time": "2025-03-20 11:00:25", "headline": "Insights Into Microsoft's Performance Versus Peers In Software Sector", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44419007/insights-into-microsofts-performance-versus-peers-in-software-sector", "tags": []}
{"id": 44419025, "time": "2025-03-20 11:00:33", "headline": "In-Depth Analysis: Meta Platforms Versus Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44419025/in-depth-analysis-meta-platforms-versus-competitors-in-interactive-media-amp-services-industry", "tags": []}
{"id": 44419028, "time": "2025-03-20 11:00:36", "headline": "Wedbush Maintains Neutral on Williams-Sonoma, Lowers Price Target to $170", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419028/wedbush-maintains-neutral-on-williams-sonoma-lowers-price-target-to-170", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419035, "time": "2025-03-20 11:00:43", "headline": "Exploring The Competitive Space: Amazon.com Versus Industry Peers In Broadline Retail", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44419035/exploring-the-competitive-space-amazon-com-versus-industry-peers-in-broadline-retail", "tags": []}
{"id": 44419038, "time": "2025-03-20 11:00:52", "headline": "Understanding Apple's Position In Technology Hardware, Storage &amp; Peripherals Industry Compared To Competitors", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44419038/understanding-apples-position-in-technology-hardware-storage-amp-peripherals-industry-compared-to-c", "tags": []}
{"id": 44419042, "time": "2025-03-20 11:01:05", "headline": "Maxim Group Maintains Buy on Silexion Therapeutics, Lowers Price Target to $5", "summary": "", "symbols": ["SLXN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419042/maxim-group-maintains-buy-on-silexion-therapeutics-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419044, "time": "2025-03-20 11:01:13", "headline": "What's Going On With ProAssurance Stock Thursday?", "summary": "ProAssurance stock is moving higher on Thursday after the company announced it will be acquired by The Doctors Company, a medical malpractice insurer.", "symbols": ["PRA"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/25/03/44419044/whats-going-on-with-proassurance-stock-thursday", "tags": ["why_moving", "merger"]}
{"id": 44419081, "time": "2025-03-20 11:02:16", "headline": "Five Below Posts Q4 Earnings Beat: FY25 Guidance Reflects Tariff Headwinds, Analysts Say", "summary": "FIVE stock up on Q4 earnings beat amid exciting earnings season. JPMorgan rates Underweight, Goldman Sachs rates Buy. ", "symbols": ["FIVE"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/news/earnings/earnings-beats/25/03/44419081/five-below-posts-q4-earnings-beat-fy25-guidance-reflects-tariff-headwinds-analysts-say", "tags": ["earnings", "guidance"]}
{"id": 44419096, "time": "2025-03-20 11:02:37", "headline": "Commercial Metals Reports Softer Q2 Results, Maintains Confidence In Upcoming Construction Season Momentum", "summary": "Commercial Metals reported Q2 2025 results, with net sales down 5.1% and adjusted EPS of 26 cents, missing expectations. Strong demand in NA and cost control boosted profitability.", "symbols": ["CMC"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/25/03/44419096/cmc-reports-softer-q2-results-maintains-confidence-in-upcoming-construction-season-momentum", "tags": ["analyst_other", "earnings"]}
{"id": 44419099, "time": "2025-03-20 11:02:46", "headline": "Wedbush Reiterates Outperform on Microsoft, Maintains $550 Price Target", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419099/wedbush-reiterates-outperform-on-microsoft-maintains-550-price-target", "tags": ["analyst_other"]}
{"id": 44419119, "time": "2025-03-20 11:03:57", "headline": "Making Kennedy Proud Again? New Poll Shows 34% Of Diners More Likely To Try Food Cooked In Beef Tallow", "summary": "Restaurant diners appear ready to try the beef tallow cooking method supported by Robert F. Kennedy Jr. based on the results of a new poll.", "symbols": ["BH", "QSR", "SG"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/25/03/44419119/making-kennedy-proud-again-new-poll-shows-34-of-diners-more-likely-to-try-food-cooked-in-beef-tallow", "tags": []}
{"id": 44419120, "time": "2025-03-20 11:03:58", "headline": "What's Going On With Aurora Cannabis Shares Thursday?", "summary": "Aurora shares are trading higher on Thursday after the company announced it discovered a novel source of genetic resistance against powdery mildew.", "symbols": ["ACB"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44419120/whats-going-on-with-aurora-cannabis-shares-thursday", "tags": ["why_moving"]}
{"id": 44419122, "time": "2025-03-20 11:04:00", "headline": "Morgan Stanley Assumes Blueprint Medicines at Equal-Weight, Lowers Price Target of $100", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419122/morgan-stanley-assumes-blueprint-medicines-at-equal-weight-lowers-price-target-of-100", "tags": ["price_target_down"]}
{"id": 44419123, "time": "2025-03-20 11:04:04", "headline": "JP Morgan Maintains Neutral on Bloomin Brands, Lowers Price Target to $9", "summary": "", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419123/jp-morgan-maintains-neutral-on-bloomin-brands-lowers-price-target-to-9", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419142, "time": "2025-03-20 11:04:52", "headline": "Wedbush Reiterates Outperform on Tesla, Maintains $550 Price Target", "summary": "", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419142/wedbush-reiterates-outperform-on-tesla-maintains-550-price-target", "tags": ["analyst_other"]}
{"id": 44419189, "time": "2025-03-20 11:06:45", "headline": "Morgan Stanley Maintains Equal-Weight on Ameren, Raises Price Target to $101", "summary": "", "symbols": ["AEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419189/morgan-stanley-maintains-equal-weight-on-ameren-raises-price-target-to-101", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419224, "time": "2025-03-20 11:07:49", "headline": "Morgan Stanley Maintains Overweight on American Electric Power, Raises Price Target to $113", "summary": "", "symbols": ["AEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419224/morgan-stanley-maintains-overweight-on-american-electric-power-raises-price-target-to-113", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419233, "time": "2025-03-20 11:08:15", "headline": "Impact BioMedical Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 311.3%", "summary": "", "symbols": ["IBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44419233/impact-biomedical-shares-resume-trade-then-again-halt-on-circuit-breaker-to-the-upside-stock-now-up", "tags": ["halt"]}
{"id": 44419251, "time": "2025-03-20 11:08:56", "headline": "Morgan Stanley Maintains Overweight on Atmos Energy, Raises Price Target to $147", "summary": "", "symbols": ["ATO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419251/morgan-stanley-maintains-overweight-on-atmos-energy-raises-price-target-to-147", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419277, "time": "2025-03-20 11:09:34", "headline": "JP Morgan Maintains Neutral on Chipotle Mexican Grill, Lowers Price Target to $58", "summary": "", "symbols": ["CMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419277/jp-morgan-maintains-neutral-on-chipotle-mexican-grill-lowers-price-target-to-58", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419292, "time": "2025-03-20 11:10:25", "headline": "Morgan Stanley Maintains Equal-Weight on CenterPoint Energy, Raises Price Target to $34", "summary": "", "symbols": ["CNP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419292/morgan-stanley-maintains-equal-weight-on-centerpoint-energy-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419298, "time": "2025-03-20 11:11:00", "headline": "Why The Future Of Stablecoins Like USDT, USDC Looks Bright: Report", "summary": "Stablecoins are rapidly evolving beyond their original role as digital cash substitutes, with a new generation of yield-bearing and revenue-sharing models reshaping how these assets are used in financial ecosystems, according to a report.", "symbols": ["BTCUSD", "ETHUSD", "SOLUSD", "USDCUSD", "USDTUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44419298/why-the-future-of-stablecoins-like-usdt-usdc-looks-bright-report", "tags": ["earnings"]}
{"id": 44419312, "time": "2025-03-20 11:11:29", "headline": "Morgan Stanley Maintains Underweight on Consolidated Edison, Raises Price Target to $91", "summary": "", "symbols": ["ED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419312/morgan-stanley-maintains-underweight-on-consolidated-edison-raises-price-target-to-91", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419381, "time": "2025-03-20 11:12:36", "headline": "Morgan Stanley Maintains Equal-Weight on Dominion Energy, Raises Price Target to $63", "summary": "", "symbols": ["D"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419381/morgan-stanley-maintains-equal-weight-on-dominion-energy-raises-price-target-to-63", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419401, "time": "2025-03-20 11:13:41", "headline": "Morgan Stanley Maintains Overweight on DTE Energy, Raises Price Target to $136", "summary": "", "symbols": ["DTE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419401/morgan-stanley-maintains-overweight-on-dte-energy-raises-price-target-to-136", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419422, "time": "2025-03-20 11:14:11", "headline": "HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target", "summary": "", "symbols": ["ATNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419422/hc-wainwright-co-reiterates-buy-on-actinium-pharma-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 44419438, "time": "2025-03-20 11:14:44", "headline": "JP Morgan Maintains Neutral on General Mills, Lowers Price Target to $54", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419438/jp-morgan-maintains-neutral-on-general-mills-lowers-price-target-to-54", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419443, "time": "2025-03-20 11:15:05", "headline": "Morgan Stanley Maintains Equal-Weight on Duke Energy, Raises Price Target to $128", "summary": "", "symbols": ["DUK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419443/morgan-stanley-maintains-equal-weight-on-duke-energy-raises-price-target-to-128", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419447, "time": "2025-03-20 11:15:18", "headline": "$1000 Invested In Marriott International 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["MAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44419447/1000-invested-in-marriott-international-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44419460, "time": "2025-03-20 11:16:03", "headline": "Decoding Snowflake's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44419460/decoding-snowflakes-options-activity-whats-the-big-picture", "tags": []}
{"id": 44419463, "time": "2025-03-20 11:16:06", "headline": "HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target", "summary": "", "symbols": ["PHAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419463/hc-wainwright-co-reiterates-buy-on-pharming-maintains-37-price-target", "tags": ["analyst_other"]}
{"id": 44419464, "time": "2025-03-20 11:16:07", "headline": "Morgan Stanley Maintains Underweight on Edison Intl, Raises Price Target to $52", "summary": "", "symbols": ["EIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419464/morgan-stanley-maintains-underweight-on-edison-intl-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419507, "time": "2025-03-20 11:17:03", "headline": "Morgan Stanley Maintains Equal-Weight on Entergy, Raises Price Target to $78", "summary": "", "symbols": ["ETR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419507/morgan-stanley-maintains-equal-weight-on-entergy-raises-price-target-to-78", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419596, "time": "2025-03-20 11:17:55", "headline": "Morgan Stanley Maintains Equal-Weight on Exelon, Raises Price Target to $48", "summary": "", "symbols": ["EXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419596/morgan-stanley-maintains-equal-weight-on-exelon-raises-price-target-to-48", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419599, "time": "2025-03-20 11:18:02", "headline": "HC Wainwright & Co. Reiterates Neutral on Xenetic Biosciencesto Neutral", "summary": "", "symbols": ["XBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419599/hc-wainwright-co-reiterates-neutral-on-xenetic-biosciencesto-neutral", "tags": ["analyst_other"]}
{"id": 44419605, "time": "2025-03-20 11:18:31", "headline": "JP Morgan Maintains Neutral on Omnicell, Lowers Price Target to $36", "summary": "", "symbols": ["OMCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419605/jp-morgan-maintains-neutral-on-omnicell-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419607, "time": "2025-03-20 11:18:53", "headline": "Baidu Stock Nears A Golden Cross As AI Ambitions Spark Bullish Momentum", "summary": "Baidu Inc. (NASDAQ:BIDU) is showing signs of a potential breakout, approaching a Golden Cross with its stock price climbing above key moving averages.", "symbols": ["BIDU"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/25/03/44419607/baidu-stock-nears-a-golden-cross-as-ai-ambitions-spark-bullish-momentum", "tags": []}
{"id": 44419609, "time": "2025-03-20 11:19:05", "headline": "Morgan Stanley Maintains Overweight on FirstEnergy, Lowers Price Target to $48", "summary": "", "symbols": ["FE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419609/morgan-stanley-maintains-overweight-on-firstenergy-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419610, "time": "2025-03-20 11:19:06", "headline": "Impact BioMedical Shares Resume Trade Then Halted On Circuit Breaker To The Downside, Stock Now Up 301.9%", "summary": "", "symbols": ["IBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44419610/impact-biomedical-shares-resume-trade-then-halted-on-circuit-breaker-to-the-downside-stock-now-up-3", "tags": ["halt"]}
{"id": 44419639, "time": "2025-03-20 11:19:36", "headline": "CORRECTION: Impact BioMedical Ticker Is \"IBO\"", "summary": "", "symbols": ["IBIO", "IBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/03/44419639/correction-impact-biomedical-ticker-is-ibo", "tags": []}
{"id": 44419652, "time": "2025-03-20 11:19:58", "headline": "Morgan Stanley Maintains Equal-Weight on Idacorp, Raises Price Target to $131", "summary": "", "symbols": ["IDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419652/morgan-stanley-maintains-equal-weight-on-idacorp-raises-price-target-to-131", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419656, "time": "2025-03-20 11:20:34", "headline": "JP Morgan Maintains Overweight on Restaurant Brands Intl, Lowers Price Target to $78", "summary": "", "symbols": ["QSR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419656/jp-morgan-maintains-overweight-on-restaurant-brands-intl-lowers-price-target-to-78", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419660, "time": "2025-03-20 11:21:03", "headline": "Morgan Stanley Maintains Underweight on MGE Energy, Raises Price Target to $80", "summary": "", "symbols": ["MGEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419660/morgan-stanley-maintains-underweight-on-mge-energy-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419665, "time": "2025-03-20 11:22:00", "headline": "Morgan Stanley Maintains Overweight on NextEra Energy, Raises Price Target to $97", "summary": "", "symbols": ["NEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419665/morgan-stanley-maintains-overweight-on-nextera-energy-raises-price-target-to-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419678, "time": "2025-03-20 11:23:00", "headline": "Morgan Stanley Maintains Equal-Weight on ONE Gas, Raises Price Target to $70", "summary": "", "symbols": ["OGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419678/morgan-stanley-maintains-equal-weight-on-one-gas-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419685, "time": "2025-03-20 11:23:57", "headline": "Morgan Stanley Maintains Underweight on PG&E, Raises Price Target to $17.5", "summary": "", "symbols": ["PCG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419685/morgan-stanley-maintains-underweight-on-pg-e-raises-price-target-to-17-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419686, "time": "2025-03-20 11:24:09", "headline": "JP Morgan Maintains Underweight on Shake Shack, Lowers Price Target to $105", "summary": "", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419686/jp-morgan-maintains-underweight-on-shake-shack-lowers-price-target-to-105", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419698, "time": "2025-03-20 11:24:50", "headline": "Morgan Stanley Maintains Equal-Weight on Pinnacle West Capital, Raises Price Target to $88", "summary": "", "symbols": ["PNW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419698/morgan-stanley-maintains-equal-weight-on-pinnacle-west-capital-raises-price-target-to-88", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419711, "time": "2025-03-20 11:25:32", "headline": "Fartcoin Soars 13% In A Day Outpacing Dogecoin, Shiba Inu: Is A Return To All-Time Highs In The Cards?", "summary": "Popular meme coin Fartcoin (CRYPTO: FARTCOIN) is rebounding, leading to renewed optimism among traders for a sustained meme coin rally.", "symbols": ["DOGEUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44419711/fartcoin-soars-13-in-a-day-outpacing-dogecoin-shiba-inu-is-a-return-to-all-time-highs-in-the-cards", "tags": []}
{"id": 44419712, "time": "2025-03-20 11:25:36", "headline": "Morgan Stanley Maintains Overweight on PPL, Raises Price Target to $38", "summary": "", "symbols": ["PPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419712/morgan-stanley-maintains-overweight-on-ppl-raises-price-target-to-38", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419721, "time": "2025-03-20 11:26:02", "headline": "PTC Therapeutics Reveals New Sepiapterin Data From Phase 3 Study In Patients With Inherited Disorder, FDA Decision Expected In July", "summary": "PTC Therapeutics presented new Phase 3 data on sepiapterin, showing potential benefits for PKU patients ahead of key regulatory decisions in 2025.", "symbols": ["PTCT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/03/44419721/ptc-therapeutics-reveals-new-sepiapterin-data-from-phase-3-study-in-patients-with-inherited-disorder-fda-decision-expected-in-july", "tags": ["fda"]}
{"id": 44419727, "time": "2025-03-20 11:26:08", "headline": "JP Morgan Maintains Neutral on Texas Roadhouse, Lowers Price Target to $184", "summary": "", "symbols": ["TXRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419727/jp-morgan-maintains-neutral-on-texas-roadhouse-lowers-price-target-to-184", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419730, "time": "2025-03-20 11:26:27", "headline": "Morgan Stanley Maintains Overweight on Public Service Enterprise, Raises Price Target to $100", "summary": "", "symbols": ["PEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419730/morgan-stanley-maintains-overweight-on-public-service-enterprise-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419751, "time": "2025-03-20 11:27:12", "headline": "Morgan Stanley Maintains Overweight on Sempra, Raises Price Target to $86", "summary": "", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419751/morgan-stanley-maintains-overweight-on-sempra-raises-price-target-to-86", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419772, "time": "2025-03-20 11:28:08", "headline": "Morgan Stanley Maintains Equal-Weight on Southern, Raises Price Target to $91", "summary": "", "symbols": ["SO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419772/morgan-stanley-maintains-equal-weight-on-southern-raises-price-target-to-91", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419779, "time": "2025-03-20 11:29:01", "headline": "JP Morgan Maintains Underweight on Cheesecake Factory, Lowers Price Target to $48", "summary": "", "symbols": ["CAKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419779/jp-morgan-maintains-underweight-on-cheesecake-factory-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 44419780, "time": "2025-03-20 11:29:02", "headline": "Morgan Stanley Maintains Equal-Weight on Spire, Raises Price Target to $78", "summary": "", "symbols": ["SR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419780/morgan-stanley-maintains-equal-weight-on-spire-raises-price-target-to-78", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419789, "time": "2025-03-20 11:29:57", "headline": "Morgan Stanley Maintains Equal-Weight on Xcel Energy, Raises Price Target to $78", "summary": "", "symbols": ["XEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419789/morgan-stanley-maintains-equal-weight-on-xcel-energy-raises-price-target-to-78", "tags": ["analyst_other", "price_target_up"]}
{"id": 44419798, "time": "2025-03-20 11:30:14", "headline": "$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44419798/1000-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44419802, "time": "2025-03-20 11:30:23", "headline": "Peering Into Penumbra's Recent Short Interest", "summary": " ", "symbols": ["PEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44419802/peering-into-penumbras-recent-short-interest", "tags": []}
{"id": 44419809, "time": "2025-03-20 11:30:28", "headline": "What Does the Market Think About Abbott Laboratories?", "summary": " ", "symbols": ["ABT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44419809/what-does-the-market-think-about-abbott-laboratories", "tags": []}
{"id": 44419814, "time": "2025-03-20 11:30:33", "headline": "Is Pure Storage Gaining or Losing Market Support?", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44419814/is-pure-storage-gaining-or-losing-market-support", "tags": []}
{"id": 44419918, "time": "2025-03-20 11:32:29", "headline": "Caleres Reports Lower Q4 Sales, Cautious Outlook For 2025 Amid Inflation And Tariffs", "summary": "Caleres shares rise after reporting Q4 results. Revenues down 8.3%, adjusted EPS beats consensus, Outlook for FY25 and Q1 is lower.", "symbols": ["CAL", "TPR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/25/03/44419918/caleres-reports-lower-q4-sales-cautious-outlook-for-2025-amid-inflation-and-tariffs", "tags": ["earnings", "guidance"]}
{"id": 44419975, "time": "2025-03-20 11:34:45", "headline": "HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target", "summary": "", "symbols": ["ESPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44419975/hc-wainwright-co-reiterates-buy-on-esperion-therapeutics-maintains-16-price-target", "tags": ["analyst_other"]}
{"id": 44420017, "time": "2025-03-20 11:38:39", "headline": "HC Wainwright & Co. Reiterates Buy on Regenxbio, Maintains $34 Price Target", "summary": "", "symbols": ["RGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420017/hc-wainwright-co-reiterates-buy-on-regenxbio-maintains-34-price-target", "tags": ["analyst_other"]}
{"id": 44420020, "time": "2025-03-20 11:39:27", "headline": "Scotiabank Maintains Sector Outperform on Alimentation Couche-Tard, Lowers Price Target to C$83", "summary": "", "symbols": ["TSX:ATD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420020/scotiabank-maintains-sector-outperform-on-alimentation-couche-tard-lowers-price-target-to-c-83", "tags": ["analyst_other", "price_target_down"]}
{"id": 44420034, "time": "2025-03-20 11:39:31", "headline": "D-Wave Unveils New Blockchain Architecture To Slash Energy Usage", "summary": "D-Wave Quantum Inc. (NYSE: QBTS) unveils a new blockchain architecture in its latest research, combining quantum computing with traditional blockchain to improve security and efficiency. The study, &#34;Blockchain with Proof of Quantum Work,&#34; introduces a quantum-powered algorithm that significantly reduces energy consumption, potentially slashing it by up to 1,000 times compared to traditional methods.", "symbols": ["QBTS"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/03/44420034/d-waves-new-blockchain-architecture-could-slash-energy-usage-by-1000x", "tags": []}
{"id": 44420061, "time": "2025-03-20 11:43:05", "headline": "Scotiabank Maintains Sector Outperform on Liquidia, Raises Price Target to $34", "summary": "", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420061/scotiabank-maintains-sector-outperform-on-liquidia-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 44420120, "time": "2025-03-20 11:45:07", "headline": "Why Bakkt (BKKT) Stock Is Skyrocketing Today", "summary": "Bakkt shares are trading higher by 35% during Thursday&#39;s session. The company announced a strategic partnership with Distributed Technologies.", "symbols": ["BKKT"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/03/44420120/why-bakkt-bkkt-stock-is-skyrocketing-today", "tags": ["why_moving", "contract"]}
{"id": 44420122, "time": "2025-03-20 11:45:12", "headline": "Donald Trump Calls For Stablecoin Legislation, Lauds Bitcoin Reserve: 'Biden Got A Fraction Of Their Value'", "summary": "U.S.", "symbols": ["BTCUSD", "MSTR", "XRPUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44420122/donald-trump-calls-for-stablecoin-legislation-lauds-bitcoin-reserve-biden-got-a-fraction-of-their-value", "tags": []}
{"id": 44420123, "time": "2025-03-20 11:45:17", "headline": "If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["COST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44420123/if-you-invested-100-in-this-stock-15-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 44420152, "time": "2025-03-20 11:46:32", "headline": "Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%", "summary": "Elevation Oncology ends EO-3021 development after Phase 1 results, shifts focus to EO-1022, and plans a major workforce reduction to extend funding.", "symbols": ["ELEV"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/03/44420152/elevation-oncology-stops-early-stage-gastric-cancer-study-after-disappointing-data-lays-off-70-of-staff", "tags": ["fda"]}
{"id": 44420278, "time": "2025-03-20 11:48:22", "headline": "BTIG Initiates Coverage On Orchestra BioMed Hldgs with Buy Rating, Announces Price Target of $12", "summary": "", "symbols": ["OBIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420278/btig-initiates-coverage-on-orchestra-biomed-hldgs-with-buy-rating-announces-price-target-of-12", "tags": ["analyst_init"]}
{"id": 44420280, "time": "2025-03-20 11:48:45", "headline": "Scotiabank Maintains Sector Perform on Sarepta Therapeutics, Lowers Price Target to $80", "summary": "", "symbols": ["SRPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420280/scotiabank-maintains-sector-perform-on-sarepta-therapeutics-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 44420327, "time": "2025-03-20 11:50:51", "headline": "Darden Restaurants CEO Says Consumers 'Likely To Keep Spending' Despite 'Challenging Environment'", "summary": "Darden Restaurants CEO Rick Cardenas says Thursday that the company has seen resilience in consumer spending when it comes to dining out.\u00a0", "symbols": ["DRI"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/restaurants/25/03/44420327/darden-restaurants-ceo-says-consumers-likely-to-keep-spending-despite-challenging-environment", "tags": ["management"]}
{"id": 44420344, "time": "2025-03-20 11:51:18", "headline": "Bernstein Initiates Coverage On HubSpot with Market Perform Rating, Announces Price Target of $693", "summary": "", "symbols": ["HUBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420344/bernstein-initiates-coverage-on-hubspot-with-market-perform-rating-announces-price-target-of-693", "tags": ["analyst_init"]}
{"id": 44420348, "time": "2025-03-20 11:51:29", "headline": "Why Is ZEEKR Stock Plunging Today?", "summary": "Zeekr Group reported 39% increase in revenue for Q4, but missed analyst estimate. Total vehicle deliveries up 99.8% Y/Y and gross margin expanded. ", "symbols": ["IDRV", "ZK"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/earnings/25/03/44420348/why-is-zeekr-stock-plunging-today", "tags": ["earnings", "why_moving"]}
{"id": 44420360, "time": "2025-03-20 11:51:52", "headline": "Monolithic Power Systems Raises Q1 Revenue Guidance From $610M-$630M To $630M-$640M Vs $578.09M Est.", "summary": "", "symbols": ["MPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420360/monolithic-power-systems-raises-q1-revenue-guidance-from-610m-630m-to-630m-640m-vs-578-09m-est", "tags": ["earnings", "guidance"]}
{"id": 44420371, "time": "2025-03-20 11:52:56", "headline": "What's Going On With XPeng (XPEV) Stock?", "summary": "XPeng shares are trading lower by 7.2% during Thursday&#39;s session. The stock has been volatile this week after reporting fourth-quarter results.", "symbols": ["XPEV"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/03/44420371/whats-going-on-with-xpeng-xpev-stock", "tags": ["why_moving"]}
{"id": 44420422, "time": "2025-03-20 11:55:21", "headline": "HC Wainwright & Co. Reiterates Neutral on Avalo Therapeuticsto Neutral", "summary": "", "symbols": ["AVTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420422/hc-wainwright-co-reiterates-neutral-on-avalo-therapeuticsto-neutral", "tags": ["analyst_other"]}
{"id": 44420425, "time": "2025-03-20 11:55:27", "headline": "Carvana 'Can Grow Aggressively,' Newcomer Amazon Auto Limited To Just One Brand: Analyst", "summary": "Amazon Auto does not represent any direct competition for Carvana since its selection is limited to just one car brand.", "symbols": ["AMZN", "CVNA"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44420425/carvana-can-grow-amazon-auto-limited-analysts", "tags": []}
{"id": 44420450, "time": "2025-03-20 11:56:16", "headline": "Short Seller Says Ibotta Is A 'Broken Business' Bound For Lower Share Prices", "summary": "Short seller The Bear Cave has taken a swipe at Ibotta Inc (NYSE:IBTA) in a new report highlighting slowing growth and collapsing customer and employee relationships.", "symbols": ["IBTA"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/25/03/44420450/short-seller-says-ibotta-is-a-broken-business-bound-for-lower-share-prices", "tags": []}
{"id": 44420557, "time": "2025-03-20 12:00:14", "headline": "Here's How Much $100 Invested In Datadog 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["DDOG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44420557/heres-how-much-100-invested-in-datadog-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44420567, "time": "2025-03-20 12:00:26", "headline": "P/E Ratio Insights for argenx", "summary": " ", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44420567/pe-ratio-insights-for-argenx", "tags": []}
{"id": 44420584, "time": "2025-03-20 12:01:03", "headline": "Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase", "summary": " ", "symbols": ["AKBA", "BHIL", "ELEV", "OPTN", "PRA", "WINT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/25/03/44420584/crude-oil-gains-over-1-us-weekly-jobless-claims-increase", "tags": []}
{"id": 44420616, "time": "2025-03-20 12:01:51", "headline": "Stagwell To Increase 2025 Ad Spend In News By 22% YoY", "summary": "", "symbols": ["STGW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420616/stagwell-to-increase-2025-ad-spend-in-news-by-22-yoy", "tags": []}
{"id": 44420654, "time": "2025-03-20 12:05:16", "headline": "'Apple Shakes Up AI Executive Ranks in Bid to Turn Around Siri; Apple Vision Pro Chief Mike Rockwell Will Take Over Siri, Which Is Being Removed From AI Chief John Giannandrea' - Bloomberg News", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420654/apple-shakes-up-ai-executive-ranks-in-bid-to-turn-around-siri-apple-vision-pro-chief-mike-rockwell-w", "tags": []}
{"id": 44420720, "time": "2025-03-20 12:13:58", "headline": "Canaccord Genuity Maintains Buy on Sportradar Gr, Raises Price Target to $30", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420720/canaccord-genuity-maintains-buy-on-sportradar-gr-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 44420762, "time": "2025-03-20 12:15:19", "headline": "$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["AXP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44420762/1000-invested-in-this-stock-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44414169, "time": "2025-03-20 12:15:31", "headline": "SoundHound AI Short Interest Jumps To 32.9%: 'Bring It On,' Says CEO, Shorts 'Only Make The Prize Of Winning Bigger' (CORRECTED)", "summary": "Short interest on SoundHound AI has risen by 18%, however, the CEO remained confident in the company&#39;s growth prospects.", "symbols": ["NVDA", "QQQ", "SOUN"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/25/03/44414169/soundhound-ai-short-interest-jumps-to-32-9-bring-it-on-says-ceo-shorts-only-make-the-price-of-winning-bigger", "tags": ["management"]}
{"id": 44420772, "time": "2025-03-20 12:15:43", "headline": "Canaccord Genuity Maintains Hold on Surf Air Mobility, Lowers Price Target to $3.75", "summary": "", "symbols": ["SRFM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420772/canaccord-genuity-maintains-hold-on-surf-air-mobility-lowers-price-target-to-3-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 44420777, "time": "2025-03-20 12:17:04", "headline": "Noble Capital Markets Reiterates Outperform on Tonix Pharmaceuticals, Maintains $70 Price Target", "summary": "", "symbols": ["TNXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420777/noble-capital-markets-reiterates-outperform-on-tonix-pharmaceuticals-maintains-70-price-target", "tags": ["analyst_other"]}
{"id": 44420778, "time": "2025-03-20 12:17:09", "headline": "US Consumers Face Risks As Rising Cost Of Living, Job Market 'Cracks' Threaten Spending, Bank of America Warns", "summary": "U.S. consumers struggling with rising housing costs, slower wage growth, and unemployment fears may have to cut back on discretionary spending.", "symbols": ["AMZN", "BKNG", "HD", "TSLA", "XLY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/25/03/44420778/us-consumers-face-risks-as-rising-cost-of-living-job-market-cracks-threaten-spending-bank-of-america-warns", "tags": []}
{"id": 44420804, "time": "2025-03-20 12:17:13", "headline": "Why Zillow Stock Is Trading Higher", "summary": "Zillow shares are trading higher by 3.9% during Thursday&#39;s session. Shares of real estate and broker stocks are trading higher following strong February existing home sales data.", "symbols": ["Z", "ZG"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/03/44420804/why-zillow-stock-is-trading-higher", "tags": ["why_moving"]}
{"id": 44420918, "time": "2025-03-20 12:21:00", "headline": "CIBC Maintains Neutral on B2Gold, Raises Price Target to $3.6", "summary": "", "symbols": ["BTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420918/cibc-maintains-neutral-on-b2gold-raises-price-target-to-3-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 44420925, "time": "2025-03-20 12:21:47", "headline": "OPEC+ Says Seven Nations Including Russia, Iraq And Kazakhstan Issue New Plans To Compensate For Pumping Above Quotas; OPEC+ Monthly Compensation Would Represent Cuts Of Between 189,000 To 435,000 Barrels/Day; OPEC+ Says New Plan For Compensation Cuts Runs To June 2026", "summary": "", "symbols": ["USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44420925/opec-says-seven-nations-including-russia-iraq-and-kazakhstan-issue-new-plans-to-c", "tags": []}
{"id": 44420933, "time": "2025-03-20 12:22:47", "headline": "Stock Of The Day: Is The Groupon Rally Over?", "summary": "Groupon stock is quiet Thursday. It has been trending higher. There is a good chance it soon reverses and sells off.", "symbols": ["GRPN"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/trading-ideas/technicals/25/03/44420933/stock-of-the-day-is-the-groupon-rally-over", "tags": []}
{"id": 44420951, "time": "2025-03-20 12:24:10", "headline": "Reported March 19, 2025: 'Oaktree Buys Up Position in Sunnova Debt Ahead of Talks' - Bloomberg News", "summary": "", "symbols": ["NOVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44420951/reported-march-19-2025-oaktree-buys-up-position-in-sunnova-debt-ahead-of-talks-bloomberg-news", "tags": []}
{"id": 44420961, "time": "2025-03-20 12:25:44", "headline": "EXCLUSIVE: Why Defiance ETF CEO Sees Big Gains Ahead During Nvidia's 6G Revolution", "summary": "Telecom, AI and semiconductor ETFs offer investors attractive opportunities as NVIDIA leads the AI-driven revolution in telecommunications.", "symbols": ["AIQ", "AMZN", "ARKQ", "AVGO", "BAH", "CIBR", "CRWD", "CSCO", "GOOG", "GOOGL", "IYZ", "MRVL", "NOK", "NVDA", "ORCL", "PANW", "QCOM", "QTUM", "SIXG", "SMH", "TMUS", "VZ"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/sector-etfs/25/03/44420961/exclusive-why-defiance-etf-ceo-sees-big-gains-ahead-during-nvidias-6g-revolution", "tags": ["management"]}
{"id": 44421005, "time": "2025-03-20 12:30:12", "headline": "If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["EME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44421005/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 44421007, "time": "2025-03-20 12:30:19", "headline": "What Does the Market Think About Seagate Tech Hldgs?", "summary": " ", "symbols": ["STX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44421007/what-does-the-market-think-about-seagate-tech-hldgs", "tags": []}
{"id": 44421015, "time": "2025-03-20 12:30:24", "headline": "What Does the Market Think About Annaly Capital Management?", "summary": " ", "symbols": ["NLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44421015/what-does-the-market-think-about-annaly-capital-management", "tags": []}
{"id": 44421019, "time": "2025-03-20 12:30:29", "headline": "How Is The Market Feeling About Global Payments?", "summary": " ", "symbols": ["GPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/25/03/44421019/how-is-the-market-feeling-about-global-payments", "tags": []}
{"id": 44421036, "time": "2025-03-20 12:30:55", "headline": "CIBC Maintains Neutral on Centerra Gold, Raises Price Target to C$10.3", "summary": "", "symbols": ["CGAU", "TSX:CG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421036/cibc-maintains-neutral-on-centerra-gold-raises-price-target-to-c-10-3", "tags": ["analyst_other", "price_target_up"]}
{"id": 44421065, "time": "2025-03-20 12:31:44", "headline": "Roth MKM Maintains Buy on PSQ Holdings, Lowers Price Target to $4", "summary": "", "symbols": ["PSQH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421065/roth-mkm-maintains-buy-on-psq-holdings-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 44421093, "time": "2025-03-20 12:33:17", "headline": "Live On CNBC, Josh Brown Announces Bought Chevron", "summary": "", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421093/live-on-cnbc-josh-brown-announces-bought-chevron", "tags": []}
{"id": 44421099, "time": "2025-03-20 12:34:51", "headline": "Piper Sandler Maintains Overweight on Chain Bridge Bancorp, Lowers Price Target to $29", "summary": "", "symbols": ["CBNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421099/piper-sandler-maintains-overweight-on-chain-bridge-bancorp-lowers-price-target-to-29", "tags": ["analyst_other", "price_target_down"]}
{"id": 44421109, "time": "2025-03-20 12:36:10", "headline": "Piper Sandler Maintains Overweight on Ollie's Bargain Outlet, Lowers Price Target to $124", "summary": "", "symbols": ["OLLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421109/piper-sandler-maintains-overweight-on-ollies-bargain-outlet-lowers-price-target-to-124", "tags": ["analyst_other", "price_target_down"]}
{"id": 44421129, "time": "2025-03-20 12:37:23", "headline": "Compass Point Maintains Neutral on NewtekOne, Raises Price Target to $14", "summary": "", "symbols": ["NEWT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421129/compass-point-maintains-neutral-on-newtekone-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 44421140, "time": "2025-03-20 12:37:49", "headline": "Piper Sandler Maintains Overweight on Century Therapeutics, Lowers Price Target to $2", "summary": "", "symbols": ["IPSC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421140/piper-sandler-maintains-overweight-on-century-therapeutics-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 44421142, "time": "2025-03-20 12:38:10", "headline": "Live On CNBC, Jim Lebenthal Names Exxon Mobil His Top Energy Pick", "summary": "", "symbols": ["XOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421142/live-on-cnbc-jim-lebenthal-names-exxon-mobil-his-top-energy-pick", "tags": []}
{"id": 44421161, "time": "2025-03-20 12:41:27", "headline": "Venus Concept Shares Halted On Circuit Breaker To The Downside, Stock Now Down -23.1%", "summary": "", "symbols": ["VERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44421161/venus-concept-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-23-1", "tags": ["halt"]}
{"id": 44421164, "time": "2025-03-20 12:41:39", "headline": "Oppenheimer Assumes Akamai Technologies at Outperform, Lowers Price Target of $100", "summary": "", "symbols": ["AKAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421164/oppenheimer-assumes-akamai-technologies-at-outperform-lowers-price-target-of-100", "tags": ["price_target_down"]}
{"id": 44421168, "time": "2025-03-20 12:42:08", "headline": "Live On CNBC, Josh Brown Hosts Segment Titled \"AbbVie Is Breaking Out\"", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421168/live-on-cnbc-josh-brown-hosts-segment-titled-abbvie-is-breaking-out", "tags": []}
{"id": 44421215, "time": "2025-03-20 12:45:15", "headline": "If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44421215/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 44421219, "time": "2025-03-20 12:45:18", "headline": "Price Over Earnings Overview: Comfort Systems USA", "summary": " ", "symbols": ["FIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44421219/price-over-earnings-overview-comfort-systems-usa", "tags": ["earnings"]}
{"id": 44421247, "time": "2025-03-20 12:46:26", "headline": "Bonk Rallies 6% In A Day, Millionaire Trader Calls It 'Incredibly Undervalued'", "summary": "Despite market volatility, Bonk (CRYPTO: BONK) continues to surge, prompting bullish sentiment from traders.", "symbols": ["BONKUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44421247/bonk-rallies-6-in-a-day-millionaire-trader-calls-it-incredibly-undervalued", "tags": []}
{"id": 44421373, "time": "2025-03-20 12:51:15", "headline": "Plus Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 199.4%", "summary": "", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44421373/plus-therapeutics-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-199-4", "tags": ["halt"]}
{"id": 44421419, "time": "2025-03-20 12:55:56", "headline": "Plus Therapeutics Shares Resume Trade", "summary": "", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/25/03/44421419/plus-therapeutics-shares-resume-trade", "tags": []}
{"id": 44421456, "time": "2025-03-20 12:58:05", "headline": "Mizuho Maintains Neutral on General Mills, Lowers Price Target to $60", "summary": "", "symbols": ["GIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421456/mizuho-maintains-neutral-on-general-mills-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 44421492, "time": "2025-03-20 12:59:09", "headline": "Mizuho Maintains Neutral on Five Below, Lowers Price Target to $88", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421492/mizuho-maintains-neutral-on-five-below-lowers-price-target-to-88", "tags": ["analyst_other", "price_target_down"]}
{"id": 44421496, "time": "2025-03-20 12:59:58", "headline": "Nvidia's First Quantum Computing Day, $4.5T Quad Witching, European Banks Beat Tech Stocks By 34%", "summary": " ", "symbols": [], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/markets/equities/25/03/44421496/nvidias-first-quantum-computing-day-4-5t-quad-witching-european-banks-beat-tech-stocks-by-34", "tags": []}
{"id": 44415917, "time": "2025-03-20 08:55:56", "headline": "How To Trade SPY Ahead Of Quad Witching, As Market Digests Fed Decision", "summary": "Traders will predominantly focus on digesting FOMC cues and positioning ahead of tomorrow&#39;s crucial Triple Witching options expiration.", "symbols": ["SPY"], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/markets/equities/25/03/44415917/how-to-trade-spy-ahead-of-triple-witching-as-market-digests-fed-decision", "tags": []}
{"id": 44421526, "time": "2025-03-20 13:00:24", "headline": "Comcast Expands High-Speed Internet To Communities In Southeast Georgia: Details", "summary": "Comcast&#39;s recent expansion brings reliable Internet, mobile, and security services to Southeast Georgia. The company&#39;s new high-speed network connects around 6,700 homes and businesses across cities like Mt. Vernon and Wrightsville.", "symbols": ["CMCSA"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/03/44421526/comcast-expands-high-speed-internet-to-southeast-georgia", "tags": []}
{"id": 44421562, "time": "2025-03-20 13:01:10", "headline": "CNBC Halftime Report Final Trades: Chevron, Fiserv, UnitedHealth Group", "summary": "", "symbols": ["CVX", "FI", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421562/cnbc-halftime-report-final-trades-chevron-fiserv-unitedhealth-group", "tags": []}
{"id": 44421564, "time": "2025-03-20 13:01:13", "headline": "Behind the Scenes of Amgen's Latest Options Trends", "summary": " ", "symbols": ["AMGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44421564/behind-the-scenes-of-amgens-latest-options-trends", "tags": []}
{"id": 44421719, "time": "2025-03-20 13:05:51", "headline": "Bitcoin Miners Core Scientific, Riot Platforms, CleanSpark, Iris Energy See Price Targets Slashed: Bernstein", "summary": "Bitcoin (CRYPTO: BTC) miners have faced a challenging year, but analysts at Bernstein remain optimistic, driven by a blen", "symbols": ["BTCUSD", "CLSK", "CORZ", "IREN", "MARA", "RIOT"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44421719/bitcoin-miners-core-scientific-riot-platforms-cleanspark-iris-energy-see-price-targets-slashed-bernstein", "tags": []}
{"id": 44421720, "time": "2025-03-20 13:05:56", "headline": "12 Information Technology Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["AEVA", "ALAR", "AUID", "CISO", "EXOD", "GRRR", "LCFY", "LDTC", "MLGO", "OSS", "RTC", "STAI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44421720/12-information-technology-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 44421721, "time": "2025-03-20 13:06:01", "headline": "12 Industrials Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["BGSF", "CLIK", "DXST", "EVI", "GRFX", "HTZ", "INLF", "MSW", "NCEW", "NRGV", "TITN", "TPIC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44421721/12-industrials-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 44421725, "time": "2025-03-20 13:06:06", "headline": "WISeKey Affiliate WISeSat.Space Teams Up With Skyroot For Satellite Launches From India", "summary": "", "symbols": ["LAES", "WKEY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44421725/wisekey-affiliate-wisesat-space-teams-up-with-skyroot-for-satellite-launches-from-india", "tags": []}
{"id": 44421728, "time": "2025-03-20 13:06:07", "headline": "12 Health Care Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["ADAP", "AKBA", "BDRX", "CRVO", "ELEV", "IBO", "OPTN", "PSTV", "RMTI", "SPRY", "VERO", "WINT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44421728/12-health-care-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 44421730, "time": "2025-03-20 13:06:12", "headline": "12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session", "summary": " ", "symbols": ["AGH", "BZUN", "FTEL", "LAZR", "LE", "MULN", "PHH", "PMNT", "RENT", "SAG", "STRRP", "VRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44421730/12-consumer-discretionary-stocks-moving-in-thursdays-intraday-session", "tags": ["why_moving"]}
{"id": 44421767, "time": "2025-03-20 13:07:16", "headline": "Coinbase Analyst 'Cautiously Optimistic' On Stock With Balanced Risk/Reward, Says Regulatory Environment Is Positive And Negative", "summary": "A Coinbase analyst is cautious on the outlook with regulatory environment one of many items that could be both a positive and negative for the crypto sector.", "symbols": ["COIN"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/government/regulations/25/03/44421767/coinbase-analyst-cautiously-optimistic-on-stock-with-balanced-riskreward-says-regulatory-environment-is-positive-and-negative", "tags": ["guidance"]}
{"id": 44421844, "time": "2025-03-20 13:11:01", "headline": "Wall Street Holds Steady As Buffett's Berkshire Hathaway Notches Record Highs: What's Driving Markets Thursday?", "summary": "U.S.", "symbols": ["ACN", "BRK", "BTCUSD", "DIA", "DRI", "FDS", "FDX", "FIVE", "IWM", "JBL", "LEN", "MU", "NKE", "PDD", "QQQ", "SPY", "XLC", "XLF", "XLK", "XLY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/25/03/44421844/wall-street-holds-steady-buffetts-berkshire-hathaway-notches-record-highs-oil-surges-whats-driving-markets-thursday", "tags": []}
{"id": 44421948, "time": "2025-03-20 13:16:16", "headline": "Spotlight on Constellation Energy: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["CEG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44421948/spotlight-on-constellation-energy-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 44421964, "time": "2025-03-20 13:17:04", "headline": "Academy Sports Q4: EPS Beat, 3% Comps Dip, Sees Tough Q1, Bets On Turnaround Later In 2025 And More", "summary": "Academy Sports beats Q4 EPS estimates but sees a 3% dip in comparable sales, while planning growth through new stores and a recent 18% dividend increase.", "symbols": ["ASO"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/25/03/44421964/academy-sports-beats-q4-eps-estimates-comparable-sales-dip-3", "tags": ["earnings", "dividend"]}
{"id": 44413337, "time": "2025-03-20 07:08:05", "headline": "RYVYL Subsidiary RYVYL EU Secures Two PaaS contracts; New Contracts Reinforce 2025 Revenue Outlook", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44413337/ryvyl-subsidiary-ryvyl-eu-secures-two-paas-sontracts-new-contracts-reinforce-2025-revenue-outlook", "tags": ["earnings", "guidance"]}
{"id": 44422119, "time": "2025-03-20 13:22:28", "headline": "JPMorgan Backs CAVA's Expansion Potential As Yum! Brands Plans Major Taco Bell, KFC Growth", "summary": "JPMorgan sees potential in restaurant stocks despite dip in consumer confidence data. Ivankoe upgrades CAVA Group, maintains neutral rating for Yum!", "symbols": ["CAVA", "YUM"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/general/restaurants/25/03/44422119/jpmorgan-backs-cavas-expansion-potential-as-yum-brands-plans-major-taco-bell-kfc-growth", "tags": ["analyst_up", "analyst_other"]}
{"id": 44422130, "time": "2025-03-20 13:23:23", "headline": "What's Going On With IonQ Stock Today?", "summary": "IonQ stock rises after announcing a milestone in quantum computing with Ansys, showing real-world improvements in medical device design.", "symbols": ["FCUS", "IONQ", "IONX"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/general/health-care/25/03/44422130/whats-going-on-with-ionq-stock-today-10", "tags": ["why_moving"]}
{"id": 44422197, "time": "2025-03-20 13:28:13", "headline": "Score Profits From Traders Dumping The Magnificent 7", "summary": " ", "symbols": ["INTC", "MU"], "source": "benzinga", "author": "Anne-Marie Baiynd", "url": "https://www.benzinga.com/25/03/44422197/score-profits-from-traders-dumping-the-magnificent-7", "tags": []}
{"id": 44422221, "time": "2025-03-20 13:31:08", "headline": "This Is What Whales Are Betting On Trade Desk", "summary": " ", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44422221/this-is-what-whales-are-betting-on-trade-desk", "tags": []}
{"id": 44422240, "time": "2025-03-20 13:31:43", "headline": "Secretary Of Defense Pete Hegseth Says Canceling Pentagon HR Software Contract; Watching Shares Of Palantir", "summary": "", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44422240/secretary-of-defense-pete-hegseth-says-canceling-pentagon-hr-software-contract-watching-shares-of-pa", "tags": ["contract"]}
{"id": 44422296, "time": "2025-03-20 13:33:58", "headline": "ACV Auctions' Recent Sell-Off Is A Chance To Own The Stock - Analyst Turns Bullish", "summary": "Piper Sandler upgrades ACV Auctions to Overweight, raises PT to $20, citing revised financial targets and growth potential. ", "symbols": ["ACVA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/03/44422296/piper-sandler-turns-bullish-on-acv-auctions-projects-20-revenue-growth", "tags": ["analyst_up"]}
{"id": 44422323, "time": "2025-03-20 13:35:13", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AMD", "CRWD", "INTC", "MRVL", "MSFT", "MSTR", "MU", "PLTR", "SOUN", "TSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44422323/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 44422324, "time": "2025-03-20 13:35:18", "headline": "10 Consumer Discretionary Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AMZN", "BABA", "CVNA", "DASH", "GCT", "KLC", "MCD", "PDD", "SG", "TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44422324/10-consumer-discretionary-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 44422326, "time": "2025-03-20 13:35:24", "headline": "10 Industrials Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AAL", "DE", "ETN", "FTAI", "GEO", "HWM", "LMT", "LUV", "VRT", "ZIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44422326/10-industrials-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 44422472, "time": "2025-03-20 13:44:52", "headline": "Perplexity In Early Talks For Funding At $18B Value", "summary": "", "symbols": [], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44422472/perplexity-in-early-talks-for-funding-at-18b-value", "tags": []}
{"id": 44422479, "time": "2025-03-20 13:46:07", "headline": "Walt Disney's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44422479/walt-disneys-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 44422643, "time": "2025-03-20 13:51:32", "headline": "Tariff Risks, Costly EVs, And Leadership Gaps Weigh Heavy On Stellantis", "summary": "Piper Sandler analyst Alexander Potter downgraded Stellantis from Overweight to Neutral, cutting the price target to $13 from $23. The firm cites challenges such as leadership issues, lower margins, and pressures from Stellantis&#39; electric vehicle strategy. ", "symbols": ["STLA"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/25/03/44422643/piper-sandler-downgrades-stellantis-on-financial-and-leadership-challenges", "tags": ["analyst_down"]}
{"id": 44422681, "time": "2025-03-20 13:52:13", "headline": "DA Davidson Maintains Neutral on NVIDIA, Lowers Price Target to $125", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44422681/da-davidson-maintains-neutral-on-nvidia-lowers-price-target-to-125", "tags": ["analyst_other", "price_target_down"]}
{"id": 44422701, "time": "2025-03-20 13:55:16", "headline": "Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough", "summary": "JNJ stock hits Golden Cross, signaling potential long-term upside. Latest breakthrough in lung cancer treatment could provide additional catalyst.", "symbols": ["JNJ"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/general/biotech/25/03/44422701/johnson-johnsons-golden-cross-technical-momentum-meets-groundbreaking-lung-cancer-breakthrough", "tags": []}
{"id": 44422737, "time": "2025-03-20 13:57:01", "headline": "DA Davidson Maintains Neutral on Lifetime Brands, Lowers Price Target to $6", "summary": "", "symbols": ["LCUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44422737/da-davidson-maintains-neutral-on-lifetime-brands-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 44422768, "time": "2025-03-20 13:59:45", "headline": "US Tiger Securities, Inc Downgrades PDD Holdings to Hold, Maintains Price Target to $130", "summary": "", "symbols": ["PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44422768/us-tiger-securities-inc-downgrades-pdd-holdings-to-hold-maintains-price-target-to-130", "tags": ["analyst_down", "analyst_other"]}
{"id": 44422782, "time": "2025-03-20 14:00:19", "headline": "Forecasting The Future: 6 Analyst Projections For Alaska Air Gr", "summary": " ", "symbols": ["ALK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44422782/forecasting-the-future-6-analyst-projections-for-alaska-air-gr", "tags": []}
{"id": 44422784, "time": "2025-03-20 14:00:28", "headline": "Boyd Gaming Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)", "summary": " ", "symbols": ["BYD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44422784/boyd-gaming-stock-a-deep-dive-into-analyst-perspectives-12-ratings", "tags": []}
{"id": 44422785, "time": "2025-03-20 14:00:31", "headline": "Prominent Bitcoin Trader Closes Longs, Anticipates Pullback To $83,500", "summary": "Bitcoin (CRYPTO: BTC) traders are taking profit on the rally to $87,000, expecting a pullback before more possible upside.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44422785/prominent-bitcoin-trader-closes-longs-anticipates-pullback-to-83500", "tags": []}
{"id": 44422786, "time": "2025-03-20 14:00:47", "headline": "Analyst Expectations For Ford Motor's Future", "summary": " ", "symbols": ["F"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44422786/analyst-expectations-for-ford-motors-future", "tags": []}
{"id": 44422793, "time": "2025-03-20 14:00:57", "headline": "Beyond The Numbers: 8 Analysts Discuss Bloomin Brands Stock", "summary": " ", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44422793/beyond-the-numbers-8-analysts-discuss-bloomin-brands-stock", "tags": []}
{"id": 44422797, "time": "2025-03-20 14:01:08", "headline": "What 4 Analyst Ratings Have To Say About General Motors", "summary": " ", "symbols": ["GM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44422797/what-4-analyst-ratings-have-to-say-about-general-motors", "tags": []}
{"id": 44422801, "time": "2025-03-20 14:01:16", "headline": "What 4 Analyst Ratings Have To Say About Liquidia", "summary": " ", "symbols": ["LQDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44422801/what-4-analyst-ratings-have-to-say-about-liquidia", "tags": []}
{"id": 44422928, "time": "2025-03-20 14:08:13", "headline": "Jefferies Maintains Buy on Williams-Sonoma, Lowers Price Target to $208", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44422928/jefferies-maintains-buy-on-williams-sonoma-lowers-price-target-to-208", "tags": ["analyst_other", "price_target_down"]}
{"id": 44423005, "time": "2025-03-20 14:15:12", "headline": "GDS Holdings Analyst Upgrade Highlights Higher AI Demand Driven By DeepSeek, Other Platforms In China", "summary": "Raymond James upgrades GDS Holdings to Strong Buy, citing AI demand growth and strategic moves, despite Q4 results causing confusion.", "symbols": ["GDS"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/analyst-ratings/upgrades/25/03/44423005/gds-holdings-analyst-upgrade-highlights-higher-ai-demand-driven-by-deepseek-other-platforms-in-china", "tags": ["analyst_up", "earnings"]}
{"id": 44423006, "time": "2025-03-20 14:15:20", "headline": "Price Over Earnings Overview: Prosperity Bancshares", "summary": " ", "symbols": ["PB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44423006/price-over-earnings-overview-prosperity-bancshares", "tags": ["earnings"]}
{"id": 44423105, "time": "2025-03-20 14:18:54", "headline": "Jefferies Maintains Buy on Sportradar Gr, Raises Price Target to $27", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423105/jefferies-maintains-buy-on-sportradar-gr-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 44423174, "time": "2025-03-20 14:25:56", "headline": "Jefferies Maintains Buy on PDD Holdings, Lowers Price Target to $156", "summary": "", "symbols": ["PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423174/jefferies-maintains-buy-on-pdd-holdings-lowers-price-target-to-156", "tags": ["analyst_other", "price_target_down"]}
{"id": 44423176, "time": "2025-03-20 14:26:35", "headline": "Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment", "summary": "Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment nearing completion.", "symbols": ["APVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/25/03/44423176/aptevo-therapeutics-says-two-additional-patients-in-early-stage-leukemia-trial-achieve-remission-within-30-days-of-treatment", "tags": ["fda"]}
{"id": 44423177, "time": "2025-03-20 14:26:38", "headline": "Rivian Analyst Downgrades Stock With 'Triple Whammy' Of Policy Risk: 'No Catalysts In 2025'", "summary": "A Rivian analyst downgrades the stock with no positive catalysts coming in 2025 and the potential for negative risk from federal policy decisions.", "symbols": ["RIVN", "VWAGY"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/25/03/44423177/rivian-analyst-downgrades-stock-with-triple-whammy-of-policy-risk-no-catalysts-in-2025", "tags": ["analyst_down"]}
{"id": 44416878, "time": "2025-03-20 09:34:29", "headline": "Is Tencent Interested in Buying DouYu?", "summary": "With renewed investor expectations for DouYu&#39;s privatization or acquisition, is Tencent, a 38% stakeholder in DouYu, interested?", "symbols": ["DOYU", "TCEHY"], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/markets/asia/25/03/44416878/is-m-a-coming-for-douyu-is-tencent-interested", "tags": []}
{"id": 44423214, "time": "2025-03-20 14:27:38", "headline": "What's Going On With Madison Square Garden Stock Thursday?", "summary": "Madison Square Garden Sports Corp. (NYSE:MSGS) stock is trading higher on Thursday after the Boston Celtics were sold for $6.1 billion, raising the bar for NBA team valuations.", "symbols": ["MSGS"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/general/sports/25/03/44423214/whats-going-on-with-madison-square-garden-stock-thursday", "tags": ["why_moving"]}
{"id": 44423216, "time": "2025-03-20 14:27:51", "headline": "Analysts See Profit Pressure For Williams-Sonoma In 2025, But Brand Strength Remains Intact", "summary": "Analysts lower price forecast for Williams-Sonoma after strong Q4 results, with revenue up 8% YoY and EPS beating expectations.", "symbols": ["SMCF", "WSM", "XMHQ"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44423216/analysts-see-profit-pressure-for-williams-sonoma-in-2025-but-brand-strength-remains-intact", "tags": ["earnings", "guidance"]}
{"id": 44423239, "time": "2025-03-20 14:29:48", "headline": "Why Plus Therapeutics (PSTV) Shares Are Exploding Higher", "summary": "Plus Therapeutics shares are trading higher by 183% during Thursday&#39;s session. The company announced that the FDA accepted the name REYOBIQ for the company&#39;s lead asset.", "symbols": ["PSTV"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/03/44423239/why-plus-therapeutics-pstv-shares-are-exploding-higher", "tags": ["why_moving", "fda"]}
{"id": 44423259, "time": "2025-03-20 14:30:44", "headline": "Holley May Bear The Brunt Of Ongoing Macroeconomic Challenges, Analyst Highlights Softer Top-line Outlook", "summary": "JP Morgan analyst maintains Neutral rating on Holley, citing macroeconomic challenges and a softer revenue outlook despite strong EBITDA guidance.", "symbols": ["HLLY"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44423259/holley-may-bear-the-brunt-of-ongoing-macroeconomic-challenges-analyst-highlights-softer-top-line-outlook", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 44423263, "time": "2025-03-20 14:30:51", "headline": "Novartis Partner Monte Rosa Therapeutics Touts Positive Data From Early-Stage Study Of Investigational Drug Candidate For Immune-Mediated Disorders", "summary": "Monte Rosa&#39;s MRT-6160 shows promising Phase 1 results, with Novartis backing its development in a deal that could reach $2.1B in milestone payments.", "symbols": ["GLUE", "NVS"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/03/44423263/novartis-partner-monte-rosa-therapeutics-touts-positive-data-from-early-stage-study-of-investigational-drug-candidate-for-immune-mediated-disorders", "tags": ["fda", "contract"]}
{"id": 44423290, "time": "2025-03-20 14:31:59", "headline": "Barclays Maintains Underweight on XPeng, Raises Price Target to $20", "summary": "", "symbols": ["XPEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423290/barclays-maintains-underweight-on-xpeng-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 44423307, "time": "2025-03-20 14:33:42", "headline": "JPMorgan: Spire Positioned For Growth With Favorable Missouri Legislation, Rate Case Developments", "summary": "JPMorgan upgrades Spire Inc. to Overweight, raises price forecast to $85. Analyst cites regulatory improvements in Missouri and positive factors for increased earnings and growth potential.", "symbols": ["PEY", "REGL", "SR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/25/03/44423307/jp-morgan-spire-positioned-for-growth-with-favorable-missouri-legislation-rate-case-developments", "tags": ["analyst_up", "earnings", "guidance"]}
{"id": 44423358, "time": "2025-03-20 14:38:16", "headline": "Sunnova Energy (NOVA) Stock Is Volatile: What's Going On?", "summary": "Sunnova Energy shares are trading higher by 42.5% during Thursday&#39;s session. Earlier this week a report suggested Oaktree Capital Management has been buying up debt in the company.", "symbols": ["NOVA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/03/44423358/sunnova-energy-nova-stock-is-volatile-whats-going-on", "tags": ["why_moving"]}
{"id": 44423371, "time": "2025-03-20 14:39:09", "headline": "Walt Disney CEO Iger Announces A 'Coco' Sequel Is In The Works; Shareholders Vote To Re-elect All 10 Company Nominees To Board Of Directors; Vote Against Proposal To Withdraw Participation In Human Rights Campaign's Corporate Equality Index; Vote Against Proposal For Publishing A Report On Risks Related To Selection Of Ad Buyers And Sellers; Vote Against Proposal For Publishing A Report On Climate Risk To Retirement Plan Beneficiaries", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423371/walt-disney-ceo-iger-announces-a-coco-sequel-is-in-the-works-shareholders-vote-to-re-elect-all-10-co", "tags": ["management"]}
{"id": 44423380, "time": "2025-03-20 14:39:35", "headline": "Lake Street Downgrades OptiNose to Hold, Lowers Price Target to $9", "summary": "", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423380/lake-street-downgrades-optinose-to-hold-lowers-price-target-to-9", "tags": ["analyst_down", "price_target_down"]}
{"id": 44423382, "time": "2025-03-20 14:39:55", "headline": "Billionaire Stanley Druckenmiller Boosts US Steel Stake By 143%: Is He Betting On Merger?", "summary": "Druckenmiller increased stake in United States Steel as company explores merger options. Company&#39;s stock up 25% due to Trump&#39;s tariffs.", "symbols": ["X"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/markets/commodities/25/03/44423382/billionaire-stanley-druckenmiller-boosts-us-steel-stake-by-143-is-he-betting-on-merger", "tags": ["merger"]}
{"id": 44423409, "time": "2025-03-20 14:42:08", "headline": "Hyundai Motor And GM Near Finalizing Deal For Hyundai To Supply Two Electric Commercial Vans To GM In North America; Hyundai Considers Manufacturing Electric Vans In North America To Sell Under Its Own And GM's Brands Starting In 2028; Hyundai In Talks To Sell GM's Mid-Sized Pickup Trucks Under Its Brand In North America; Hyundai In Talks To Supply Creta SUV To GM For Sales In Brazil", "summary": "", "symbols": ["GM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423409/hyundai-motor-and-gm-near-finalizing-deal-for-hyundai-to-supply-two-electric-commercial-vans-to-gm-i", "tags": ["contract"]}
{"id": 44423417, "time": "2025-03-20 14:43:16", "headline": "Record-Breaking High-Risk Bitcoin Whale Allegedly Outed As UK Fraudster With Casino Theft History", "summary": "On-chain investigator ZachXBT has linked the Hyperliquid whale, a trader who profited $20 million through high-leverage crypto trades, to a British online fraudster.", "symbols": ["BTCUSD", "ETHUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44423417/record-breaking-high-risk-bitcoin-whale-allegedly-outed-as-uk-fraudster-with-casino-theft-history", "tags": []}
{"id": 44423418, "time": "2025-03-20 14:43:18", "headline": "Amentum Faces Growth Slump As Government Cuts Spending, Analyst Expects Merger To Boost Margins", "summary": "Goldman Sachs analyst Noah Poponak initiated coverage on Amentum Holdings with a Neutral Rating, and a price forecast of $21.", "symbols": ["AMTM"], "source": "benzinga", "author": "Nabaparna Bhattacharya", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44423418/amentum-faces-growth-slump-as-government-cuts-spending-analyst-expects-merger-to-boost-margins", "tags": ["guidance", "merger"]}
{"id": 44423447, "time": "2025-03-20 14:44:34", "headline": "Charter And Comcast Launch Satellite Connectivity For Mobile Devices; Spectrum Mobile And Xfinity Mobile Customers Benefit From Always-on Connectivity Even When Cellular Or WiFi Service Is Unavailable", "summary": "", "symbols": ["CHTR", "CMCSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423447/charter-and-comcast-launch-satellite-connectivity-for-mobile-devices-spectrum-mobile-and-xfinity-mob", "tags": []}
{"id": 44423474, "time": "2025-03-20 14:46:13", "headline": "Coca-Cola Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["KO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44423474/coca-cola-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 44423579, "time": "2025-03-20 14:54:08", "headline": "ArriVent Lead Drug Candidate Shows Promise In Lung Cancer Type, Analyst Sees Over 50% Upside", "summary": "B. Riley initiates coverage on ArriVent Biopharma, citing firmonertinib&#39;s potential in NSCLC. The analyst sees strong upside with a $37 price target.", "symbols": ["AVBP"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/03/44423579/arrivent-lead-drug-candidate-shows-promise-in-lung-cancer-type-analyst-sees-over-50-upside", "tags": ["analyst_init"]}
{"id": 44423599, "time": "2025-03-20 14:54:43", "headline": "Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress", "summary": "Wedbush initiates coverage on Zenas BioPharma, citing strong potential for obexelimab in autoimmune diseases, with key clinical data expected in 2025 and 2026.", "symbols": ["AMGN", "ZBIO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/25/03/44423599/zenas-biopharma-gains-outperform-rating-from-analyst-as-key-autoimmune-trials-progress", "tags": ["analyst_init", "fda"]}
{"id": 44423649, "time": "2025-03-20 14:58:36", "headline": "Signet Jewelers Sharpens Focus On Loyalty, Luxury And Bridal: Analyst", "summary": "Telsey Advisory Group&#39;s Dana Telsey reiterated a Market Perform rating on Signet Jewelers and raised the price forecast $55 to $62.", "symbols": ["SIG"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/analyst-ratings/price-target/25/03/44423649/signet-jewelers-sharpens-focus-on-loyalty-luxury-and-bridal-analyst", "tags": ["guidance"]}
{"id": 44423681, "time": "2025-03-20 15:00:25", "headline": "Forecasting The Future: 14 Analyst Projections For Texas Roadhouse", "summary": " ", "symbols": ["TXRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44423681/forecasting-the-future-14-analyst-projections-for-texas-roadhouse", "tags": []}
{"id": 44423683, "time": "2025-03-20 15:00:33", "headline": "What 9 Analyst Ratings Have To Say About Quest Diagnostics", "summary": " ", "symbols": ["DGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44423683/what-9-analyst-ratings-have-to-say-about-quest-diagnostics", "tags": []}
{"id": 44423686, "time": "2025-03-20 15:00:45", "headline": "Deep Dive Into Shake Shack Stock: Analyst Perspectives (13 Ratings)", "summary": " ", "symbols": ["SHAK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44423686/deep-dive-into-shake-shack-stock-analyst-perspectives-13-ratings", "tags": []}
{"id": 44423688, "time": "2025-03-20 15:00:56", "headline": "Analyst Expectations For Cheesecake Factory's Future", "summary": " ", "symbols": ["CAKE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44423688/analyst-expectations-for-cheesecake-factorys-future", "tags": []}
{"id": 44423689, "time": "2025-03-20 15:01:03", "headline": "5 Analysts Assess Veracyte: What You Need To Know", "summary": " ", "symbols": ["VCYT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44423689/5-analysts-assess-veracyte-what-you-need-to-know", "tags": []}
{"id": 44423694, "time": "2025-03-20 15:01:11", "headline": "What 34 Analyst Ratings Have To Say About Amazon.com", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44423694/what-34-analyst-ratings-have-to-say-about-amazon-com", "tags": []}
{"id": 44423701, "time": "2025-03-20 15:01:25", "headline": "Decoding T-Mobile US's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["TMUS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44423701/decoding-t-mobile-uss-options-activity-whats-the-big-picture", "tags": []}
{"id": 44423721, "time": "2025-03-20 15:02:21", "headline": "NorthEast Community Bancorp Increases Quarterly Dividend From $0.15 To $0.20 Per Share", "summary": "", "symbols": ["NECB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423721/northeast-community-bancorp-increases-quarterly-dividend-from-0-15-to-0-20-per-share", "tags": ["dividend"]}
{"id": 44423766, "time": "2025-03-20 15:04:33", "headline": "Citigroup Maintains Neutral on Lululemon Athletica, Lowers Price Target to $330", "summary": "", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423766/citigroup-maintains-neutral-on-lululemon-athletica-lowers-price-target-to-330", "tags": ["analyst_other", "price_target_down"]}
{"id": 44423799, "time": "2025-03-20 15:06:12", "headline": "Citigroup Maintains Buy on LENZ Therapeutics, Raises Price Target to $47", "summary": "", "symbols": ["LENZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423799/citigroup-maintains-buy-on-lenz-therapeutics-raises-price-target-to-47", "tags": ["analyst_other", "price_target_up"]}
{"id": 44423826, "time": "2025-03-20 15:08:26", "headline": "Is Tariff An Issue For Restaurant Sector? J.P. Morgan Highlights Winners & Losers", "summary": "J.P. Morgan analyst John Ivankoe hosted Bloomin&#39; Brands, CAVA Group and others at the Las Vegas forum. A major takeaway: focus on &#34;doing fewer things better&#34; with continued investments in customer and employee experiences. The analyst recommends adding fresh investments in BROS, SBUX, and CAVA, while maintaining cautious optimism on CMG and EAT.", "symbols": ["BLMN", "BROS", "CAVA", "CMG", "DNUT", "DPZ", "DRI", "EAT", "MCD", "QSR", "SBUX", "SG", "SHAK", "TXRH", "YUM"], "source": "benzinga", "author": "Shivani Kumaresan", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44423826/is-tariff-an-issue-for-restaurant-sector-j-p-morgan-highlights-winners-losers", "tags": []}
{"id": 44423834, "time": "2025-03-20 15:09:00", "headline": "Citigroup Maintains Buy on Sportradar Gr, Raises Price Target to $27", "summary": "", "symbols": ["SRAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44423834/citigroup-maintains-buy-on-sportradar-gr-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 44423904, "time": "2025-03-20 15:16:11", "headline": "What the Options Market Tells Us About Axon Enterprise", "summary": " ", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44423904/what-the-options-market-tells-us-about-axon-enterprise", "tags": []}
{"id": 44423961, "time": "2025-03-20 15:17:29", "headline": "Options Corner: Smart Money Inflows Into Salesforce Signal A Possible Recovery Play", "summary": "Although Salesforce has encountered macroeconomic headwinds, the smart money is sniffing out a recovery play in CRM stock.", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/25/03/44423961/smart-money-buying-crm-stock-recovery-play", "tags": []}
{"id": 44423999, "time": "2025-03-20 15:17:44", "headline": "Peter Schiff Says Strategic Bitcoin Reserve Is A 'Scam' To Lure Americans Into Buying More Crypto", "summary": "Bitcoin (CRYPTO: BTC) critic Peter Schff is warning that the strategic Bitcoin reserve is a tool to trick Americans into speculative losses.", "symbols": ["BTCUSD", "TRUMPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44423999/peter-schiff-says-strategic-bitcoin-reserve-is-a-scam-to-lure-americans-into-buying-more-crypto", "tags": []}
{"id": 44424018, "time": "2025-03-20 15:18:53", "headline": "TD Securities Maintains Buy on Suncor Energy, Lowers Price Target to C$61", "summary": "", "symbols": ["TSX:SU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424018/td-securities-maintains-buy-on-suncor-energy-lowers-price-target-to-c-61", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424030, "time": "2025-03-20 15:20:09", "headline": "EXCLUSIVE: 'Volatility Will Likely Be Hanging Around' \u2014 TrueShares CEO On Rising Demand For Buffered ETFs", "summary": "Market volatility has led to re-evaluation of risk management. Buffered ETFs, like TrueShares Structured Outcome ETF, offer downside protection and upside potential. CEO of TrueMark Investments explains why these ETFs are in demand.", "symbols": ["AUGZ"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/specialty-etfs/25/03/44424030/exclusive-volatility-will-likely-be-hanging-around-trueshares-ceo-on-rising-demand-for-buffered-etfs", "tags": ["management"]}
{"id": 44424059, "time": "2025-03-20 15:22:46", "headline": "Tigress Financial Maintains Buy on Microsoft, Raises Price Target to $595", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424059/tigress-financial-maintains-buy-on-microsoft-raises-price-target-to-595", "tags": ["analyst_other", "price_target_up"]}
{"id": 44424102, "time": "2025-03-20 15:27:11", "headline": "DoubleLine Capital's Jeffrey Gundlach Says I Don't Believe We Are Going To See A Cut In The Next Fed Meeting; Says I Think The First Cut Might Come In June-July", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/25/03/44424102/doubleline-capitals-jeffrey-gundlach-says-i-dont-believe-we-are-going-to-see-a-cu", "tags": []}
{"id": 44424132, "time": "2025-03-20 15:28:12", "headline": "Telsey Advisory Group Maintains Outperform on Waldencast, Lowers Price Target to $5", "summary": "", "symbols": ["WALD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424132/telsey-advisory-group-maintains-outperform-on-waldencast-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424140, "time": "2025-03-20 15:29:45", "headline": "'Microsoft Chose Not To Exercise $12 Billion Coreweave Option' - Semafor", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424140/microsoft-chose-not-to-exercise-12-billion-coreweave-option-semafor", "tags": []}
{"id": 44424151, "time": "2025-03-20 15:30:35", "headline": "Telsey Advisory Group Maintains Market Perform on Designer Brands, Maintains $6 Price Target", "summary": "", "symbols": ["DBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424151/telsey-advisory-group-maintains-market-perform-on-designer-brands-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 44424172, "time": "2025-03-20 15:31:34", "headline": "Looking At Marvell Tech's Recent Unusual Options Activity", "summary": " ", "symbols": ["MRVL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44424172/looking-at-marvell-techs-recent-unusual-options-activity", "tags": []}
{"id": 44424247, "time": "2025-03-20 15:33:45", "headline": "D. Boral Capital Maintains Buy on Invivyd, Maintains $9 Price Target", "summary": "", "symbols": ["IVVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424247/d-boral-capital-maintains-buy-on-invivyd-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 44424251, "time": "2025-03-20 15:34:14", "headline": "Energy Vault Holdings Shares Are Down Today: What's Going On?", "summary": "Energy Vault Holdings Inc. (NYSE: NRGV) shares are trading lower Thursday following the fourth-quarter earnings and revenue miss on Monday.", "symbols": ["NRGV"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/25/03/44424251/energy-vault-holdings-shares-are-down-today-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 44424286, "time": "2025-03-20 15:37:17", "headline": "D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target", "summary": "", "symbols": ["VNRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424286/d-boral-capital-maintains-buy-on-volitionrx-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 44424293, "time": "2025-03-20 15:38:49", "headline": "D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target", "summary": "", "symbols": ["KAPA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424293/d-boral-capital-maintains-buy-on-kairos-pharma-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 44424304, "time": "2025-03-20 15:41:09", "headline": "Telsey Advisory Group Maintains Outperform on Academy Sports, Maintains $60 Price Target", "summary": "", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424304/telsey-advisory-group-maintains-outperform-on-academy-sports-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 44424312, "time": "2025-03-20 15:42:15", "headline": "Eli Lilly Shares Are Up Today: What's Going On?", "summary": "Eli Lilly &amp; Co. (NYSE: LLY) shares are trading higher Thursday after the company launched its weight-loss drug Mounjaro in India. ", "symbols": ["LLY"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44424312/eli-lilly-shares-are-up-today-whats-going-on", "tags": ["why_moving"]}
{"id": 44424330, "time": "2025-03-20 15:43:39", "headline": "What's Going On With PulteGroup (PHM) Stock?", "summary": "Shares of PulteGroup, one of the nation&#39;s largest homebuilders, moved higher by 1.4% Thursday. The stock is rising following a strong rebound in existing home sales and rising home prices.", "symbols": ["PHM"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/25/03/44424330/whats-going-on-with-pultegroup-phm-stock", "tags": ["why_moving"]}
{"id": 44424359, "time": "2025-03-20 15:44:59", "headline": "Telsey Advisory Group Maintains Market Perform on J.Jill, Lowers Price Target to $21", "summary": "", "symbols": ["JILL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424359/telsey-advisory-group-maintains-market-perform-on-j-jill-lowers-price-target-to-21", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424374, "time": "2025-03-20 15:46:45", "headline": "Unpacking the Latest Options Trading Trends in Lululemon Athletica", "summary": " ", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44424374/unpacking-the-latest-options-trading-trends-in-lululemon-athletica", "tags": []}
{"id": 44424446, "time": "2025-03-20 15:50:46", "headline": "UBS Downgrades FinVolution Gr to Neutral, Raises Price Target to $11.8", "summary": "", "symbols": ["FINV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424446/ubs-downgrades-finvolution-gr-to-neutral-raises-price-target-to-11-8", "tags": ["analyst_down", "price_target_up"]}
{"id": 44424454, "time": "2025-03-20 15:52:17", "headline": "William Blair Downgrades Beacon Roofing Supply to Market Perform", "summary": "", "symbols": ["BECN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424454/william-blair-downgrades-beacon-roofing-supply-to-market-perform", "tags": ["analyst_down"]}
{"id": 44424473, "time": "2025-03-20 15:54:18", "headline": "Wells Fargo Maintains Equal-Weight on Ovintiv, Raises Price Target to $45", "summary": "", "symbols": ["OVV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424473/wells-fargo-maintains-equal-weight-on-ovintiv-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 44424486, "time": "2025-03-20 15:54:52", "headline": "Casino Stocks Set For A Winning Streak: Why March Madness, Spring Break Could Fuel Big Gains", "summary": "Casino stocks experience seasonal strength due to sports betting and travel during spring break, and potential boost from tax refunds.", "symbols": ["CZR", "LVS", "MGM", "WYNN"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/general/sports-betting/25/03/44424486/casino-stocks-set-for-a-winning-streak-why-march-madness-spring-break-could-fuel-big-gains", "tags": []}
{"id": 44424510, "time": "2025-03-20 15:55:57", "headline": "Wells Fargo Maintains Overweight on Apollo Global Management, Lowers Price Target to $177", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424510/wells-fargo-maintains-overweight-on-apollo-global-management-lowers-price-target-to-177", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424533, "time": "2025-03-20 15:57:36", "headline": "Wells Fargo Maintains Overweight on Ares Management, Lowers Price Target to $187", "summary": "", "symbols": ["ARES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424533/wells-fargo-maintains-overweight-on-ares-management-lowers-price-target-to-187", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424540, "time": "2025-03-20 15:58:36", "headline": "Wells Fargo Maintains Equal-Weight on Blackstone, Lowers Price Target to $160", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424540/wells-fargo-maintains-equal-weight-on-blackstone-lowers-price-target-to-160", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424547, "time": "2025-03-20 15:59:23", "headline": "Wells Fargo Maintains Equal-Weight on Blue Owl Capital, Lowers Price Target to $22", "summary": "", "symbols": ["OWL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424547/wells-fargo-maintains-equal-weight-on-blue-owl-capital-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424580, "time": "2025-03-20 16:00:18", "headline": "Wells Fargo Maintains Equal-Weight on Bridge Investment Group, Lowers Price Target to $11", "summary": "", "symbols": ["BRDG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424580/wells-fargo-maintains-equal-weight-on-bridge-investment-group-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424583, "time": "2025-03-20 16:00:25", "headline": "What Analysts Are Saying About Omnicell Stock", "summary": " ", "symbols": ["OMCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44424583/what-analysts-are-saying-about-omnicell-stock", "tags": []}
{"id": 44424584, "time": "2025-03-20 16:00:33", "headline": "Analyst Expectations For scPharmaceuticals's Future", "summary": " ", "symbols": ["SCPH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44424584/analyst-expectations-for-scpharmaceuticalss-future", "tags": []}
{"id": 44424591, "time": "2025-03-20 16:00:41", "headline": "The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts", "summary": " ", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44424591/the-analyst-verdict-blueprint-medicines-in-the-eyes-of-14-experts", "tags": []}
{"id": 44424599, "time": "2025-03-20 16:00:48", "headline": "AbbVie Options Trading: A Deep Dive into Market Sentiment", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44424599/abbvie-options-trading-a-deep-dive-into-market-sentiment", "tags": []}
{"id": 44424600, "time": "2025-03-20 16:00:51", "headline": "Demystifying Beacon Roofing Supply: Insights From 7 Analyst Reviews", "summary": " ", "symbols": ["BECN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44424600/demystifying-beacon-roofing-supply-insights-from-7-analyst-reviews", "tags": []}
{"id": 44424603, "time": "2025-03-20 16:00:54", "headline": "Micron Technology Q2 Adj $1.56 Beats $1.42 Estimate, Sales $8.05B Beat $7.89B Estimate", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424603/micron-technology-q2-adj-1-56-beats-1-42-estimate-sales-8-05b-beat-7-89b-estimate", "tags": []}
{"id": 44424605, "time": "2025-03-20 16:01:00", "headline": "Expert Outlook: Precigen Through The Eyes Of 4 Analysts", "summary": " ", "symbols": ["PGEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44424605/expert-outlook-precigen-through-the-eyes-of-4-analysts", "tags": ["guidance"]}
{"id": 44424634, "time": "2025-03-20 16:01:13", "headline": "Where Consolidated Edison Stands With Analysts", "summary": " ", "symbols": ["ED"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44424634/where-consolidated-edison-stands-with-analysts", "tags": []}
{"id": 44424637, "time": "2025-03-20 16:01:28", "headline": "Wells Fargo Maintains Underweight on Brookfield Asset Mgmt, Lowers Price Target to $50", "summary": "", "symbols": ["BAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424637/wells-fargo-maintains-underweight-on-brookfield-asset-mgmt-lowers-price-target-to-50", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424648, "time": "2025-03-20 16:01:39", "headline": "Micron Technology Sees Q3 EPS $1.57 +/- $0.10 Vs $1.47 Est.; Revenue $8.8B +/- $200M Vs $8.485B Est.", "summary": "", "symbols": ["MU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424648/micron-technology-sees-q3-eps-1-57-0-10-vs-1-47-est-revenue-8-8b-200m-vs-8-485b-est", "tags": ["earnings"]}
{"id": 44424708, "time": "2025-03-20 16:02:28", "headline": "Spectral AI Subsidiary, Spectral IP, Filed Registration Statement With SEC Relating To Planned Spinoff Through IPO", "summary": "", "symbols": ["MDAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424708/spectral-ai-subsidiary-spectral-ip-filed-registration-statement-with-sec-relating-to-planned-spinoff", "tags": []}
{"id": 44424710, "time": "2025-03-20 16:02:31", "headline": "Wells Fargo Maintains Equal-Weight on Hamilton Lane, Lowers Price Target to $152", "summary": "", "symbols": ["HLNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424710/wells-fargo-maintains-equal-weight-on-hamilton-lane-lowers-price-target-to-152", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424724, "time": "2025-03-20 16:02:48", "headline": "Rhythm Reacquires Rights To Imcivree In China As It Agreed To Terminate Its 2021 Licensing Agreement With RareStone; Agrees To Repay $6.3M In Cash To RareStone", "summary": "", "symbols": ["RYTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424724/rhythm-reacquires-rights-to-imcivree-in-china-as-it-agreed-to-terminate-its-2021-licensing-agreement", "tags": ["contract"]}
{"id": 44424752, "time": "2025-03-20 16:03:29", "headline": "Wells Fargo Maintains Equal-Weight on Carlyle Group, Lowers Price Target to $48", "summary": "", "symbols": ["CG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424752/wells-fargo-maintains-equal-weight-on-carlyle-group-lowers-price-target-to-48", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424772, "time": "2025-03-20 16:04:02", "headline": "ARB IOT Secures Order For 2K Acres Palm Oil Plantation With Smart IOT System; Expects $13M Yearly Recurring Revenue Boost", "summary": "", "symbols": ["ARBB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424772/arb-iot-secures-order-for-2k-acres-palm-oil-plantation-with-smart-iot-system-expects-13m-yearly-recu", "tags": ["earnings"]}
{"id": 44424777, "time": "2025-03-20 16:04:07", "headline": "FedEx Q3 2025 Adj EPS $4.51 Misses $4.54 Estimate, Sales $22.20B Beat $21.89B Estimate", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424777/fedex-q3-2025-adj-eps-4-51-misses-4-54-estimate-sales-22-20b-beat-21-89b-estimate", "tags": ["earnings"]}
{"id": 44424778, "time": "2025-03-20 16:04:08", "headline": "Scholastic Q3 2025 Adj. EPS $(0.05) Beats $(0.78) Estimate, Sales $335.400M Miss $347.680M Estimate", "summary": "", "symbols": ["SCHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424778/scholastic-q3-2025-adj-eps-0-05-beats-0-78-estimate-sales-335-400m-miss-347-680m-estimate", "tags": ["earnings"]}
{"id": 44424782, "time": "2025-03-20 16:04:14", "headline": "Editas Medicine CFO Erick Lucera To Step Down To Pursue Another Opportunity; Amy Parison Appointed As CFO", "summary": "", "symbols": ["EDIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424782/editas-medicine-cfo-erick-lucera-to-step-down-to-pursue-another-opportunity-amy-parison-appointed-as", "tags": ["management"]}
{"id": 44424826, "time": "2025-03-20 16:05:05", "headline": "FedEx Says Unable To Forecast FY25 Market-To-Market Retirement Plans Accounting Adjustments", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424826/fedex-says-unable-to-forecast-fy25-market-to-market-retirement-plans-accounting-adjustments", "tags": ["guidance"]}
{"id": 44424842, "time": "2025-03-20 16:05:12", "headline": "Scholastic Sees Modest FY25 Revenue Growth", "summary": "", "symbols": ["SCHL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424842/scholastic-sees-modest-fy25-revenue-growth", "tags": ["earnings"]}
{"id": 44424845, "time": "2025-03-20 16:05:17", "headline": "Quantum Computing Q4 EPS $(0.47) Misses $(0.05) Estimate, Sales $62.00K Miss $200.00K Estimate", "summary": "", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424845/quantum-computing-q4-eps-0-47-misses-0-05-estimate-sales-62-00k-miss-200-00k-estimate", "tags": ["earnings"]}
{"id": 44424848, "time": "2025-03-20 16:05:22", "headline": "Nio Q4 Earnings Preview: CATL Battery Swap Deal, ONVO Vehicles Top Items To Watch", "summary": "Nio&#39;s earnings report will be closely watched by the EV sector and could provide a deeper look at how China&#39;s market is going.", "symbols": ["NIO"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/25/03/44424848/nio-q4-earnings-preview-catl-battery-swap-deal-onvo-vehicles-top-items-to-watch", "tags": ["earnings", "contract"]}
{"id": 44424853, "time": "2025-03-20 16:05:28", "headline": "FedEx Unable To Provide FY25 EPS Or Effective Tax Rate", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424853/fedex-unable-to-provide-fy25-eps-or-effective-tax-rate", "tags": ["earnings"]}
{"id": 44424864, "time": "2025-03-20 16:05:39", "headline": "Tectonic Therapeutic Q4 2024 GAAP EPS $(0.84) Beats $(1.39) Estimate", "summary": "", "symbols": ["TECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424864/tectonic-therapeutic-q4-2024-gaap-eps-0-84-beats-1-39-estimate", "tags": ["earnings"]}
{"id": 44424879, "time": "2025-03-20 16:05:51", "headline": "FedEx Sees FY25 Revenue Slightly Down YoY", "summary": "", "symbols": ["FDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424879/fedex-sees-fy25-revenue-slightly-down-yoy", "tags": ["earnings"]}
{"id": 44424905, "time": "2025-03-20 16:06:25", "headline": "Wells Fargo Maintains Overweight on TPG, Lowers Price Target to $66", "summary": "", "symbols": ["TPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424905/wells-fargo-maintains-overweight-on-tpg-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 44424913, "time": "2025-03-20 16:06:47", "headline": "Erasca Q4 2024 GAAP EPS $(0.11) Beats $(0.12) Estimate", "summary": "", "symbols": ["ERAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424913/erasca-q4-2024-gaap-eps-0-11-beats-0-12-estimate", "tags": ["earnings"]}
{"id": 44424917, "time": "2025-03-20 16:07:13", "headline": "Senti Bio Sciences Q4 EPS ($0.67) Up From ($4.19) YoY.", "summary": "", "symbols": ["SNTI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424917/senti-bio-sciences-q4-eps-0-67-up-from-4-19-yoy", "tags": ["earnings"]}
{"id": 44424967, "time": "2025-03-20 16:08:23", "headline": "Verastem Q4 Adj $(0.60) Beats $(0.81) Estimate", "summary": "", "symbols": ["VSTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424967/verastem-q4-adj-0-60-beats-0-81-estimate", "tags": []}
{"id": 44424977, "time": "2025-03-20 16:08:31", "headline": "Wells Fargo Maintains Equal-Weight on Expand Energy, Raises Price Target to $107", "summary": "", "symbols": ["EXE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44424977/wells-fargo-maintains-equal-weight-on-expand-energy-raises-price-target-to-107", "tags": ["analyst_other", "price_target_up"]}
{"id": 44424995, "time": "2025-03-20 16:09:51", "headline": "Vaxart FY 2024 GAAP EPS $(0.33) Beats $(0.39) Estimate, Sales $28.700M Beat $16.550M Estimate", "summary": "", "symbols": ["VXRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44424995/vaxart-fy-2024-gaap-eps-0-33-beats-0-39-estimate-sales-28-700m-beat-16-550m-estimate", "tags": ["earnings"]}
{"id": 44425003, "time": "2025-03-20 16:10:01", "headline": "Skye Bioscience Q4 2024 GAAP EPS $(0.24) Beats $(0.27) Estimate", "summary": "", "symbols": ["SKYE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425003/skye-bioscience-q4-2024-gaap-eps-0-24-beats-0-27-estimate", "tags": ["earnings"]}
{"id": 44425013, "time": "2025-03-20 16:10:06", "headline": "Wells Fargo Maintains Equal-Weight on Williams-Sonoma, Lowers Price Target to $170", "summary": "", "symbols": ["WSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425013/wells-fargo-maintains-equal-weight-on-williams-sonoma-lowers-price-target-to-170", "tags": ["analyst_other", "price_target_down"]}
{"id": 44425021, "time": "2025-03-20 16:10:16", "headline": "Flux Power Holdings Q1 2025 GAAP EPS $(0.10) Beats $(0.13) Estimate, Sales $16.125 Miss $14.324M Estimate", "summary": "", "symbols": ["FLUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425021/flux-power-holdings-q1-2025-gaap-eps-0-10-beats-0-13-estimate-sales-16-125-miss-14-324m-estimate", "tags": ["earnings"]}
{"id": 44425022, "time": "2025-03-20 16:10:21", "headline": "Luminar Technologies Q4 2024 GAAP EPS $(1.26) May Not Be Comparable To $(2.54) Estimate, Sales $22.48M Beat $17.72M Estimate", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425022/luminar-technologies-q4-2024-gaap-eps-1-26-may-not-be-comparable-to-2-54-estimate-sales-22-48m-beat", "tags": ["earnings"]}
{"id": 44425039, "time": "2025-03-20 16:11:14", "headline": "Wells Fargo Maintains Overweight on Signet Jewelers, Lowers Price Target to $80", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425039/wells-fargo-maintains-overweight-on-signet-jewelers-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 44425055, "time": "2025-03-20 16:11:34", "headline": "Eledon Pharma FY 2024 GAAP EPS $(0.75) Misses $(0.64) Estimate", "summary": "", "symbols": ["ELDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425055/eledon-pharma-fy-2024-gaap-eps-0-75-misses-0-64-estimate", "tags": ["earnings"]}
{"id": 44424543, "time": "2025-03-20 16:10:04", "headline": "Why Rolling Trading Profits into Investments is Key", "summary": "By rolling most of your trading profits into investments, you&#39;re effectively reducing the amount of capital at risk in your trading account.", "symbols": [], "source": "benzinga", "author": "mayhem@traderade.com", "url": "https://www.benzinga.com/opinion/25/03/44424543/why-rolling-trading-profits-into-investments-is-key", "tags": []}
{"id": 44425060, "time": "2025-03-20 16:11:58", "headline": "Assembly Biosciences FY 2024 GAAP EPS $(6.69) Beats $(7.54) Estimate, Sales $28.520M Beat $26.838M Estimate", "summary": "", "symbols": ["ASMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425060/assembly-biosciences-fy-2024-gaap-eps-6-69-beats-7-54-estimate-sales-28-520m-beat-26-838m-estimate", "tags": ["earnings"]}
{"id": 44425068, "time": "2025-03-20 16:12:31", "headline": "MacroGenics 2024 EPS $(1.07) Down From $(0.15) YoY", "summary": "", "symbols": ["MGNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425068/macrogenics-2024-eps-1-07-down-from-0-15-yoy", "tags": ["earnings"]}
{"id": 44425069, "time": "2025-03-20 16:12:31", "headline": "Itron To Deploy An Advanced Virtual Power Plant In Colorado In Collaboration With Xcel Energy And Tesla", "summary": "", "symbols": ["ITRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425069/itron-to-deploy-an-advanced-virtual-power-plant-in-colorado-in-collaboration-with-xcel-energy-and-te", "tags": []}
{"id": 44425074, "time": "2025-03-20 16:12:35", "headline": "NuCana Q4 EPS \u00a3(0.01) Up From \u00a3(0.14) YoY.", "summary": "", "symbols": ["NCNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425074/nucana-q4-eps-0-01-up-from-0-14-yoy", "tags": ["earnings"]}
{"id": 44425088, "time": "2025-03-20 16:13:10", "headline": "Amprius Technologies Q4 EPS $(0.10) Beats $(0.11) Estimate, Sales $10.63M Beat $8.34M Estimate", "summary": "", "symbols": ["AMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425088/amprius-technologies-q4-eps-0-10-beats-0-11-estimate-sales-10-63m-beat-8-34m-estimate", "tags": ["earnings"]}
{"id": 44425101, "time": "2025-03-20 16:13:50", "headline": "Vor Biopharma FY 2024 GAAP EPS $(1.70) Misses $(1.40) Estimate", "summary": "", "symbols": ["VOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425101/vor-biopharma-fy-2024-gaap-eps-1-70-misses-1-40-estimate", "tags": ["earnings"]}
{"id": 44425117, "time": "2025-03-20 16:13:57", "headline": "TELA Bio Q4 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate, Sales $17.649M Miss $23.166M Estimate", "summary": "", "symbols": ["TELA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425117/tela-bio-q4-2024-gaap-eps-0-23-misses-0-22-estimate-sales-17-649m-miss-23-166m-estimate", "tags": ["earnings"]}
{"id": 44425123, "time": "2025-03-20 16:14:01", "headline": "Dyne Therapeutics Appoints Erick J. Lucera As Chief Financial Officer, Effective March 31, 2025", "summary": "", "symbols": ["DYN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425123/dyne-therapeutics-appoints-erick-j-lucera-as-chief-financial-officer-effective-march-31-2025", "tags": ["management"]}
{"id": 44425139, "time": "2025-03-20 16:14:35", "headline": "Arcadia Biosciences Q4 2024 GAAP EPS $(2.98) Misses $(0.89) Estimate, Sales $1.216M Beat $1.200M Estimate", "summary": "", "symbols": ["RKDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425139/arcadia-biosciences-q4-2024-gaap-eps-2-98-misses-0-89-estimate-sales-1-216m-beat-1-200m-estimate", "tags": ["earnings"]}
{"id": 44425153, "time": "2025-03-20 16:15:02", "headline": "Cibus Q4 2024 Adj EPS $(0.87) Misses $(0.76) Estimate, Sales $1.21M Beat $1.13M Estimate", "summary": "", "symbols": ["CBUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425153/cibus-q4-2024-adj-eps-0-87-misses-0-76-estimate-sales-1-21m-beat-1-13m-estimate", "tags": ["earnings"]}
{"id": 44425155, "time": "2025-03-20 16:15:02", "headline": "Amprius Technologies Says \"We Expect To Spend Another $1M On Supporting Equipment To Complete The 2 MWh Line In Fremont In Addition To Normal Operating Capital Requirements\"", "summary": "", "symbols": ["AMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425155/amprius-technologies-says-we-expect-to-spend-another-1m-on-supporting-equipment-to-complete-the-2-mw", "tags": []}
{"id": 44425180, "time": "2025-03-20 16:15:11", "headline": "Here's How Much $100 Invested In Wells Fargo 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["WFC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44425180/heres-how-much-100-invested-in-wells-fargo-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44425199, "time": "2025-03-20 16:15:32", "headline": "Blue Owl Technology Finance Corp. And Blue Owl Technology Finance Corp. II Announce Shareholder Approval Of All Proposals Related To Merger", "summary": "", "symbols": ["OWL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/25/03/44425199/blue-owl-technology-finance-corp-and-blue-owl-technology-finance-corp-ii-announce-shareholder-approv", "tags": ["merger"]}
{"id": 44425232, "time": "2025-03-20 16:16:17", "headline": "Check Out What Whales Are Doing With HUBS", "summary": " ", "symbols": ["HUBS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44425232/check-out-what-whales-are-doing-with-hubs", "tags": []}
{"id": 44425234, "time": "2025-03-20 16:16:21", "headline": "Allurion Announces Initial Results On Combination Of Allurion Program With Low-Dose GLP-1 Therapy To Optimize Muscle Mass And GLP-1 Adherence", "summary": "", "symbols": ["ALUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44425234/allurion-announces-initial-results-on-combination-of-allurion-program-with-low-dose-glp-1-therapy", "tags": []}
{"id": 44425236, "time": "2025-03-20 16:16:22", "headline": "Behind the Scenes of AT&T's Latest Options Trends", "summary": " ", "symbols": ["T"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44425236/behind-the-scenes-of-at-ts-latest-options-trends", "tags": []}
{"id": 44425237, "time": "2025-03-20 16:16:24", "headline": "Nike Q3 2025 GAAP EPS $0.54 Beats $0.28 Estimate, Sales $11.27B Beat $11.01B Estimate", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425237/nike-q3-2025-gaap-eps-0-54-beats-0-28-estimate-sales-11-27b-beat-11-01b-estimate", "tags": ["earnings"]}
{"id": 44425273, "time": "2025-03-20 16:17:04", "headline": "Dakota Gold Announces Offering Of 12.4M Shares Of Common Stock", "summary": "", "symbols": ["DC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425273/dakota-gold-announces-offering-of-12-4m-shares-of-common-stock", "tags": ["offering"]}
{"id": 44425283, "time": "2025-03-20 16:17:21", "headline": "Intellicheck Q4 2024 GAAP EPS $0.03 Beats $(0.01) Estimate, Sales $5.94M Beat $5.05M Estimate", "summary": "", "symbols": ["IDN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425283/intellicheck-q4-2024-gaap-eps-0-03-beats-0-01-estimate-sales-5-94m-beat-5-05m-estimate", "tags": ["earnings"]}
{"id": 44425286, "time": "2025-03-20 16:17:26", "headline": "Terns Pharma Q4 2024 GAAP EPS $(0.24) Beats $(0.30) Estimate", "summary": "", "symbols": ["TERN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425286/terns-pharma-q4-2024-gaap-eps-0-24-beats-0-30-estimate", "tags": ["earnings"]}
{"id": 44425384, "time": "2025-03-20 16:18:01", "headline": "Torrid Holdings Q4 2024 GAAP EPS $(0.03) Beats $(0.07) Estimate, Sales $275.600M Beat $264.656M Estimate", "summary": "", "symbols": ["CURV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425384/torrid-holdings-q4-2024-gaap-eps-0-03-beats-0-07-estimate-sales-275-600m-beat-264-656m-estimate", "tags": ["earnings"]}
{"id": 44425397, "time": "2025-03-20 16:18:38", "headline": "Consumer Portfolio Services Announces The Closing Of A $65.0M Securitization Of Residual Interests From Previously Issued Securitizations", "summary": "", "symbols": ["CPSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425397/consumer-portfolio-services-announces-the-closing-of-a-65-0m-securitization-of-residual-interests-fr", "tags": []}
{"id": 44425403, "time": "2025-03-20 16:18:49", "headline": "NIKE Says Progress Made Against The 'Win Now' Strategic Priorities Reinforces Confidence It Is On The Right Path; Says Operating Environment Is Dynamic", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425403/nike-says-progress-made-against-the-win-now-strategic-priorities-reinforces-confidence-it-is-on-the", "tags": []}
{"id": 44425416, "time": "2025-03-20 16:19:29", "headline": "Immuneering Q4 EPS $(0.58) Misses $(0.46) Estimate", "summary": "", "symbols": ["IMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425416/immuneering-q4-eps-0-58-misses-0-46-estimate", "tags": ["earnings"]}
{"id": 44425440, "time": "2025-03-20 16:19:41", "headline": "Runway Gwth Fin Q4 2024 GAAP EPS $0.39 Misses $0.42 Estimate, Sales $33.779M Miss $36.100M Estimate", "summary": "", "symbols": ["RWAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425440/runway-gwth-fin-q4-2024-gaap-eps-0-39-misses-0-42-estimate-sales-33-779m-miss-36-100m-estimate", "tags": ["earnings"]}
{"id": 44425462, "time": "2025-03-20 16:19:59", "headline": "Torrid Holdings Sees Q1 Net Sales $264M-$274M Vs $278.667M Est; Adj. EBITDA $24M-$28M.", "summary": "", "symbols": ["CURV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425462/torrid-holdings-sees-q1-net-sales-264m-274m-vs-278-667m-est-adj-ebitda-24m-28m", "tags": []}
{"id": 44425480, "time": "2025-03-20 16:20:32", "headline": "Independent Bank Corp. Increase Quarterly Dividend From $0.57 To $0.59 Per Share", "summary": "", "symbols": ["INDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425480/independent-bank-corp-increase-quarterly-dividend-from-0-57-to-0-59-per-share", "tags": ["dividend"]}
{"id": 44425485, "time": "2025-03-20 16:20:50", "headline": "Chardan Capital Maintains Buy on Seres Therapeutics, Maintains $1.25 Price Target", "summary": "", "symbols": ["MCRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425485/chardan-capital-maintains-buy-on-seres-therapeutics-maintains-1-25-price-target", "tags": ["analyst_other"]}
{"id": 44425486, "time": "2025-03-20 16:20:53", "headline": "Micron Q2 Earnings: Revenue Beat, Data Center Sales Triple, EPS Beat, Strong Guidance, Shares Jump", "summary": "Micron announces second-quarter revenue of $8.05 billion, beating the\u00a0consensus estimate\u00a0of $7.89 billion.", "symbols": ["MU"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/25/03/44425486/micron-q2-earnings-revenue-beat-data-center-sales-triple-eps-beat-strong-guidance-shares-jump", "tags": ["earnings", "guidance"]}
{"id": 44425506, "time": "2025-03-20 16:21:22", "headline": "Alto Neuroscience FY 2024 GAAP EPS $(2.50) Beats $(2.59) Estimate", "summary": "", "symbols": ["ANRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425506/alto-neuroscience-fy-2024-gaap-eps-2-50-beats-2-59-estimate", "tags": ["earnings"]}
{"id": 44425515, "time": "2025-03-20 16:22:00", "headline": "Motorsport Games Q4 EPS $(0.94) Down From $0.25 YoY, Sales $1.97M Up From $1.75M YoY", "summary": "", "symbols": ["MSGM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425515/motorsport-games-q4-eps-0-94-down-from-0-25-yoy-sales-1-97m-up-from-1-75m-yoy", "tags": ["earnings"]}
{"id": 44425524, "time": "2025-03-20 16:22:21", "headline": "Ouster Q4 2024 GAAP EPS $(0.48) Beats $(0.59) Estimate, Sales $30.092M Beat $30.000M Estimate", "summary": "", "symbols": ["OUST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425524/ouster-q4-2024-gaap-eps-0-48-beats-0-59-estimate-sales-30-092m-beat-30-000m-estimate", "tags": ["earnings"]}
{"id": 44425525, "time": "2025-03-20 16:22:32", "headline": "Telsey Advisory Group Maintains Market Perform on Five Below, Maintains $85 Price Target", "summary": "", "symbols": ["FIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425525/telsey-advisory-group-maintains-market-perform-on-five-below-maintains-85-price-target", "tags": ["analyst_other"]}
{"id": 44425527, "time": "2025-03-20 16:22:48", "headline": "Alight Expects Mid-Term Financial Outlook Annual Revenue Growth Rate 4%-6% By 2027", "summary": "", "symbols": ["ALIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425527/alight-expects-mid-term-financial-outlook-annual-revenue-growth-rate-4-6-by-2027", "tags": ["earnings", "guidance"]}
{"id": 44425534, "time": "2025-03-20 16:22:56", "headline": "Luminar Expects FY25 Total Revenue Growth Of 10% - 20%, Q1'25 Revenue To Be Lower Sequentially", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425534/luminar-expects-fy25-total-revenue-growth-of-10-20-q125-revenue-to-be-lower-sequentially", "tags": ["earnings"]}
{"id": 44425539, "time": "2025-03-20 16:23:12", "headline": "Ouster Sees Q1 Revenue $30M-$32M vs $31.325M Est.", "summary": "", "symbols": ["OUST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425539/ouster-sees-q1-revenue-30m-32m-vs-31-325m-est", "tags": ["earnings"]}
{"id": 44425540, "time": "2025-03-20 16:23:19", "headline": "NANOBIOTIX Presents Data From Two Phase 1 Studies Evaluating JNJ-1900 At European Lung Cancer Conference", "summary": "", "symbols": ["NBTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/25/03/44425540/nanobiotix-presents-data-from-two-phase-1-studies-evaluating-jnj-1900-at-european-lung-cancer-con", "tags": ["fda"]}
{"id": 44425551, "time": "2025-03-20 16:24:07", "headline": "SEALSQ FY 2024 GAAP EPS $(0.60) Down From $(0.21) YoY, Sales $10.981 Miss $7.400M Estimate", "summary": "", "symbols": ["LAES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425551/sealsq-fy-2024-gaap-eps-0-60-down-from-0-21-yoy-sales-10-981-miss-7-400m-estimate", "tags": ["earnings"]}
{"id": 44425552, "time": "2025-03-20 16:24:09", "headline": "FedEx Shares Fall After Q3 Earnings Miss, Lower FY25 Revenue Forecast", "summary": "FedEx Corp. releases its third-quarter results after Thursday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["FDX"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/03/44425552/fedex-shares-fall-after-q3-earnings-miss-lower-fy25-revenue-forecast", "tags": ["earnings", "guidance"]}
{"id": 44425589, "time": "2025-03-20 16:25:01", "headline": "Telsey Advisory Group Maintains Market Perform on Lulus Fashion Lounge, Maintains $2 Price Target", "summary": "", "symbols": ["LVLU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425589/telsey-advisory-group-maintains-market-perform-on-lulus-fashion-lounge-maintains-2-price-target", "tags": ["analyst_other"]}
{"id": 44425590, "time": "2025-03-20 16:25:11", "headline": "SEALSQ Expects Revenue To Increase In FY25 Compared To 2024", "summary": "", "symbols": ["LAES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425590/sealsq-expects-revenue-to-increase-in-fy25-compared-to-2024", "tags": ["earnings"]}
{"id": 44425608, "time": "2025-03-20 16:25:50", "headline": "KinderCare Learning Q4 2024 Adj EPS $0.09 Beats $0.05 Estimate, Sales $646.96M Beat $646.73M Estimate", "summary": "", "symbols": ["KLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425608/kindercare-learning-q4-2024-adj-eps-0-09-beats-0-05-estimate-sales-646-96m-beat-646-73m-estimate", "tags": ["earnings"]}
{"id": 44425626, "time": "2025-03-20 16:26:15", "headline": "Luminar Technologies Q4 Adj EPS $(1.42) Beats $(2.17) Estimate, Sales $22.48M Beat $17.72M Estimate", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425626/luminar-technologies-q4-adj-eps-1-42-beats-2-17-estimate-sales-22-48m-beat-17-72m-estimate", "tags": ["earnings"]}
{"id": 44425628, "time": "2025-03-20 16:26:17", "headline": "FVCBankcorp Extends 1.3M Share Repurchase Program; To Expire On March 31, 2026", "summary": "", "symbols": ["FVCB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425628/fvcbankcorp-extends-1-3m-share-repurchase-program-to-expire-on-march-31-2026", "tags": ["buyback"]}
{"id": 44425661, "time": "2025-03-20 16:27:12", "headline": "U.S. Judge Blocks Elon Musk's Doge From Accessing Social Security Records", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/25/03/44425661/u-s-judge-blocks-elon-musks-doge-from-accessing-social-security-records", "tags": []}
{"id": 44425690, "time": "2025-03-20 16:27:44", "headline": "Macquarie Maintains Neutral on Salesforce, Maintains $320 Price Target", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425690/macquarie-maintains-neutral-on-salesforce-maintains-320-price-target", "tags": ["analyst_other"]}
{"id": 44425698, "time": "2025-03-20 16:28:05", "headline": "Vaxart Implements 10% Workforce Reduction", "summary": "", "symbols": ["VXRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425698/vaxart-implements-10-workforce-reduction", "tags": []}
{"id": 44425699, "time": "2025-03-20 16:28:10", "headline": "KinderCare Expects FY25 Revenue Of $2.75B - $2.85B (Est $2.857B), Adjusted EPS Of $0.75 - $0.85 (Est $0.75)", "summary": "", "symbols": ["KLC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425699/kindercare-expects-fy25-revenue-of-2-75b-2-85b-est-2-857b-adjusted-eps-of-0-75-0-85-est-0-75", "tags": ["earnings"]}
{"id": 44425722, "time": "2025-03-20 16:29:04", "headline": "United States Steel Corp Sees Q1 2025 EPS $(0.53)-$(0.49) Vs $(0.30) Est; Sees Adj. EBITDA Of ~$125M", "summary": "", "symbols": ["X"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425722/united-states-steel-corp-sees-q1-2025-eps-0-53-0-49-vs-0-30-est-sees-adj-ebitda-of-125m", "tags": ["earnings"]}
{"id": 44425760, "time": "2025-03-20 16:30:07", "headline": "Cannabis Stock Gainers And Losers From March 20, 2025", "summary": " ", "symbols": ["ACB", "BBRRF", "CARA", "CBDY", "CBWTF", "CLSH", "CURLF", "CURR", "CVSI", "CXXIF", "ELLXF", "FFNTF", "FUAPF", "GRWG", "LBUY", "LVRLF", "MXC", "NWVCF", "OILFF", "RMHB", "RSSFF", "SOLCF", "TGIFF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cannabis/25/03/44425760/cannabis-stock-gainers-and-losers-from-march-20-2025", "tags": []}
{"id": 44425763, "time": "2025-03-20 16:30:11", "headline": "Here's How Much $1000 Invested In Corteva 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["CTVA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44425763/heres-how-much-1000-invested-in-corteva-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44425769, "time": "2025-03-20 16:30:22", "headline": "3 ETFs To Watch As Interest Rate Trends Take A Turn", "summary": "President Trump urges Fed to cut interest rates amid new tariffs, adding to economic uncertainty. 3 ETFs identified for potential gains.", "symbols": ["RFIX", "VBIL", "VGUS"], "source": "benzinga", "author": "Chandrima Sanyal", "url": "https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44425769/3-etfs-to-watch-as-interest-rate-trends-take-a-turn", "tags": []}
{"id": 44425823, "time": "2025-03-20 16:31:12", "headline": "Unpacking the Latest Options Trading Trends in Morgan Stanley", "summary": " ", "symbols": ["MS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/25/03/44425823/unpacking-the-latest-options-trading-trends-in-morgan-stanley", "tags": []}
{"id": 44425827, "time": "2025-03-20 16:31:19", "headline": "President Trump Says Signed Order To Increase Production Of Critical Minerals; Says We Are Doing Well With Ukraine And Russia; Signing Deal Shortly With Ukraine On Rare Earths", "summary": "", "symbols": ["SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/25/03/44425827/president-trump-says-signed-order-to-increase-production-of-critical-minerals-says-we-are-doing-well", "tags": ["contract"]}
{"id": 44425836, "time": "2025-03-20 16:31:29", "headline": "Curtiss-Wright Secures Multiple Contracts To Provide Its Turret Drive Aiming And Stabilization Technology To Rheinmetall", "summary": "", "symbols": ["CW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425836/curtiss-wright-secures-multiple-contracts-to-provide-its-turret-drive-aiming-and-stabilization-techn", "tags": []}
{"id": 44425925, "time": "2025-03-20 16:33:04", "headline": "Luminar Technologies Shares Rally After Strong Q4 Report: Details", "summary": "Luminar Technologies releases its fourth-quarter results after Thursday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["LAZR"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/03/44425925/luminar-technologies-shares-rally-after-strong-q4-report-details", "tags": []}
{"id": 44425927, "time": "2025-03-20 16:33:13", "headline": "BioAge Labs FY24 EPS $(6.63) Up From $(38.17) YoY", "summary": "", "symbols": ["BIOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425927/bioage-labs-fy24-eps-6-63-up-from-38-17-yoy", "tags": ["earnings"]}
{"id": 44425968, "time": "2025-03-20 16:34:31", "headline": "Phoenix Motor's EdisonFuture Partners With Beijing Guorun To Establish $140M M&A Fund For EV Manufacturing Sites In China", "summary": "", "symbols": ["PEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425968/phoenix-motors-edisonfuture-partners-with-beijing-guorun-to-establish-140m-m-a-fund-for-ev-manufactu", "tags": ["contract"]}
{"id": 44426020, "time": "2025-03-20 16:36:11", "headline": "Colgate-Palmolive Plans Repurchase Of Shares Of Up To $5B Under New Share Repurchase Program", "summary": "", "symbols": ["CL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426020/colgate-palmolive-plans-repurchase-of-shares-of-up-to-5b-under-new-share-repurchase-program", "tags": ["buyback"]}
{"id": 44426022, "time": "2025-03-20 16:36:17", "headline": "Sunoco LP Announces That It Has Priced At 100% A Private Offering Of 6.250% Senior Notes Due 2033 In An Aggregate Principal Amount Of $1B", "summary": "", "symbols": ["SUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426022/sunoco-lp-announces-that-it-has-priced-at-100-a-private-offering-of-6-250-senior-notes-due-2033-in-a", "tags": ["offering"]}
{"id": 44426034, "time": "2025-03-20 16:37:08", "headline": "Colgate-Palmolive Increases Quarterly Common Stock Cash Dividend From $0.50 To $0.52 Per Share", "summary": "", "symbols": ["CL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426034/colgate-palmolive-increases-quarterly-common-stock-cash-dividend-from-0-50-to-0-52-per-share", "tags": ["dividend"]}
{"id": 44426060, "time": "2025-03-20 16:39:20", "headline": "Oxford Lane Capital Corp. Adopts A Share Repurchase Program Of Up To $150M", "summary": "", "symbols": ["OXLC", "OXLCG", "OXLCI", "OXLCL", "OXLCN", "OXLCO", "OXLCP", "OXLCZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426060/oxford-lane-capital-corp-adopts-a-share-repurchase-program-of-up-to-150m", "tags": ["buyback"]}
{"id": 44426095, "time": "2025-03-20 16:42:29", "headline": "Bitcoin, Ethereum, XRP, Dogecoin Pull Back After FOMC: $84,000 Support Is Key, Traders Note", "summary": "Cryptocurrencies slightly retraced gains on Thursday as President Trump addressed cryptocurrency investors via a pre-recorded statement.", "symbols": ["BONKUSD", "BTCUSD", "DOGEUSD", "ETHUSD", "KAVAUSD", "PEPEUSD", "SHIBUSD", "SOLUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/25/03/44426095/bitcoin-ethereum-xrp-dogecoin-pull-back-after-fomc-84000-support-is-key-traders-note", "tags": []}
{"id": 44426104, "time": "2025-03-20 16:42:52", "headline": "Nike Q3 Earnings: Revenue Beat, EPS Beat, Inventories Down 2% \u2014 'We Are On The Right Path'", "summary": "Nike announces third-quarter revenue of $11.27 billion, beating analyst\u00a0estimates\u00a0of $11.01 billion.", "symbols": ["NKE"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/general/sports/25/03/44426104/nike-q3-earnings-revenue-beat-eps-beat-inventories-down-2-we-are-on-the-right-path", "tags": ["earnings"]}
{"id": 44426112, "time": "2025-03-20 16:42:59", "headline": "Tenon Medical Q4 2024 GAAP EPS $(0.98) Beats $(2.54) Estimate, Sales $770.000K Miss $1.450M Estimate", "summary": "", "symbols": ["TNON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44426112/tenon-medical-q4-2024-gaap-eps-0-98-beats-2-54-estimate-sales-770-000k-miss-1-450m-estimate", "tags": ["earnings"]}
{"id": 44426149, "time": "2025-03-20 16:43:58", "headline": "Vaxart Q4 2024 GAAP EPS $(0.04) Beats $(0.10) Estimate, Sales $15.185M Miss $20.767M Estimate", "summary": "", "symbols": ["VXRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44426149/vaxart-q4-2024-gaap-eps-0-04-beats-0-10-estimate-sales-15-185m-miss-20-767m-estimate", "tags": ["earnings"]}
{"id": 44425216, "time": "2025-03-20 16:15:58", "headline": "SELLAS Life Sciences Gr FY 2024 GAAP EPS $(0.50) Beats $(0.54) Estimate", "summary": "", "symbols": ["SLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425216/sellas-life-sciences-gr-fy-2024-gaap-eps-0-50-beats-0-54-estimate", "tags": ["earnings"]}
{"id": 44426185, "time": "2025-03-20 16:45:17", "headline": "$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["MMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44426185/100-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44426186, "time": "2025-03-20 16:45:19", "headline": "P/E Ratio Insights for Cohen & Steers", "summary": " ", "symbols": ["CNS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44426186/pe-ratio-insights-for-cohen-steers", "tags": []}
{"id": 44425529, "time": "2025-03-20 16:22:49", "headline": "Palomar Holdings Enters Into Definitive Agreement To Acquire Advanced AgProtection; Terms Not Disclosed", "summary": "", "symbols": ["PLMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44425529/palomar-holdings-enters-into-definitive-agreement-to-acquire-advanced-agprotection-terms-not-disclos", "tags": ["merger", "contract"]}
{"id": 44426389, "time": "2025-03-20 16:47:52", "headline": "Nucor Expects Q1 Adjusted EPS Of $0.50 - $0.60, Est $1.06", "summary": "", "symbols": ["NUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426389/nucor-expects-q1-adjusted-eps-of-0-50-0-60-est-1-06", "tags": ["earnings"]}
{"id": 44426406, "time": "2025-03-20 16:48:36", "headline": "Context Therapeutics FY 2024 GAAP EPS $(0.46) Beats $(0.58) Estimate", "summary": "", "symbols": ["CNTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44426406/context-therapeutics-fy-2024-gaap-eps-0-46-beats-0-58-estimate", "tags": ["earnings"]}
{"id": 44426419, "time": "2025-03-20 16:49:19", "headline": "Nucor Expects Q1 Earnings In Steel Products Segment To Decrease Q/Q Due Primarily To Lower Average Selling Prices", "summary": "", "symbols": ["NUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426419/nucor-expects-q1-earnings-in-steel-products-segment-to-decrease-qq-due-primarily-to-lower-average-se", "tags": ["earnings"]}
{"id": 44426456, "time": "2025-03-20 16:52:15", "headline": "Phunware 2024 EPS (0.94), Revenue $3.189M Down From $4.832M YoY", "summary": "", "symbols": ["PHUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44426456/phunware-2024-eps-0-94-revenue-3-189m-down-from-4-832m-yoy", "tags": ["earnings"]}
{"id": 44426484, "time": "2025-03-20 16:53:42", "headline": "AstroNova Executes Waiver And Amendment Of Its Revolving Credit Facility And Term Loans With Bank Of America", "summary": "", "symbols": ["ALOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426484/astronova-executes-waiver-and-amendment-of-its-revolving-credit-facility-and-term-loans-with-bank-of", "tags": []}
{"id": 44426487, "time": "2025-03-20 16:53:57", "headline": "Ashford Hospitality Trust Targets $50M Annual Run-Rate EBITDA Growth Through $11M Hotel Expense Cuts and Ancillary Initiatives; Expects Completed Initiatives To Contribute Over $30M Per Year In Incremental EBITDA Towards Its $50M Goal", "summary": "", "symbols": ["AHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426487/ashford-hospitality-trust-targets-50m-annual-run-rate-ebitda-growth-through-11m-hotel-expense-cuts-a", "tags": []}
{"id": 44426492, "time": "2025-03-20 16:54:20", "headline": "Rivian Police Cruiser Nears Debut For Palo Alto Police Department: Could EV Company Gain Fleet Customers?", "summary": "Rivian will soon have at least one police vehicle on the streets in the United States. A mayor&#39;s endorsement and sales pitch could help land more deals.", "symbols": ["RIVN"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/25/03/44426492/rivian-police-cruiser-nears-debut-for-palo-alto-police-department-could-ev-company-gain-fleet-customers", "tags": []}
{"id": 44426518, "time": "2025-03-20 16:55:36", "headline": "AstroNova Implements Restructuring Actions To Generate $3M In Annualized Savings; Plan Includes Reduction Of 10% Of Global Workforce", "summary": "", "symbols": ["ALOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426518/astronova-implements-restructuring-actions-to-generate-3m-in-annualized-savings-plan-includes-reduct", "tags": []}
{"id": 44426530, "time": "2025-03-20 16:56:04", "headline": "Quantum Computing Stock Tumbles On Q4 Earnings: The Details", "summary": "Quantum Computing shares are trading lower in Thursday&#39;s after-hours session on the heels of the company&#39;s fourth-quarter results. Here&#39;s a rundown of the report.", "symbols": ["QUBT"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/25/03/44426530/quantum-computing-stock-tumbles-on-q4-earnings-the-details", "tags": ["earnings", "why_moving"]}
{"id": 44426552, "time": "2025-03-20 16:57:08", "headline": "Buffett's Berkshire Hathaway Outpaces S&P 500 With Best 2-Month Run Since 2010", "summary": "Buffett&#39;s Berkshire Hathaway Inc. outperforms S&amp;P 500 by 20% in 2 months, reflecting his long-term view and record-high share price.", "symbols": ["AAPL", "AXP", "BAC", "BRK", "SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/news/large-cap/25/03/44426552/buffetts-berkshire-hathaway-outpaces-sp-500-with-best-2-month-run-since-2010", "tags": []}
{"id": 44426570, "time": "2025-03-20 16:57:44", "headline": "AstroNova Reports Preliminarily Q4'25 Revenues Of $37.4M, Expects $13.4M Non-cash Goodwill Impairment Charge", "summary": "", "symbols": ["ALOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426570/astronova-reports-preliminarily-q425-revenues-of-37-4m-expects-13-4m-non-cash-goodwill-impairment-ch", "tags": []}
{"id": 44426588, "time": "2025-03-20 16:59:03", "headline": "AstroNova Sees FY26 Revenues Of $160M - $165M, Expects Further Improvements Beyond FY26", "summary": "", "symbols": ["ALOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426588/astronova-sees-fy26-revenues-of-160m-165m-expects-further-improvements-beyond-fy26", "tags": []}
{"id": 44426613, "time": "2025-03-20 17:00:19", "headline": "Forecasting The Future: 10 Analyst Projections For Akamai Technologies", "summary": " ", "symbols": ["AKAM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44426613/forecasting-the-future-10-analyst-projections-for-akamai-technologies", "tags": []}
{"id": 44426621, "time": "2025-03-20 17:00:33", "headline": "Analyst Expectations For TPG's Future", "summary": " ", "symbols": ["TPG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44426621/analyst-expectations-for-tpgs-future", "tags": []}
{"id": 44426628, "time": "2025-03-20 17:00:44", "headline": "21 Analysts Assess Expand Energy: What You Need To Know", "summary": " ", "symbols": ["EXE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44426628/21-analysts-assess-expand-energy-what-you-need-to-know", "tags": []}
{"id": 44426630, "time": "2025-03-20 17:00:50", "headline": "Where Ameren Stands With Analysts", "summary": " ", "symbols": ["AEE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44426630/where-ameren-stands-with-analysts", "tags": []}
{"id": 44426631, "time": "2025-03-20 17:00:58", "headline": "Sempra Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)", "summary": " ", "symbols": ["SRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44426631/sempra-stock-a-deep-dive-into-analyst-perspectives-11-ratings", "tags": []}
{"id": 44426640, "time": "2025-03-20 17:01:09", "headline": "6 Analysts Assess Hamilton Lane: What You Need To Know", "summary": " ", "symbols": ["HLNE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44426640/6-analysts-assess-hamilton-lane-what-you-need-to-know", "tags": []}
{"id": 44426664, "time": "2025-03-20 17:01:58", "headline": "Patriot National Bancorp Enters Securities Purchase Agreements To Raise Over $50M In  Private Placement", "summary": "", "symbols": ["PNBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426664/patriot-national-bancorp-enters-securities-purchase-agreements-to-raise-over-50m-in-private-placemen", "tags": ["offering"]}
{"id": 44426705, "time": "2025-03-20 17:03:23", "headline": "Patriot National Bancorp President Steven Sugarman Enters Long-term Employment Agreement; CEO David Lowery To Depart", "summary": "", "symbols": ["PNBK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426705/patriot-national-bancorp-president-steven-sugarman-enters-long-term-employment-agreement-ceo-david-l", "tags": ["contract", "management"]}
{"id": 44426736, "time": "2025-03-20 17:05:35", "headline": "New Concept Energy 2024 EPS $(0.01), Same YoY", "summary": "", "symbols": ["GBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426736/new-concept-energy-2024-eps-0-01-same-yoy", "tags": ["earnings"]}
{"id": 44426740, "time": "2025-03-20 17:06:10", "headline": "12 Information Technology Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["AEVA", "BTCT", "GREE", "IFBD", "INVE", "LEDS", "MU", "OUST", "PCLA", "QUBT", "VLN", "WTO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44426740/12-information-technology-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 44426745, "time": "2025-03-20 17:06:15", "headline": "12 Industrials Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["DSS", "DXST", "FDX", "LNKS", "NCL", "NEOV", "NRGV", "OPTT", "PL", "SGBX", "SRFM", "UGRO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44426745/12-industrials-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 44426746, "time": "2025-03-20 17:06:20", "headline": "12 Health Care Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["APGE", "BJDX", "CYTH", "EYEN", "GCTK", "IBO", "INTS", "MRVI", "OSTX", "PSTV", "TELA", "WGRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44426746/12-health-care-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 44426749, "time": "2025-03-20 17:06:26", "headline": "12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session", "summary": " ", "symbols": ["AGH", "ALUR", "FTEL", "GNLN", "LAZR", "NAAS", "NWTN", "PEV", "QVCGA", "SNBR", "TCTM", "WKHS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/25/03/44426749/12-consumer-discretionary-stocks-moving-in-thursdays-after-market-session", "tags": ["why_moving"]}
{"id": 44426796, "time": "2025-03-20 17:08:03", "headline": "Avalon Holdings Q4 EPS $(0.13) Up From $(0.21) YoY, Revenues $17.6M Down From $17.7M YoY", "summary": "", "symbols": ["AWX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44426796/avalon-holdings-q4-eps-0-13-up-from-0-21-yoy-revenues-17-6m-down-from-17-7m-yoy", "tags": ["earnings"]}
{"id": 44426887, "time": "2025-03-20 17:15:22", "headline": "Here's How Much $1000 Invested In Xylem 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["XYL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44426887/heres-how-much-1000-invested-in-xylem-10-years-ago-would-be-worth-today", "tags": []}
{"id": 44426913, "time": "2025-03-20 17:15:51", "headline": "Tectonic Therapeutic Expects Cash And Equivalents Of $141.2M As Of December 2024 And February Private Placement Gross Proceeds Of $185M, To Provide Cash Runway Into Q4'28", "summary": "", "symbols": ["TECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44426913/tectonic-therapeutic-expects-cash-and-equivalents-of-141-2m-as-of-december-2024-and-february-private", "tags": ["offering"]}
{"id": 44425100, "time": "2025-03-20 16:13:50", "headline": "Planet Labs Q4 Adj EPS $(0.08) Misses $(0.02) Estimate, Sales $61.55M Miss $61.87M Estimate", "summary": "", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44425100/planet-labs-q4-2024-adj-eps-0-08-misses-0-02-estimate-sales-61-55m-miss-61-87m-estimate", "tags": ["earnings"]}
{"id": 44427048, "time": "2025-03-20 17:22:33", "headline": "Lennar Q1 2025 Adj EPS $2.14 Beats $1.73 Estimate, Sales $7.63B Beat $7.43B Estimate", "summary": "", "symbols": ["LEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427048/lennar-q1-2025-adj-eps-2-14-beats-1-73-estimate-sales-7-63b-beat-7-43b-estimate", "tags": ["earnings"]}
{"id": 44427058, "time": "2025-03-20 17:23:47", "headline": "Lennar Expects Q2 New Orders Of 22,500 - 23,500, Financial Services Operating Earnings Of $135M - $145M", "summary": "", "symbols": ["LEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44427058/lennar-expects-q2-new-orders-of-22-500-23-500-financial-services-operating-earnings-of-135m-145m", "tags": ["earnings"]}
{"id": 44427110, "time": "2025-03-20 17:27:24", "headline": "Planet Labs PBC Expects Revenue Of $61M - $63M For Q1, $260M - $280M For FY26", "summary": "", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44427110/planet-labs-pbc-expects-revenue-of-61m-63m-for-q1-260m-280m-for-fy26", "tags": ["earnings"]}
{"id": 44427152, "time": "2025-03-20 17:30:26", "headline": "$100 Invested In CRH 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["CRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44427152/100-invested-in-crh-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44427172, "time": "2025-03-20 17:31:24", "headline": "Lennar Shares Slide After 'Weakness In The Market' Leads To Lower Sales Prices And Gross Margin", "summary": "Lennar releases its first-quarter results after Thursday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["LEN"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/25/03/44427172/lennar-shares-slide-after-weakness-in-the-market-leads-to-lower-sales-prices-and-gross-margin", "tags": []}
{"id": 44427195, "time": "2025-03-20 17:33:28", "headline": "American Realty Investors Q4 EPS $(0.01) Down From $(0.13) YoY, Total Revenue $12.04M Down From $14.05M YoY", "summary": "", "symbols": ["ARL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427195/american-realty-investors-q4-eps-0-01-down-from-0-13-yoy-total-revenue-12-04m-down-from-14-05m-yoy", "tags": ["earnings"]}
{"id": 44427217, "time": "2025-03-20 17:36:22", "headline": "Transcontinental Realty Q4 EPS $0.01 Up From $(0.30) YoY, Total Revenue $11.79M Down From $13.45M YoY", "summary": "", "symbols": ["TCI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427217/transcontinental-realty-q4-eps-0-01-up-from-0-30-yoy-total-revenue-11-79m-down-from-13-45m-yoy", "tags": ["earnings"]}
{"id": 44427219, "time": "2025-03-20 17:37:40", "headline": "vTv Therapeutics Q4 2024 GAAP EPS $(0.55) Beats $(0.87) Estimate", "summary": "", "symbols": ["VTVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427219/vtv-therapeutics-q4-2024-gaap-eps-0-55-beats-0-87-estimate", "tags": ["earnings"]}
{"id": 44427268, "time": "2025-03-20 17:45:16", "headline": "Here's How Much You Would Have Made Owning KKR Stock In The Last 10 Years", "summary": " ", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44427268/heres-how-much-you-would-have-made-owning-kkr-stock-in-the-last-10-years", "tags": []}
{"id": 44427292, "time": "2025-03-20 17:47:32", "headline": "Eupraxia Pharmaceuticals Q4 Net Profit $(7.5)M Up From $(10.6)M YoY", "summary": "", "symbols": ["EPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427292/eupraxia-pharmaceuticals-q4-net-profit-7-5-m-up-from-10-6-m-yoy", "tags": []}
{"id": 44427425, "time": "2025-03-20 17:49:16", "headline": "Income Opportunity Realty Q4 EPS $0.27 Down From $0.60 YoY", "summary": "", "symbols": ["IOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427425/income-opportunity-realty-q4-eps-0-27-down-from-0-60-yoy", "tags": ["earnings"]}
{"id": 44427488, "time": "2025-03-20 17:58:21", "headline": "Alnylam Secures FDA Approval Of sNDA For Its RNAi Therapeutic, AMVUTTRA, For Treatment Of ATTR-CM In Adults To Reduce Cardiovascular Mortality, Cardiovascular Hospitalizations And Urgent Heart Failure Visits", "summary": "", "symbols": ["ALNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/25/03/44427488/alnylam-secures-fda-approval-of-snda-for-its-rnai-therapeutic-amvuttra-for-treatment-of-attr-cm-in-a", "tags": ["fda"]}
{"id": 44427511, "time": "2025-03-20 18:00:07", "headline": "Elon Musk, Ted Cruz Joke About Cannabis On Podcast: Should I 'Pull Out A Joint' To Boost Ratings?", "summary": "Elon Musk goes on Ted Cruz podcast \u2014 talks his age and 4/20 cannabis holiday; drug-testing after Joe Rogan podcast.", "symbols": [], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/general/entertainment/25/03/44427511/elon-musk-ted-cruz-joke-about-cannabis-on-podcast-should-i-pull-out-a-joint-to-boost-ratings", "tags": []}
{"id": 44427512, "time": "2025-03-20 18:00:10", "headline": "Armata Pharmaceuticals Q4 2024 GAAP EPS $(0.23) Beats $(0.35) Estimate, Sales $1.24M Miss $1.56M Estimate", "summary": "", "symbols": ["ARMP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44427512/armata-pharmaceuticals-q4-2024-gaap-eps-0-23-beats-0-35-estimate-sales-1-24m-miss-1-56m-estimate", "tags": ["earnings"]}
{"id": 44427515, "time": "2025-03-20 18:00:15", "headline": "Here's How Much You Would Have Made Owning SS&C Technologies Hldgs Stock In The Last 15 Years", "summary": " ", "symbols": ["SSNC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44427515/heres-how-much-you-would-have-made-owning-ss-c-technologies-hldgs-stock-in-the-last-15-years", "tags": []}
{"id": 44427516, "time": "2025-03-20 18:00:19", "headline": "Breaking Down Blue Owl Capital: 9 Analysts Share Their Views", "summary": " ", "symbols": ["OWL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44427516/breaking-down-blue-owl-capital-9-analysts-share-their-views", "tags": []}
{"id": 44427518, "time": "2025-03-20 18:00:26", "headline": "Analyst Expectations For Spire's Future", "summary": " ", "symbols": ["SR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44427518/analyst-expectations-for-spires-future", "tags": []}
{"id": 44427525, "time": "2025-03-20 18:00:33", "headline": "Where Allegiant Travel Stands With Analysts", "summary": " ", "symbols": ["ALGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44427525/where-allegiant-travel-stands-with-analysts", "tags": []}
{"id": 44427543, "time": "2025-03-20 18:00:50", "headline": "7 Analysts Have This To Say About Celldex Therapeutics", "summary": " ", "symbols": ["CLDX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44427543/7-analysts-have-this-to-say-about-celldex-therapeutics", "tags": []}
{"id": 44427545, "time": "2025-03-20 18:01:09", "headline": "What Analysts Are Saying About Bridge Investment Group Stock", "summary": " ", "symbols": ["BRDG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44427545/what-analysts-are-saying-about-bridge-investment-group-stock", "tags": []}
{"id": 44427551, "time": "2025-03-20 18:01:21", "headline": "Cigna Group Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)", "summary": " ", "symbols": ["CI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/25/03/44427551/cigna-group-stock-a-deep-dive-into-analyst-perspectives-12-ratings", "tags": []}
{"id": 44427677, "time": "2025-03-20 18:15:16", "headline": "$100 Invested In Eaton Corp 10 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44427677/100-invested-in-eaton-corp-10-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44427895, "time": "2025-03-20 18:30:11", "headline": "Here's How Much $100 Invested In Hilton Worldwide Holdings 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["HLT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44427895/heres-how-much-100-invested-in-hilton-worldwide-holdings-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44428025, "time": "2025-03-20 18:34:36", "headline": "Netflix To Launch First MMO Video Game: Is It The Streaming Company's Biggest Gaming Bet Yet?", "summary": "Netflix announces a new MMO set to be released later this year. Here&#39;s why the launch could be something Netflix investors should keep their eyes on.", "symbols": ["NFLX"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/25/03/44428025/netflix-to-launch-first-mmo-video-game-is-it-the-streaming-companys-biggest-gaming-bet-yet", "tags": []}
{"id": 44428072, "time": "2025-03-20 18:41:30", "headline": "CORRECTION: PDD Holdings Q4 2024 Adj EPS $2.76 Misses $19.81 Estimate, Sales $15.15B Miss $115.38B Estimate", "summary": "", "symbols": ["PDD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/25/03/44428072/correction-pdd-holdings-q4-2024-adj-eps-2-76-misses-19-81-estimate-sales-15-15b-miss-115-38b-estima", "tags": ["earnings"]}
{"id": 44428097, "time": "2025-03-20 18:45:15", "headline": "Here's How Much You Would Have Made Owning Guidewire Software Stock In The Last 10 Years", "summary": " ", "symbols": ["GWRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44428097/heres-how-much-you-would-have-made-owning-guidewire-software-stock-in-the-last-10-years", "tags": []}
{"id": 44428226, "time": "2025-03-20 19:00:12", "headline": "Here's How Much $1000 Invested In Enterprise Prods Partners 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["EPD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44428226/heres-how-much-1000-invested-in-enterprise-prods-partners-5-years-ago-would-be-worth-today", "tags": []}
{"id": 44428362, "time": "2025-03-20 19:15:14", "headline": "$100 Invested In Ventas 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["VTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44428362/100-invested-in-ventas-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 44428409, "time": "2025-03-20 19:30:11", "headline": "Here's How Much You Would Have Made Owning Interactive Brokers Group Stock In The Last 15 Years", "summary": " ", "symbols": ["IBKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44428409/heres-how-much-you-would-have-made-owning-interactive-brokers-group-stock-in-the-last-15-years", "tags": []}
{"id": 44428481, "time": "2025-03-20 19:45:15", "headline": "Here's How Much $1000 Invested In Franco-Nevada 10 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["FNV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/25/03/44428481/heres-how-much-1000-invested-in-franco-nevada-10-years-ago-would-be-worth-today", "tags": []}
{"id": 44428767, "time": "2025-03-20 20:28:34", "headline": "Trump Administration Failed To Respond To Court Order On Deportation Flights: Explain Non-Compliance By Tuesday, Says Judge", "summary": "A federal judge criticized the Trump administration for failing to provide sufficient details on Venezuelan deportation flights and missing a court-ordered deadline.", "symbols": [], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/25/03/44428767/trump-administration-failed-to-respond-to-court-order-on-deportation-flights-explain-non-compliance-by-tuesday-says-judge", "tags": ["legal"]}
{"id": 44429127, "time": "2025-03-20 21:29:49", "headline": "Cathie Wood Bets On Elon Musk's Tesla Despite Cybertruck Recall, Dumps Zuckerberg's Meta Shares Again", "summary": "On Thursday, March 20, 2025, Cathie Wood&#39;s Ark Invest purchases $2.2M in Tesla shares despite Cybertruck recalls and financial concerns, while simultaneously selling $2.7M of Meta stock amid the company&#39;s privacy challenges.", "symbols": ["ARKK", "META", "TSLA"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/25/03/44429127/cathie-wood-bets-on-elon-musks-tesla-despite-cybertruck-recall-dumps-zuckerbergs-meta-shares-again", "tags": []}
{"id": 44429160, "time": "2025-03-20 21:45:36", "headline": "Apple Stock Down Over 12% This Year \u2014 Now Tim Cook Is Reportedly Betting On Vision Pro's Mike Rockwell To Fix Siri After Losing Confidence In AI Boss John Giannandrea", "summary": "Apple CEO Tim Cook has reportedly reassigned Vision Pro chief Mike Rockwell to lead Siri, signaling a major AI leadership shake-up after months of delays and a 12% stock decline shook investor confidence.", "symbols": ["AAPL", "GOOG", "GOOGL", "MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/25/03/44429160/apple-stock-down-over-12-this-year-now-tim-cook-is-reportedly-betting-on-vision-pros-mike-rockwell-to-fix-siri-after-losing-confidence-in-ai-boss-john-giannandrea", "tags": ["management"]}
{"id": 44429282, "time": "2025-03-20 22:00:03", "headline": "Bitcoin, Ethereum, Dogecoin Erase Gains Even As Trump Reiterates 'Crypto Capital' Pledge: Arthur Hayes Says 'Odds Are Shifting More Bullish' For BTC", "summary": "Leading cryptocurrencies pulled back Thursday despite President Donald Trump&#39;s supportive remarks for the industry at an event.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44429282/bitcoin-ethereum-dogecoin-erase-gains-even-as-trump-reiterates-crypto-capital-pledge-arthur-hayes-says-odds-are-shifting-more-bullish-for-btc", "tags": ["analyst_other"]}
{"id": 44429466, "time": "2025-03-20 22:23:45", "headline": "Top 5 Trending Stocks: Nike, Quantum Computing, Fedex, D-Wave Quantum, And Tesla", "summary": "U.S. stocks closed lower on Thursday, with the Dow Jones finishing nearly unchanged at 41,953.32.", "symbols": ["FDX", "NKE", "QBTS", "QUBT", "TSLA"], "source": "benzinga", "author": "Shivdeep Dhaliwal", "url": "https://www.benzinga.com/25/03/44429466/top-5-trending-stocks-nike-quantum-computing-fedex-d-wave-quantum-and-tesla", "tags": []}
{"id": 44429500, "time": "2025-03-20 22:40:27", "headline": "Tesla's Cybertruck Sales At Just 47K Is 'Really Bad' For 250K Target, Says Ross Gerber Amid Recall Troubles", "summary": "Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, highlighted Tesla Inc.&#39;s struggling Cybertruck sales in a recent social media post, noting figures significantly below company projections.", "symbols": ["TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/25/03/44429500/teslas-cybertruck-sales-at-just-47k-is-really-bad-for-250k-target-says-ross-gerber-amid-recall-troubles", "tags": ["management"]}
{"id": 44429523, "time": "2025-03-20 22:47:40", "headline": "Elon Musk's New X Post Sends Kekius Maximus Soaring 75%\u2014Frog-Themed Pepe Also Rallies", "summary": "Kekius Maximus (KEKIUS) meme coin woke up from slumber, skyrocketing over 70% Thursday, after tech mogul Elon Musk posted a photo referencing the cartoon character.", "symbols": ["PEPEUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/03/44429523/elon-musks-new-x-post-sends-kekium-maximus-soaring-75frog-themed-pepe-also-rallies", "tags": []}
{"id": 44429635, "time": "2025-03-20 23:41:44", "headline": "Eminem's Unreleased Music Allegedly Sold Online By Ex-Sound Engineer For $50,000 In Bitcoin", "summary": "A former sound engineer for Grammy award-winning rapper\u00a0Eminem\u00a0has been accused of leaking and selling the artist\u2019s unreleased music for thousands in Bitcoin (CRYPTO: BTC).", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/25/03/44429635/eminems-unreleased-music-sold-online-by-ex-sound-engineer-for-50000-in-bitcoin", "tags": []}
{"id": 44429645, "time": "2025-03-20 23:45:27", "headline": "Perplexity Can Make 'Apple Intelligence Work' Says CEO Aravind Srinivas As iPhone Maker Attracts Criticism On Siri And AI Delays", "summary": "Perplexity AI CEO Aravind Srinivas said on Thursday that &#34;Perplexity will make Apple Intelligence work,&#34; responding to a social media post suggesting the artificial intelligence startup should replace Siri on iPhones.", "symbols": ["AAPL", "AMZN", "GOOG", "GOOGL", "META", "MSFT", "NVDA", "SFTBY"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/25/03/44429645/perplexity-ceo-says-app-will-make-apple-intelligence-work-amid-iphone-makers-ai-challenges", "tags": ["management"]}
{"id": 44429586, "time": "2025-03-20 23:15:15", "headline": "Elon Musk Says 'Hang On To Your Stock' In Surprise Late-Evening Tesla All-Hands Meeting \u2014 Touts 7 Million EVs, Optimus Robot, And AI Supercomputer Dojo (CORRECTED)", "summary": "Elon Musk surprised Tesla employees with a late-night all-hands meeting, unveiling major milestones, AI and robotics updates\u2014including Optimus and Dojo\u2014and urging staff and investors to stay the course despite recent volatility and confusion surrounding the event.", "symbols": ["TSLA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/25/03/44429586/elon-musk-says-hang-on-to-your-stock-in-surprise-late-evening-tesla-all-hands-meeting-touts-7-million-evs-optimus-robot-and-ai-supercomputer-dojo", "tags": []}
{"id": 44410127, "time": "2025-03-20 00:45:52", "headline": "Top Wall Street Forecasters Revamp Darden Restaurants Price Expectations Ahead Of Q3 Earnings", "summary": " ", "symbols": ["DRI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44410127/top-wall-street-forecasters-revamp-darden-restaurants-price-expectations-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 44412265, "time": "2025-03-20 06:05:56", "headline": "Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["AGMH", "AKBA", "BHIL", "BKD", "DEVS", "EFXT", "FIVE", "IMG", "IOBT", "LSE", "MAZE", "MHUA", "MSN", "OPTN", "PRA", "RVSB", "SAG", "VRPX", "YY", "ZCAR"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/25/03/44412265/why-five-below-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
